NCDL 10-Q Quarterly Report Sept. 30, 2024 | Alphaminr
Nuveen Churchill Direct Lending Corp.

NCDL 10-Q Quarter ended Sept. 30, 2024

ncdlc-20240930
0001737924 12/31 FALSE 2024 Q3 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure ncdlc:investment ncdlc:portfolioCompany ncdlc:member 0001737924 2024-01-01 2024-09-30 0001737924 2024-11-05 0001737924 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-09-30 0001737924 us-gaap:InvestmentUnaffiliatedIssuerMember 2023-12-31 0001737924 2024-09-30 0001737924 2023-12-31 0001737924 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-07-01 2024-09-30 0001737924 us-gaap:InvestmentUnaffiliatedIssuerMember 2023-07-01 2023-09-30 0001737924 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-01-01 2024-09-30 0001737924 us-gaap:InvestmentUnaffiliatedIssuerMember 2023-01-01 2023-09-30 0001737924 2024-07-01 2024-09-30 0001737924 2023-07-01 2023-09-30 0001737924 2023-01-01 2023-09-30 0001737924 2024-06-30 0001737924 2023-06-30 0001737924 2022-12-31 0001737924 2023-09-30 0001737924 AEgis Technologies 1 2024-09-30 0001737924 AEgis Technologies 2 2024-09-30 0001737924 Arotech Corporation 2024-09-30 0001737924 Arotech Corporation (Delayed Draw) 2024-09-30 0001737924 BTX Precision 2024-09-30 0001737924 BTX Precision (Delayed Draw) 1 2024-09-30 0001737924 BTX Precision (Delayed Draw) 2 2024-09-30 0001737924 Precision Aviation Group 2024-09-30 0001737924 Precision Aviation Group (Delayed Draw) 2024-09-30 0001737924 Prime Buyer, L.L.C. 2024-09-30 0001737924 Turbine Engine Specialists 1 2024-09-30 0001737924 Valkyrie / Hill Technical Solutions 2024-09-30 0001737924 ncdlc:AerospaceAndDefenseMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Covercraft 1 2024-09-30 0001737924 High Bar Brands 1 2024-09-30 0001737924 High Bar Brands (Delayed Draw) 2024-09-30 0001737924 JEGS Automotive 2024-09-30 0001737924 PGW Auto Glass 1 2024-09-30 0001737924 PGW Auto Glass 2 2024-09-30 0001737924 Randy's Worldwide Automotive 2024-09-30 0001737924 Randy's Worldwide Automotive (Delayed Draw) 2024-09-30 0001737924 S&S Truck Parts 1 2024-09-30 0001737924 S&S Truck Parts 2 2024-09-30 0001737924 S&S Truck Parts (Delayed Draw) 1 2024-09-30 0001737924 S&S Truck Parts (Delayed Draw) 2 2024-09-30 0001737924 S&S Truck Parts 3 2024-09-30 0001737924 us-gaap:AutomotiveSectorMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Ascend 2024-09-30 0001737924 Ascend (Delayed Draw) 2024-09-30 0001737924 Long Term Care Group 2024-09-30 0001737924 Patriot Growth (Delayed Draw) 2024-09-30 0001737924 RSC Acquisition Inc (Delayed Draw) 2024-09-30 0001737924 Vensure 2024-09-30 0001737924 Vensure (Delayed Draw) 2024-09-30 0001737924 World Insurance Associates, LLC 2024-09-30 0001737924 ncdlc:BankingFinanceInsuranceRealEstateMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 AmerCareRoyal 2024-09-30 0001737924 AmerCareRoyal (Delayed Draw) 1 2024-09-30 0001737924 AmerCareRoyal (Delayed Draw) 2 2024-09-30 0001737924 Bardstown Bourbon Company 1 2024-09-30 0001737924 Commercial Bakeries 1 2024-09-30 0001737924 Commercial Bakeries 2 2024-09-30 0001737924 Death Wish Coffee 2024-09-30 0001737924 Dessert Holdings 1 2024-09-30 0001737924 Dessert Holdings 2 2024-09-30 0001737924 Fresh Edge 1 2024-09-30 0001737924 Fresh Edge 2 2024-09-30 0001737924 Fresh Edge 3 2024-09-30 0001737924 Handgards, LLC 2024-09-30 0001737924 KSLB Holdings LLC 2024-09-30 0001737924 Rise Baking 1 2024-09-30 0001737924 Rise Baking (Delayed Draw) 2024-09-30 0001737924 Rise Baking 2 2024-09-30 0001737924 Summit Hill Foods 2024-09-30 0001737924 Sunny Sky Products 2024-09-30 0001737924 Sunny Sky Products (Delayed Draw) 2024-09-30 0001737924 Tech24 1 2024-09-30 0001737924 Tech24 (Delayed Draw) 2024-09-30 0001737924 Watermill Express (Delayed Draw) 1 2024-09-30 0001737924 Watermill Express (Delayed Draw) 2 2024-09-30 0001737924 Watermill Express 1 2024-09-30 0001737924 Watermill Express 2 2024-09-30 0001737924 Watermill Express (Delayed Draw) 3 2024-09-30 0001737924 ncdlc:BeverageFoodTobaccoMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Clean Solutions Buyer 2024-09-30 0001737924 Crete 1 2024-09-30 0001737924 Crete (Delayed Draw) 1 2024-09-30 0001737924 Crete (Delayed Draw) 2 2024-09-30 0001737924 EFC International 2024-09-30 0001737924 E-Technologies / Superior 1 2024-09-30 0001737924 Firstcall Mechanical Group 2024-09-30 0001737924 Firstcall Mechanical Group (Delayed Draw) 2024-09-30 0001737924 Helios Buyer, Inc. 2024-09-30 0001737924 Helios Buyer, Inc. (Delayed Draw) 1 2024-09-30 0001737924 Helios Buyer, Inc. (Delayed Draw) 2 2024-09-30 0001737924 Hyperion 2024-09-30 0001737924 Ovation Holdings 2024-09-30 0001737924 Ovation Holdings (Delayed Draw) 2024-09-30 0001737924 Precision Surfacing Solutions 1 2024-09-30 0001737924 PT Intermediate Holdings III, LLC 2024-09-30 0001737924 PT Intermediate Holdings III, LLC (Delayed Draw) 2024-09-30 0001737924 Rhino Tool House 2024-09-30 0001737924 Rhino Tool House (Delayed Draw) 2024-09-30 0001737924 Service Logic 2024-09-30 0001737924 Vessco 1 2024-09-30 0001737924 Vessco (Delayed Draw) 2024-09-30 0001737924 Vessco 2 2024-09-30 0001737924 ncdlc:CapitalEquipmentMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Ascensus 2024-09-30 0001737924 Boulder Scientific Company LLC 2024-09-30 0001737924 Chroma Color 2024-09-30 0001737924 Chroma Color (Delayed Draw) 2024-09-30 0001737924 Spartech 2024-09-30 0001737924 ncdlc:ChemicalsPlasticsRubberMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Allstar Holdings 2024-09-30 0001737924 Allstar Holdings (Delayed Draw) 1 2024-09-30 0001737924 Allstar Holdings (Delayed Draw) 2 2024-09-30 0001737924 Erie Construction 1 2024-09-30 0001737924 Gannett Fleming 1 2024-09-30 0001737924 Gannett Fleming 2 2024-09-30 0001737924 Heartland Paving Partners (Delayed Draw) 1 2024-09-30 0001737924 Heartland Paving Partners (Delayed Draw) 2 2024-09-30 0001737924 Heartland Paving Partners 2024-09-30 0001737924 ICE USA Infrastructure LLC 2024-09-30 0001737924 MEI Buyer LLC 2024-09-30 0001737924 MEI Buyer LLC (Delayed Draw) 2024-09-30 0001737924 RMA Companies (Delayed Draw) 1 2024-09-30 0001737924 RMA Companies (Delayed Draw) 2 2024-09-30 0001737924 RMA Companies 2024-09-30 0001737924 Sciens Building Solutions, LLC 2024-09-30 0001737924 Sciens Building Solutions, LLC (Delayed Draw) 2024-09-30 0001737924 WSB / EST 2024-09-30 0001737924 WSB / EST (Delayed Draw) 2024-09-30 0001737924 ncdlc:ConstructionBuildingMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Halo Buyer, Inc. 2024-09-30 0001737924 SmartSign 1 2024-09-30 0001737924 SmartSign 2 2024-09-30 0001737924 ncdlc:ConsumerGoodsDurableMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 ACP Tara Holdings, Inc. 1 2024-09-30 0001737924 ACP Tara Holdings, Inc. 2 2024-09-30 0001737924 Elevation Labs 2024-09-30 0001737924 Elevation Labs (Delayed Draw) 2024-09-30 0001737924 FoodScience LLC 2024-09-30 0001737924 Market Performance Group 2024-09-30 0001737924 Market Performance Group (Delayed Draw) 2024-09-30 0001737924 PIP 2024-09-30 0001737924 Ultima 1 2024-09-30 0001737924 ncdlc:ConsumerGoodsNonDurableMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 B2B/AMW Acquisition Company, Inc. 1 2024-09-30 0001737924 B2B/AMW Acquisition Company, Inc. 2 2024-09-30 0001737924 Five Star Packaging 2024-09-30 0001737924 Good2Grow 1 2024-09-30 0001737924 Good2Grow 2 2024-09-30 0001737924 Good2Grow 3 2024-09-30 0001737924 Oliver Inc 1 2024-09-30 0001737924 Oliver Inc 2 2024-09-30 0001737924 Online Labels Group 2024-09-30 0001737924 Online Labels Group (Delayed Draw) 1 2024-09-30 0001737924 Online Labels Group (Delayed Draw) 2 2024-09-30 0001737924 Specialized Packaging Group (SPG) 1 2024-09-30 0001737924 Specialized Packaging Group (SPG) 2 2024-09-30 0001737924 Specialized Packaging Group (SPG) 3 2024-09-30 0001737924 Specialized Packaging Group (SPG) 4 2024-09-30 0001737924 Specialized Packaging Group (SPG) 5 2024-09-30 0001737924 ncdlc:ContainersPackagingAndGlassMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Insulation Technology Group 2024-09-30 0001737924 Insulation Technology Group (Delayed Draw) 2024-09-30 0001737924 MGM Transformer Company 2024-09-30 0001737924 MGM Transformer Company (Delayed Draw) 2024-09-30 0001737924 National Power 2024-09-30 0001737924 National Power (Delayed Draw) 2024-09-30 0001737924 ncdlc:EnergyElectricityMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 101 Inc 2024-09-30 0001737924 Contract Land Staff 2024-09-30 0001737924 Contract Land Staff (Delayed Draw) 1 2024-09-30 0001737924 Contract Land Staff (Delayed Draw) 2 2024-09-30 0001737924 Impact Environmental Group 1 2024-09-30 0001737924 Impact Environmental Group (Delayed Draw) 1 2024-09-30 0001737924 Impact Environmental Group (Delayed Draw) 2 2024-09-30 0001737924 Impact Environmental Group 2 2024-09-30 0001737924 Leo Facilities 1 2024-09-30 0001737924 Leo Facilities (Delayed Draw) 1 2024-09-30 0001737924 Leo Facilities 2 2024-09-30 0001737924 Leo Facilities (Delayed Draw) 2 2024-09-30 0001737924 SI Solutions 2024-09-30 0001737924 SI Solutions (Delayed Draw) 2024-09-30 0001737924 The Facilities Group 1 2024-09-30 0001737924 The Facilities Group 2 2024-09-30 0001737924 The Facilities Group (Delayed Draw) 1 2024-09-30 0001737924 The Facilities Group (Delayed Draw) 2 2024-09-30 0001737924 ncdlc:EnvironmentalIndustriesMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Action Behavior Centers 2024-09-30 0001737924 Action Behavior Centers (Delayed Draw) 2024-09-30 0001737924 Affinity Hospice 2024-09-30 0001737924 Anne Arundel 1 2024-09-30 0001737924 Anne Arundel (Delayed Draw) 2024-09-30 0001737924 Anne Arundel 2 2024-09-30 0001737924 Anne Arundel 3 2024-09-30 0001737924 Coding Solutions Acquisition Inc. 1 2024-09-30 0001737924 Coding Solutions Acquisition Inc. (Delayed Draw) 2024-09-30 0001737924 Coding Solutions Acquisition Inc. 2 2024-09-30 0001737924 EyeSouth 2024-09-30 0001737924 EyeSouth (Delayed Draw) 2024-09-30 0001737924 Forefront Dermatology 2024-09-30 0001737924 Genesee Scientific LLC 2024-09-30 0001737924 Genesee Scientific LLC (Delayed Draw) 2024-09-30 0001737924 GHR Healthcare 1 2024-09-30 0001737924 GHR Healthcare (Delayed Draw) 1 2024-09-30 0001737924 GHR Healthcare (Delayed Draw) 2 2024-09-30 0001737924 GHR Healthcare (Delayed Draw) 3 2024-09-30 0001737924 GHR Healthcare 2 2024-09-30 0001737924 GHR Healthcare 3 2024-09-30 0001737924 GHR Healthcare 4 2024-09-30 0001737924 Health Management Associates 1 2024-09-30 0001737924 Health Management Associates (Delayed Draw) 2024-09-30 0001737924 Heartland Veterinary Partners (Delayed Draw) 1 2024-09-30 0001737924 Heartland Veterinary Partners (Delayed Draw) 2 2024-09-30 0001737924 Heartland Veterinary Partners 2024-09-30 0001737924 HemaSource 1 2024-09-30 0001737924 Infucare 2024-09-30 0001737924 Midwest Eye Services, LLC 2024-09-30 0001737924 Mosaic Dental 1 2024-09-30 0001737924 Mosaic Dental (Delayed Draw) 2024-09-30 0001737924 Prime Time Healthcare 1 2024-09-30 0001737924 Prime Time Healthcare 2 2024-09-30 0001737924 Prompt Care (Delayed Draw) 1 2024-09-30 0001737924 Prompt Care 2024-09-30 0001737924 Prompt Care (Delayed Draw) 2 2024-09-30 0001737924 QHR Holdco, Inc. 1 2024-09-30 0001737924 QHR Holdco, Inc. (Delayed Draw) 2024-09-30 0001737924 QHR Holdco, Inc. 2 2024-09-30 0001737924 Smile Brands 2024-09-30 0001737924 Solis Mammography 2024-09-30 0001737924 Southern Veterinary Partners 2024-09-30 0001737924 Team Services Group 2024-09-30 0001737924 Thorne HealthTech 2024-09-30 0001737924 TIDI Products 2024-09-30 0001737924 TIDI Products (Delayed Draw) 2024-09-30 0001737924 US Fertility 2024-09-30 0001737924 VMG Health 2024-09-30 0001737924 Wellspring 1 2024-09-30 0001737924 Wellspring 2 2024-09-30 0001737924 Wellspring (Delayed Draw) 1 2024-09-30 0001737924 Wellspring (Delayed Draw) 2 2024-09-30 0001737924 Wellspring 3 2024-09-30 0001737924 Young Innovations 2024-09-30 0001737924 Young Innovations (Delayed Draw) 2024-09-30 0001737924 ncdlc:HealthcareAndPharmaceuticalsMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 AQ Holdco Inc. (Delayed Draw) 1 2024-09-30 0001737924 AQ Holdco Inc. (Delayed Draw) 2 2024-09-30 0001737924 AQ Holdco Inc. (Delayed Draw) 3 2024-09-30 0001737924 Diligent Corporation (Delayed Draw) 2024-09-30 0001737924 Diligent Corporation 1 2024-09-30 0001737924 Diligent Corporation 2 2024-09-30 0001737924 Eliassen Group, LLC 2024-09-30 0001737924 Eliassen Group, LLC (Delayed Draw) 2024-09-30 0001737924 Evergreen Services Group II 2024-09-30 0001737924 Evergreen Services Group II (Delayed Draw) 2024-09-30 0001737924 Exterro, Inc. 2024-09-30 0001737924 FineLine 2024-09-30 0001737924 Go Engineer 1 2024-09-30 0001737924 Go Engineer (Delayed Draw) 2024-09-30 0001737924 Go Engineer 2 2024-09-30 0001737924 Infobase 2024-09-30 0001737924 ITSavvy 1 2024-09-30 0001737924 North Haven CS Acquisition Inc 1 2024-09-30 0001737924 North Haven CS Acquisition Inc 2 2024-09-30 0001737924 Options IT 1 2024-09-30 0001737924 Options IT (Delayed Draw) 2024-09-30 0001737924 Options IT 2 2024-09-30 0001737924 Prosci, Inc. 2024-09-30 0001737924 Quickbase 2024-09-30 0001737924 SmartWave 2024-09-30 0001737924 Solve Industrial 1 2024-09-30 0001737924 Solve Industrial 2 2024-09-30 0001737924 Solve Industrial (Delayed Draw) 2024-09-30 0001737924 Velosio 2024-09-30 0001737924 Velosio (Delayed Draw) 2024-09-30 0001737924 ncdlc:HighTechIndustriesMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Tinuiti 2024-09-30 0001737924 Tinuiti (Delayed Draw) 2024-09-30 0001737924 Tinuiti (Delayed Draw) (Incremental) 2024-09-30 0001737924 Wpromote 2024-09-30 0001737924 Wpromote (Delayed Draw) 2024-09-30 0001737924 ncdlc:MediaAdvertisingPrintingPublishingMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 BroadcastMed 1 2024-09-30 0001737924 CVI Parent, Inc. 1 2024-09-30 0001737924 CVI Parent, Inc. 2 2024-09-30 0001737924 Spectrio 2024-09-30 0001737924 Spectrio (Delayed Draw) 1 2024-09-30 0001737924 Spectrio (Delayed Draw) 2 2024-09-30 0001737924 ncdlc:MediaDiversifiedProductionMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Syndigo 2024-09-30 0001737924 us-gaap:RetailSectorMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 ALKU 2024-09-30 0001737924 ARMstrong 2024-09-30 0001737924 ARMstrong (Delayed Draw) 2024-09-30 0001737924 Bounteous 1 2024-09-30 0001737924 Bounteous 2 2024-09-30 0001737924 Bounteous (Delayed Draw) 1 2024-09-30 0001737924 Bounteous (Delayed Draw) 2 2024-09-30 0001737924 Bullhorn 2024-09-30 0001737924 BusinesSolver 2024-09-30 0001737924 BusinesSolver (Delayed Draw) 2024-09-30 0001737924 Caldwell & Gregory 2024-09-30 0001737924 Career Now 1 2024-09-30 0001737924 Cornerstone Advisors of Arizona, LLC 1 2024-09-30 0001737924 Cornerstone Advisors of Arizona, LLC 2 2024-09-30 0001737924 Cornerstone Advisors of Arizona, LLC (Delayed Draw) 2024-09-30 0001737924 Cornerstone Advisors of Arizona, LLC 3 2024-09-30 0001737924 CrossCountry Consulting 2024-09-30 0001737924 CrossCountry Consulting (Delayed Draw) 2024-09-30 0001737924 D&H United Fueling Solutions 1 2024-09-30 0001737924 D&H United Fueling Solutions (Delayed Draw) 1 2024-09-30 0001737924 D&H United Fueling Solutions (Delayed Draw) 2 2024-09-30 0001737924 D&H United Fueling Solutions 2 2024-09-30 0001737924 D&H United Fueling Solutions (Delayed Draw) 3 2024-09-30 0001737924 E78 1 2024-09-30 0001737924 E78 2 2024-09-30 0001737924 E78 (Delayed Draw) 1 2024-09-30 0001737924 E78 (Delayed Draw) 2 2024-09-30 0001737924 E78 (Delayed Draw) 3 2024-09-30 0001737924 Engage 2024-09-30 0001737924 Engage (Delayed Draw) 1 2024-09-30 0001737924 Engage (Delayed Draw) 2 2024-09-30 0001737924 Esquire Deposition Services 1 2024-09-30 0001737924 Evergreen Services Group 2024-09-30 0001737924 Evergreen Services Group (Delayed Draw) 2024-09-30 0001737924 Gabriel Partners, LLC 1 2024-09-30 0001737924 Gabriel Partners, LLC (Delayed Draw) 2024-09-30 0001737924 Gabriel Partners, LLC 2 2024-09-30 0001737924 Image First 2024-09-30 0001737924 Integrated Power Services (Delayed Draw) 2024-09-30 0001737924 Integrated Power Services 2024-09-30 0001737924 Lion Merger Sub, Inc. 1 2024-09-30 0001737924 Lion Merger Sub, Inc. 2 2024-09-30 0001737924 LSCS Holdings, Inc. (Dohmen) 2024-09-30 0001737924 LYNX FRANCHISING, LLC 1 2024-09-30 0001737924 LYNX FRANCHISING, LLC 2 2024-09-30 0001737924 Output Services Group, Inc. 1 2024-09-30 0001737924 Output Services Group, Inc. 2 2024-09-30 0001737924 Phaidon 2024-09-30 0001737924 PLZ Aeroscience 2024-09-30 0001737924 Press Ganey 2024-09-30 0001737924 Propark Mobility 2024-09-30 0001737924 Propark Mobility (Delayed Draw) 1 2024-09-30 0001737924 Propark Mobility (Delayed Draw) 2 2024-09-30 0001737924 Province 2024-09-30 0001737924 Riveron 1 2024-09-30 0001737924 Riveron (Delayed Draw) 2024-09-30 0001737924 Safety Infrastructure Services 2024-09-30 0001737924 Scaled Agile 2024-09-30 0001737924 Scaled Agile (Delayed Draw) 2024-09-30 0001737924 System One 2024-09-30 0001737924 Technical Safety Services 1 2024-09-30 0001737924 Technical Safety Services (Delayed Draw) 2024-09-30 0001737924 Technical Safety Services 2 2024-09-30 0001737924 Trilon Group 2024-09-30 0001737924 Trilon Group (Delayed Draw) 2024-09-30 0001737924 Vistage 2024-09-30 0001737924 Vital Records Control 1 2024-09-30 0001737924 Vital Records Control 2 2024-09-30 0001737924 ncdlc:ServicesBusinessMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 360 Training 2024-09-30 0001737924 360 Training (Delayed Draw) 2024-09-30 0001737924 All My Sons 2024-09-30 0001737924 Apex Services (Delayed Draw) 1 2024-09-30 0001737924 Apex Services (Delayed Draw) 2 2024-09-30 0001737924 Apex Services 1 2024-09-30 0001737924 Apex Services 2 2024-09-30 0001737924 Excel Fitness 2024-09-30 0001737924 Excel Fitness (Delayed Draw) 2024-09-30 0001737924 Fairway Lawns 2024-09-30 0001737924 Fairway Lawns (Delayed Draw) 1 2024-09-30 0001737924 Fairway Lawns (Delayed Draw) 2 2024-09-30 0001737924 Legacy Service Partners 1 2024-09-30 0001737924 Legacy Service Partners (Delayed Draw) 2024-09-30 0001737924 Liberty Group 2024-09-30 0001737924 Liberty Group (Delayed Draw) 2024-09-30 0001737924 NearU 1 2024-09-30 0001737924 NearU (Delayed Draw) 1 2024-09-30 0001737924 NearU (Delayed Draw) 2 2024-09-30 0001737924 NearU (Delayed Draw) 3 2024-09-30 0001737924 NJEye, LLC 1 2024-09-30 0001737924 NJEye, LLC (Delayed Draw) 1 2024-09-30 0001737924 NJEye, LLC (Delayed Draw) 2 2024-09-30 0001737924 NJEye, LLC 2 2024-09-30 0001737924 North Haven Spartan US Holdco LLC 2024-09-30 0001737924 North Haven Spartan US Holdco LLC (Delayed Draw) 1 2024-09-30 0001737924 North Haven Spartan US Holdco LLC (Delayed Draw) 2 2024-09-30 0001737924 One World Fitness PFF, LLC 2024-09-30 0001737924 Palmetto Exterminators 1 2024-09-30 0001737924 Palmetto Exterminators (Delayed Draw) 2024-09-30 0001737924 Perennial Services Group 1 2024-09-30 0001737924 Perennial Services Group (Delayed Draw) 2024-09-30 0001737924 Repipe Specialists 1 2024-09-30 0001737924 Repipe Specialists (Delayed Draw) 2024-09-30 0001737924 us-gaap:ConsumerSectorMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 LMI 1 2024-09-30 0001737924 ncdlc:SovereignAndPublicFinanceMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 BCM One 2024-09-30 0001737924 BCM One (Delayed Draw) 2024-09-30 0001737924 MBS Holdings, Inc. 1 2024-09-30 0001737924 MBS Holdings, Inc. 2 2024-09-30 0001737924 MBS Holdings, Inc. 3 2024-09-30 0001737924 Mobile Communications America Inc 2024-09-30 0001737924 Mobile Communications America Inc (Delayed Draw) 2024-09-30 0001737924 Sapphire Telecom Inc 2024-09-30 0001737924 Tyto Athene 2024-09-30 0001737924 ncdlc:TelecommunicationsMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Armstrong Transport Group 1 2024-09-30 0001737924 Armstrong Transport Group 2 2024-09-30 0001737924 Kamps Pallets 2024-09-30 0001737924 Kenco 2024-09-30 0001737924 Kenco (Delayed Draw) 1 2024-09-30 0001737924 Kenco (Delayed Draw) 2 2024-09-30 0001737924 Quantix SCS, LLC 1 2024-09-30 0001737924 Quantix SCS, LLC 2 2024-09-30 0001737924 Quantix SCS, LLC 3 2024-09-30 0001737924 Quantix SCS, LLC 4 2024-09-30 0001737924 Quantix SCS, LLC 5 2024-09-30 0001737924 RoadOne 1 2024-09-30 0001737924 Seko Global Logistics LLC 1 2024-09-30 0001737924 Seko Global Logistics LLC 2 2024-09-30 0001737924 Seko Global Logistics LLC 3 2024-09-30 0001737924 Seko Global Logistics LLC (Delayed Draw) 1 2024-09-30 0001737924 Seko Global Logistics LLC (Delayed Draw) 2 2024-09-30 0001737924 Seko Global Logistics LLC 4 2024-09-30 0001737924 TI Acquisition NC, LLC 2024-09-30 0001737924 ncdlc:TransportationCargoMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Alternative Logistics Technologies Buyer, LLC 2024-09-30 0001737924 Alternative Logistics Technologies Buyer, LLC (Delayed Draw) 2024-09-30 0001737924 American Student Transportation Partners 1 2024-09-30 0001737924 ncdlc:TransportationConsumerMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 CRCI Holdings Inc 1 2024-09-30 0001737924 CRCI Holdings Inc (Delayed Draw) 2024-09-30 0001737924 CRCI Holdings Inc 2 2024-09-30 0001737924 DMC Power 2024-09-30 0001737924 DMC Power (Delayed Draw) 2024-09-30 0001737924 Pinnacle Supply Partners, LLC 1 2024-09-30 0001737924 Pinnacle Supply Partners, LLC (Delayed Draw) 2024-09-30 0001737924 ncdlc:UtilitiesElectricMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 USA Water 1 2024-09-30 0001737924 USA Water (Delayed Draw) 2024-09-30 0001737924 ncdlc:UtilitiesWaterMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Ergotech (INS) 2024-09-30 0001737924 Ergotech (INS) (Delayed Draw) 2024-09-30 0001737924 Industrial Service Group 2024-09-30 0001737924 Industrial Service Group (Delayed Draw) 2024-09-30 0001737924 Micronics 2024-09-30 0001737924 TPC Wire & Cable Corp 2024-09-30 0001737924 TPC Wire & Cable Corp (Delayed Draw) 1 2024-09-30 0001737924 TPC Wire & Cable Corp (Delayed Draw) 2 2024-09-30 0001737924 ncdlc:WholesaleMember us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 us-gaap:DebtSecuritiesMember 2024-09-30 0001737924 Turbine Engine Specialists 2 2024-09-30 0001737924 ncdlc:AerospaceAndDefenseMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Covercraft 2024-09-30 0001737924 High Bar Brands 2024-09-30 0001737924 S&S Truck Parts 4 2024-09-30 0001737924 S&S Truck Parts 5 2024-09-30 0001737924 S&S Truck Parts 6 2024-09-30 0001737924 S&S Truck Parts 7 2024-09-30 0001737924 us-gaap:AutomotiveSectorMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Bardstown Bourbon Company 2024-09-30 0001737924 Fresh Edge 4 2024-09-30 0001737924 Fresh Edge 5 2024-09-30 0001737924 Tech24 2024-09-30 0001737924 ncdlc:BeverageFoodTobaccoMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Crete 2024-09-30 0001737924 EFC International 1 2024-09-30 0001737924 EFC International 2 2024-09-30 0001737924 E-Technologies / Superior 2024-09-30 0001737924 Precision Surfacing Solutions 2024-09-30 0001737924 ncdlc:CapitalEquipmentMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Erie Construction 2024-09-30 0001737924 Gannett Fleming 3 2024-09-30 0001737924 Gannett Fleming 4 2024-09-30 0001737924 ncdlc:ConstructionBuildingMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 FoodScience LLC 1 2024-09-30 0001737924 FoodScience LLC 2 2024-09-30 0001737924 Ultima 2024-09-30 0001737924 ncdlc:ConsumerGoodsNonDurableMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Oliver Inc 2024-09-30 0001737924 Specialized Packaging Group (SPG) 2024-09-30 0001737924 ncdlc:ContainersPackagingAndGlassMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Anne Arundel 2024-09-30 0001737924 Health Management Associates 2024-09-30 0001737924 HemaSource 2024-09-30 0001737924 Mosaic Dental 2024-09-30 0001737924 ncdlc:HealthcareAndPharmaceuticalsMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 ITSavvy 2 2024-09-30 0001737924 Solve Industrial 2024-09-30 0001737924 ncdlc:HighTechIndustriesMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 BroadcastMed 2024-09-30 0001737924 ncdlc:MediaDiversifiedProductionMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Apex Companies 2024-09-30 0001737924 Career Now 2 2024-09-30 0001737924 Career Now 3 2024-09-30 0001737924 E78 2024-09-30 0001737924 Esquire Deposition Services 2024-09-30 0001737924 Output Services Group, Inc. 2024-09-30 0001737924 Riveron 2024-09-30 0001737924 ncdlc:ServicesBusinessMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Legacy Service Partners 2024-09-30 0001737924 NearU 2024-09-30 0001737924 Palmetto Exterminators 2024-09-30 0001737924 Perennial Services Group 2024-09-30 0001737924 Repipe Specialists 2024-09-30 0001737924 us-gaap:ConsumerSectorMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 LMI 2 2024-09-30 0001737924 ncdlc:SovereignAndPublicFinanceMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 RoadOne 2024-09-30 0001737924 Seko Global Logistics LLC 2024-09-30 0001737924 ncdlc:TransportationCargoMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 American Student Transportation Partners 2024-09-30 0001737924 ncdlc:TransportationConsumerMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 Pinnacle Supply Partners, LLC 2024-09-30 0001737924 ncdlc:UtilitiesElectricMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 USA Water 2024-09-30 0001737924 ncdlc:UtilitiesWaterMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 BlackRock Liquidity Funds T-Fund - Institutional Class 2024-09-30 0001737924 First American Government Obligations Fund - Class Z 2024-09-30 0001737924 us-gaap:CashEquivalentsMember 2024-09-30 0001737924 ncdlc:OneMonthSOFRMember 2024-09-30 0001737924 ncdlc:ThreeMonthSOFRMember 2024-09-30 0001737924 ncdlc:SixMonthSOFRMember 2024-09-30 0001737924 ncdlc:TwelveMonthSOFRMember 2024-09-30 0001737924 ncdlc:RestrictedSecurityMember 2024-09-30 0001737924 ncdlc:QualifyingAssetsMember 2024-09-30 0001737924 ncdlc:NonQualifyingAssetsMember 2024-09-30 0001737924 AEgis Technologies 2023-12-31 0001737924 Arotech 2023-12-31 0001737924 Arotech (Delayed Draw) 2023-12-31 0001737924 Loc Performance Products 2023-12-31 0001737924 Precision Aviation Group 2023-12-31 0001737924 Precision Aviation Group (Delayed Draw) 2023-12-31 0001737924 Turbine Engine Specialist, Inc 2023-12-31 0001737924 Valkyrie 2023-12-31 0001737924 ncdlc:AerospaceAndDefenseMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 American Auto Auction Group 2023-12-31 0001737924 Classic Collision (Delayed Draw) (Incremental Tranche A-4) 2023-12-31 0001737924 Classic Collision (Delayed Draw) (Incremental) 2023-12-31 0001737924 Classic Collision (Incremental) 2023-12-31 0001737924 Collision Right 1 2023-12-31 0001737924 Collision Right 2 2023-12-31 0001737924 Collision Right (Delayed Draw) 2023-12-31 0001737924 Covercraft 2023-12-31 0001737924 Covercraft (Delayed Draw) 2023-12-31 0001737924 High Bar Brands 2023-12-31 0001737924 High Bar Brands (Delayed Draw) 2023-12-31 0001737924 JEGS Automotive 2023-12-31 0001737924 OEP Glass Purchaser 2023-12-31 0001737924 Randys Holdings, Inc 2023-12-31 0001737924 Randys Holdings, Inc (Delayed Draw) 2023-12-31 0001737924 S&S Truck Parts 1 2023-12-31 0001737924 S&S Truck Parts 2 2023-12-31 0001737924 S&S Truck Parts (Delayed Draw) 1 2023-12-31 0001737924 S&S Truck Parts (Delayed Draw) 2 2023-12-31 0001737924 us-gaap:AutomotiveSectorMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Coding Solutions Acquisitions 2023-12-31 0001737924 Coding Solutions Acquisitions (Delayed Draw) 2023-12-31 0001737924 Long Term Care Group 2023-12-31 0001737924 Patriot Growth Insurance Service (Delayed Draw) (Incremental) 2023-12-31 0001737924 Risk Strategies (Delayed Draw) 2023-12-31 0001737924 Vensure Employer Services 2023-12-31 0001737924 World Insurance Associates (Delayed Draw) 2023-12-31 0001737924 ncdlc:BankingFinanceInsuranceRealEstateMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries) 2023-12-31 0001737924 Bardstown PPC Holdings LLC 2023-12-31 0001737924 Death Wish Coffee 2023-12-31 0001737924 Dessert Holdings 2023-12-31 0001737924 Fresh Edge 2023-12-31 0001737924 Fresh Edge (Incremental) 1 2023-12-31 0001737924 Fresh Edge (Incremental) 2 2023-12-31 0001737924 Handgards 2023-12-31 0001737924 Harvest Hill Beverage Company 2023-12-31 0001737924 KSLB Holdings LLC 2023-12-31 0001737924 Palmetto Acquisitionco, Inc. 2023-12-31 0001737924 Palmetto Acquisitionco, Inc. (Delayed Draw) 2023-12-31 0001737924 Rise Baking 2023-12-31 0001737924 Rise Baking (Delayed Draw) 2023-12-31 0001737924 Summit Hill Foods 2023-12-31 0001737924 Sunny Sky Products (Delayed Draw) 2023-12-31 0001737924 Sunny Sky Products 2023-12-31 0001737924 Watermill Express, LLC 2023-12-31 0001737924 Watermill Express, LLC (Delayed Draw) 2023-12-31 0001737924 ncdlc:BeverageFoodTobaccoMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Crete Mechanical Group 2023-12-31 0001737924 Crete Mechanical Group (Delayed Draw) 1 2023-12-31 0001737924 Crete Mechanical Group (Delayed Draw) 2 2023-12-31 0001737924 EFC Holdings, LLC 2023-12-31 0001737924 Heartland Home Services 2023-12-31 0001737924 Heartland Home Services (Delayed Draw) 1 2023-12-31 0001737924 Heartland Home Services (Delayed Draw) 2 2023-12-31 0001737924 Ovation Holdings, Inc. 2023-12-31 0001737924 Ovation Holdings, Inc. (Delayed Draw) 2023-12-31 0001737924 Precision Surfacing 2023-12-31 0001737924 PT Intermediate Holdings III, LLC 2023-12-31 0001737924 PT Intermediate Holdings III, LLC (Incremental) 2023-12-31 0001737924 Repipe Specialists 2023-12-31 0001737924 Repipe Specialists (Delayed Draw) 2023-12-31 0001737924 RTH Buyer LLC (dba Rhino Tool House) 2023-12-31 0001737924 RTH Buyer LLC (dba Rhino Tool House) (Delayed Draw) 2023-12-31 0001737924 ncdlc:CapitalEquipmentMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Ascensus 2023-12-31 0001737924 Ascensus Specialties 2023-12-31 0001737924 Boulder Scientific Company LLC 2023-12-31 0001737924 Chroma Color Corporation (dba Chroma Color) 2023-12-31 0001737924 Chroma Color Corporation (dba Chroma Color) (Delayed Draw) 2023-12-31 0001737924 Spartech 2023-12-31 0001737924 ncdlc:ChemicalsPlasticsRubberMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Allstar Holdings 2023-12-31 0001737924 Allstar Holdings (Delayed Draw) 1 2023-12-31 0001737924 Allstar Holdings (Delayed Draw) 2 2023-12-31 0001737924 Erie Construction 2023-12-31 0001737924 Gannett Fleming 2023-12-31 0001737924 MEI Rigging & Crating 2023-12-31 0001737924 MEI Rigging & Crating (Delayed Draw) 2023-12-31 0001737924 Royal Holdco Corporation (Delayed Draw A) 2023-12-31 0001737924 Royal Holdco Corporation (Delayed Draw B) 2023-12-31 0001737924 Royal Holdco Corporation (Incremental) 2023-12-31 0001737924 Sciens Building Solutions, LLC 2023-12-31 0001737924 Sciens Building Solutions, LLC (Delayed Draw) 2023-12-31 0001737924 WSB Engineering Holdings Inc. 2023-12-31 0001737924 WSB Engineering Holdings Inc. (Delayed Draw) 2023-12-31 0001737924 ncdlc:ConstructionBuildingMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Halo Buyer Inc 2023-12-31 0001737924 Petmate 2023-12-31 0001737924 Xpressmyself.com LLC (a/k/a SmartSign) 1 2023-12-31 0001737924 Xpressmyself.com LLC (a/k/a SmartSign) 2 2023-12-31 0001737924 ncdlc:ConsumerGoodsDurableMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Arcadia Consumer Health 2023-12-31 0001737924 Arcadia Consumer Health (Incremental) 2023-12-31 0001737924 Badger Sportswear Acquisition Inc 2023-12-31 0001737924 FoodScience 1 2023-12-31 0001737924 FoodScience 2 2023-12-31 0001737924 Protective Industrial Products (“PIP”) 2023-12-31 0001737924 Elevation Labs 2023-12-31 0001737924 Elevation Labs (Delayed Draw) 2023-12-31 0001737924 Market Performance Group 1 2023-12-31 0001737924 Market Performance Group 2 2023-12-31 0001737924 Ultima Health Holdings, LLC 2023-12-31 0001737924 ncdlc:ConsumerGoodsNonDurableMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 B2B Packaging 2023-12-31 0001737924 B2B Packaging (Delayed Draw) 2023-12-31 0001737924 Five Star Packing 2023-12-31 0001737924 Good2Grow 1 2023-12-31 0001737924 Good2Grow 2 2023-12-31 0001737924 Oliver Packaging 2023-12-31 0001737924 Online Labels Group 2023-12-31 0001737924 Online Labels Group (Delayed Draw) 1 2023-12-31 0001737924 Online Labels Group (Delayed Draw) 2 2023-12-31 0001737924 Specialized Packaging Group 1 2023-12-31 0001737924 Specialized Packaging Group 2 2023-12-31 0001737924 Specialized Packaging Group (Incremental) 1 2023-12-31 0001737924 Specialized Packaging Group (Incremental) 2 2023-12-31 0001737924 ncdlc:ContainersPackagingAndGlassMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 MGM Transformer Company (Delayed Draw) 2023-12-31 0001737924 MGM Transformer Company 2023-12-31 0001737924 National Power 2023-12-31 0001737924 National Power (Delayed Draw) 2023-12-31 0001737924 ncdlc:EnergyElectricityMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Impact Environmental Group 2023-12-31 0001737924 Impact Environmental Group (Delayed Draw) 2023-12-31 0001737924 Impact Environmental Group (Incremental) 2023-12-31 0001737924 Impact Environmental Group (Delayed Draw) (Incremental) 2023-12-31 0001737924 Nutrition 101 Buyer LLC (a/k/a 101, Inc.) 2023-12-31 0001737924 Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) 2023-12-31 0001737924 Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw) 2023-12-31 0001737924 The Facilities Group 1 2023-12-31 0001737924 The Facilities Group (Delayed Draw) 1 2023-12-31 0001737924 The Facilities Group 2 2023-12-31 0001737924 The Facilities Group (Delayed Draw) 2 2023-12-31 0001737924 ncdlc:EnvironmentalIndustriesMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Affinity Hospice 2023-12-31 0001737924 Anne Arundel 1 2023-12-31 0001737924 Anne Arundel 2 2023-12-31 0001737924 Anne Arundel (Delayed Draw) 2023-12-31 0001737924 Forefront Dermatology 2023-12-31 0001737924 Genesee Scientific 2023-12-31 0001737924 Genesee Scientific (Delayed Draw) 2023-12-31 0001737924 GHR Healthcare 2023-12-31 0001737924 GHR Healthcare (Delayed Draw) 2023-12-31 0001737924 GHR Healthcare (Incremental) 2023-12-31 0001737924 Health Management Associates 2023-12-31 0001737924 Health Management Associates (Delayed Draw) 2023-12-31 0001737924 Heartland Veterinary Partners LLC (Incremental) 2023-12-31 0001737924 Heartland Veterinary Partners LLC (Incremental) (Delayed Draw) 2023-12-31 0001737924 HemaSource Inc. 2023-12-31 0001737924 InfuCare RX 2023-12-31 0001737924 MDC Intermediate Holdings II, LLC 2023-12-31 0001737924 MDC Intermediate Holdings II, LLC (Delayed Draw) 2023-12-31 0001737924 Midwest Eye Consultants 2023-12-31 0001737924 PromptCare 2023-12-31 0001737924 PromptCare (Delayed Draw) 2023-12-31 0001737924 Quorum Health Resources, LLC 2023-12-31 0001737924 Quorum Health Resources, LLC (Delayed Draw) (Incremental) 2023-12-31 0001737924 Quorum Health Resources, LLC (Incremental) 2023-12-31 0001737924 Sandlot Buyer, LLC (Prime Time Healthcare) 2023-12-31 0001737924 Sandlot Buyer, LLC (Prime Time Healthcare) (Incremental) 2023-12-31 0001737924 SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) 2023-12-31 0001737924 SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw) 2023-12-31 0001737924 SM Wellness Holdings, Inc 2023-12-31 0001737924 Thorne HealthTech 2023-12-31 0001737924 TIDI Products 2023-12-31 0001737924 TIDI Products (Delayed Draw) 2023-12-31 0001737924 US Fertility 2023-12-31 0001737924 Wellspring Pharmaceutical 2023-12-31 0001737924 Wellspring Pharmaceutical (Delayed Draw) 2023-12-31 0001737924 Wellspring Pharmaceutical (Delayed Draw) (Incremental) 2023-12-31 0001737924 Wellspring Pharmaceutical (Incremental) 2023-12-31 0001737924 Young Innovations (Delayed Draw) 2023-12-31 0001737924 Young Innovations 2023-12-31 0001737924 ncdlc:HealthcareAndPharmaceuticalsMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Acclaim MidCo, LLC (dba ClaimLogiQ) 2023-12-31 0001737924 Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw) 2023-12-31 0001737924 Argano, LLC 2023-12-31 0001737924 Argano, LLC (Delayed Draw) 2023-12-31 0001737924 Argano, LLC (Delayed Draw) (Incremental) 2023-12-31 0001737924 Diligent Corporation 1 2023-12-31 0001737924 Diligent Corporation 2 2023-12-31 0001737924 Diligent Corporation 3 2023-12-31 0001737924 Diligent Corporation (Delayed Draw) 1 2023-12-31 0001737924 Diligent Corporation (Delayed Draw) 2 2023-12-31 0001737924 Eliassen Group LLC 2023-12-31 0001737924 Eliassen Group LLC (Delayed Draw) 2023-12-31 0001737924 Evergreen Services Group II (Delayed Draw) 2023-12-31 0001737924 Evergreen Services Group II 2023-12-31 0001737924 Exterro 2023-12-31 0001737924 Fineline Merger 2023-12-31 0001737924 Go Engineer 2023-12-31 0001737924 Go Engineer (Delayed Draw) 2023-12-31 0001737924 Infinite Electronics (Incremental) 2023-12-31 0001737924 Infobase Acquisition, Inc. 2023-12-31 0001737924 Infobase Acquisition, Inc. (Delayed Draw) 2023-12-31 0001737924 ITSavvy LLC 2023-12-31 0001737924 ITSavvy LLC (Delayed Draw) 2023-12-31 0001737924 North Haven CS Acquisition Inc 2023-12-31 0001737924 Prosci, Inc. 2023-12-31 0001737924 Revalize (Delayed Draw) 1 2023-12-31 0001737924 Revalize (Delayed Draw) 2 2023-12-31 0001737924 Revalize (Delayed Draw) 3 2023-12-31 0001737924 SmartWave 2023-12-31 0001737924 Solve Industrial Motion Group 1 2023-12-31 0001737924 Solve Industrial Motion Group 2 2023-12-31 0001737924 Solve Industrial Motion Group (Delayed Draw) 2023-12-31 0001737924 ncdlc:HighTechIndustriesMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Tinuiti 2023-12-31 0001737924 Tinuiti (Delayed Draw) 2023-12-31 0001737924 Tinuiti (Delayed Draw) (Incremental) 2023-12-31 0001737924 Wpromote 2023-12-31 0001737924 Wpromote (Delayed Draw) 2023-12-31 0001737924 ncdlc:MediaAdvertisingPrintingPublishingMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Corporate Visions 1 2023-12-31 0001737924 Corporate Visions 2 2023-12-31 0001737924 Spectrio II 2023-12-31 0001737924 Spectrio II (Delayed Draw) 1 2023-12-31 0001737924 Spectrio II (Delayed Draw) 2 2023-12-31 0001737924 ncdlc:MediaDiversifiedProductionMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 Syndigo 2023-12-31 0001737924 us-gaap:RetailSectorMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 ALKU Intermediate Holdings, LLC 2023-12-31 0001737924 Apex Companies Holdings, LLC 2023-12-31 0001737924 Apex Companies Holdings, LLC (Delayed Draw) 2023-12-31 0001737924 ARMstrong (Delayed Draw) 2023-12-31 0001737924 ARMstrong 2023-12-31 0001737924 Big Truck Rental 1 2023-12-31 0001737924 Big Truck Rental 2 2023-12-31 0001737924 Bounteous 1 2023-12-31 0001737924 Bounteous 2 2023-12-31 0001737924 Bounteous (Delayed Draw) 1 2023-12-31 0001737924 Bounteous (Delayed Draw) 2 2023-12-31 0001737924 BroadcastMed Holdco, LLC 2023-12-31 0001737924 Bullhorn Inc 2023-12-31 0001737924 BusinesSolver 2023-12-31 0001737924 BusinesSolver (Delayed Draw) 2023-12-31 0001737924 Career Now 2023-12-31 0001737924 Cornerstone Advisors of Arizona LLC 1 2023-12-31 0001737924 Cornerstone Advisors of Arizona LLC 2 2023-12-31 0001737924 Cornerstone Advisors of Arizona LLC (Delayed Draw) 2023-12-31 0001737924 CrossCountry Consulting 2023-12-31 0001737924 CrossCountry Consulting (Delayed Draw) 2023-12-31 0001737924 D&H United Fueling Solutions 2023-12-31 0001737924 D&H United Fueling Solutions (Delayed Draw) 2023-12-31 0001737924 D&H United Fueling Solutions (Delayed Draw) (Incremental) 2023-12-31 0001737924 D&H United Fueling Solutions (Incremental) 2023-12-31 0001737924 E78 1 2023-12-31 0001737924 E78 2 2023-12-31 0001737924 E78 (Delayed Draw) 1 2023-12-31 0001737924 E78 (Delayed Draw) 2 2023-12-31 0001737924 Evergreen Services Group 2023-12-31 0001737924 Evergreen Services Group (Delayed Draw) 2023-12-31 0001737924 Gabriel Partners LLC 2023-12-31 0001737924 Gabriel Partners LLC (Delayed Draw) 2023-12-31 0001737924 Gabriel Partners LLC (Incremental) 2023-12-31 0001737924 Keng Acquisition, Inc. (Engage Group Holdings, LLC) 2023-12-31 0001737924 Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw) 2023-12-31 0001737924 KRIV Acquisition, Inc 2023-12-31 0001737924 KRIV Acquisition, Inc (Delayed Draw) 2023-12-31 0001737924 Lion Merger Sub Inc 2023-12-31 0001737924 Lion Merger Sub Inc (Incremental) 2023-12-31 0001737924 LSCS Holdings Inc. 2023-12-31 0001737924 LYNX FRANCHISING, LLC 2023-12-31 0001737924 Micronics 2023-12-31 0001737924 Output Services Group, Inc. 1 2023-12-31 0001737924 Output Services Group, Inc. 2 2023-12-31 0001737924 Phaidon International 2023-12-31 0001737924 Plaze 2023-12-31 0001737924 Scaled Agile 2023-12-31 0001737924 Scaled Agile (Delayed Draw) 2023-12-31 0001737924 Smile Brands 2023-12-31 0001737924 Soliant Health 2023-12-31 0001737924 Technical Safety Services 2023-12-31 0001737924 Technical Safety Services (Delayed Draw) 2023-12-31 0001737924 Technical Safety Services (Incremental) 2023-12-31 0001737924 TouchTunes Interactive 2023-12-31 0001737924 Transit Buyer LLC (dba“Propark”) 2023-12-31 0001737924 Transit Buyer LLC (dba“Propark”) (Delayed Draw) 2023-12-31 0001737924 Trilon Group, LLC 1 2023-12-31 0001737924 Trilon Group, LLC 2 2023-12-31 0001737924 Trilon Group, LLC 3 2023-12-31 0001737924 Trilon Group, LLC (Delayed Draw) 1 2023-12-31 0001737924 Trilon Group, LLC (Delayed Draw) 2 2023-12-31 0001737924 Trilon Group, LLC (Delayed Draw) 3 2023-12-31 0001737924 Vital Records Control 1 2023-12-31 0001737924 Vital Records Control 2 2023-12-31 0001737924 Vital Records Control (Delayed Draw) 2023-12-31 0001737924 ncdlc:ServicesBusinessMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 ADPD Holdings, LLC (a/k/a NearU) 2023-12-31 0001737924 ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 1 2023-12-31 0001737924 ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 2 2023-12-31 0001737924 All My Sons 2023-12-31 0001737924 COP Exterminators Acquisition, Inc. 2023-12-31 0001737924 COP Exterminators Acquisition, Inc. (Delayed Draw) 2023-12-31 0001737924 Excel Fitness 2023-12-31 0001737924 Fairway Lawns 2023-12-31 0001737924 Fairway Lawns (Delayed Draw) 2023-12-31 0001737924 Legacy Service Partners, LLC (“LSP”) 2023-12-31 0001737924 Legacy Service Partners, LLC (“LSP”) (Delayed Draw) 2023-12-31 0001737924 Liberty Buyer 2023-12-31 0001737924 Liberty Buyer (Delayed Draw) 2023-12-31 0001737924 NJEye LLC 2023-12-31 0001737924 NJEye LLC (Delayed Draw) 1 2023-12-31 0001737924 NJEye LLC (Delayed Draw) 2 2023-12-31 0001737924 NJEye LLC (Delayed Draw) 3 2023-12-31 0001737924 North Haven Spartan US Holdco LLC 2023-12-31 0001737924 North Haven Spartan US Holdco LLC (Delayed Draw) 2023-12-31 0001737924 One World Fitness PFF LLC 2023-12-31 0001737924 Perennial Services, Group, LLC 2023-12-31 0001737924 Perennial Services, Group, LLC (Delayed Draw) 2023-12-31 0001737924 us-gaap:ConsumerSectorMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 LMI Consulting, LLC (LMI) 2023-12-31 0001737924 LMI Consulting, LLC (LMI) (Incremental) 2023-12-31 0001737924 ncdlc:SovereignAndPublicFinanceMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 BCM One 2023-12-31 0001737924 BCM One (Delayed Draw) 2023-12-31 0001737924 MBS Holdings, Inc. 2023-12-31 0001737924 Mobile Communications America Inc 2023-12-31 0001737924 Mobile Communications America Inc (Delayed Draw) 2023-12-31 0001737924 Momentum Telecom II 2023-12-31 0001737924 Momentum Telecom II (Incremental) 2023-12-31 0001737924 Sapphire Telecom Inc 2023-12-31 0001737924 Tyto Athene, LLC 2023-12-31 0001737924 ncdlc:TelecommunicationsMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 FSK Pallet Holding Corp. (DBA Kamps Pallets) 2023-12-31 0001737924 Kenco Group, Inc. 2023-12-31 0001737924 Kenco Group, Inc. (Delayed Draw) 2023-12-31 0001737924 Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 1 2023-12-31 0001737924 Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 2 2023-12-31 0001737924 Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 3 2023-12-31 0001737924 Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 4 2023-12-31 0001737924 Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) 5 2023-12-31 0001737924 RoadOne (Delayed Draw) 2023-12-31 0001737924 RoadOne 2023-12-31 0001737924 SEKO Global Logistics 1 2023-12-31 0001737924 SEKO Global Logistics 2 2023-12-31 0001737924 SEKO Global Logistics 3 2023-12-31 0001737924 SEKO Global Logistics (Delayed Draw) 2023-12-31 0001737924 SEKO Global Logistics (Delayed Draw) (Incremental) 2023-12-31 0001737924 SEKO Global Logistics (Incremental) 2023-12-31 0001737924 TI ACQUISITION NC LLC 2023-12-31 0001737924 ncdlc:TransportationCargoMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 American Student Transportaton Partners, Inc 2023-12-31 0001737924 ncdlc:TransportationConsumerMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 DMC HoldCo LLC (DMC Power) 2023-12-31 0001737924 DMC HoldCo LLC (DMC Power) (Delayed Draw) 2023-12-31 0001737924 Pinnacle Supply Partners, LLC 2023-12-31 0001737924 Pinnacle Supply Partners, LLC (Delayed Draw) 2023-12-31 0001737924 TPC Wire & Cable 2023-12-31 0001737924 TPC Wire & Cable (Delayed Draw) 2023-12-31 0001737924 ncdlc:UtilitiesElectricMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) 2023-12-31 0001737924 INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw) 2023-12-31 0001737924 ISG Merger Sub, LLC (dba Industrial Service Group) 2023-12-31 0001737924 ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw) 2023-12-31 0001737924 ncdlc:WholesaleMember us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 us-gaap:DebtSecuritiesMember 2023-12-31 0001737924 BPC Kodiak LLC (Turbine Engine Specialist, Inc) 2023-12-31 0001737924 ncdlc:AerospaceAndDefenseMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 Covercraft 1 2023-12-31 0001737924 High Bar Brands 1 2023-12-31 0001737924 S&S Truck Parts 3 2023-12-31 0001737924 S&S Truck Parts 4 2023-12-31 0001737924 us-gaap:AutomotiveSectorMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 Bardstown PPC Holdings LLC 1 2023-12-31 0001737924 Fresh Edge - Common 2023-12-31 0001737924 Fresh Edge - Preferred 2023-12-31 0001737924 Tech24 2023-12-31 0001737924 ncdlc:BeverageFoodTobaccoMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 Crete Mechanical Group 1 2023-12-31 0001737924 EFC Holdings, LLC 1 2023-12-31 0001737924 EFC Holdings, LLC 2 2023-12-31 0001737924 Precision Surfacing - Common 2023-12-31 0001737924 Repipe Specialists 1 2023-12-31 0001737924 ncdlc:CapitalEquipmentMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 Erie Construction 1 2023-12-31 0001737924 Gannett Fleming 1 2023-12-31 0001737924 Gannett Fleming 2 2023-12-31 0001737924 ncdlc:ConstructionBuildingMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 FoodScience 3 2023-12-31 0001737924 FoodScience 4 2023-12-31 0001737924 Ultima Health Holdings, LLC 1 2023-12-31 0001737924 ncdlc:ConsumerGoodsNonDurableMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 Oliver Packaging 1 2023-12-31 0001737924 Specialized Packaging Group 3 2023-12-31 0001737924 ncdlc:ContainersPackagingAndGlassMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 AG MDC Holdings, Inc 2023-12-31 0001737924 Anne Arundel 3 2023-12-31 0001737924 Health Management Associates 1 2023-12-31 0001737924 REP HS Topco Holdings (HemaSource Inc.) 2023-12-31 0001737924 ncdlc:HealthcareAndPharmaceuticalsMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 ITSavvy LLC 1 2023-12-31 0001737924 Solve Industrial Motion Group 3 2023-12-31 0001737924 ncdlc:HighTechIndustriesMember 2023-12-31 0001737924 Apex Companies Holdings, LLC 1 2023-12-31 0001737924 BroadcastMed Holdco, LLC 1 2023-12-31 0001737924 Career Now 1 2023-12-31 0001737924 Career Now 2 2023-12-31 0001737924 E78 3 2023-12-31 0001737924 KRIV Acquisition, Inc 1 2023-12-31 0001737924 Output Services Group, Inc. 3 2023-12-31 0001737924 ncdlc:ServicesBusinessMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 ADPD Holdings, LLC (a/k/a NearU) 1 2023-12-31 0001737924 COP Exterminators Investment, LLC 2023-12-31 0001737924 Legacy Service Partners, LLC (“LSP”) 1 2023-12-31 0001737924 Perennial Services Investors LLC 2023-12-31 0001737924 us-gaap:ConsumerSectorMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 LMI Renaissance 2023-12-31 0001737924 ncdlc:SovereignAndPublicFinanceMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 RoadOne - Common 2023-12-31 0001737924 SEKO Global Logistics 4 2023-12-31 0001737924 ncdlc:TransportationCargoMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 ASTP Holdings Co-Investment LP 2023-12-31 0001737924 ncdlc:TransportationConsumerMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 Pinnacle Supply Partners, LLC 1 2023-12-31 0001737924 ncdlc:UtilitiesElectricMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 BlackRock Liquidity Funds Treasury 2023-12-31 0001737924 First American Government Obligations Fund 2023-12-31 0001737924 U.S. Bank National Association Money Market Deposit Account 2023-12-31 0001737924 us-gaap:CashEquivalentsMember 2023-12-31 0001737924 ncdlc:OneMonthSOFRMember 2023-12-31 0001737924 ncdlc:ThreeMonthSOFRMember 2023-12-31 0001737924 ncdlc:SixMonthSOFRMember 2023-12-31 0001737924 ncdlc:TwelveMonthSOFRMember 2023-12-31 0001737924 ncdlc:RestrictedSecurityMember 2023-12-31 0001737924 ncdlc:QualifyingAssetsMember 2023-12-31 0001737924 ncdlc:NonQualifyingAssetsMember 2023-12-31 0001737924 us-gaap:PaymentInKindPIKNoteMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-07-01 2024-09-30 0001737924 us-gaap:PaymentInKindPIKNoteMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 us-gaap:PaymentInKindPIKNoteMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-07-01 2023-09-30 0001737924 us-gaap:PaymentInKindPIKNoteMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-09-30 0001737924 ncdlc:NonAccrualLoansMember 2024-09-30 0001737924 ncdlc:NonAccrualLoansMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:NonAccrualLoansMember 2023-12-31 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 ncdlc:DebtSecuritiesFirstLienMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:SubordinatedDebtMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:SubordinatedDebtMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 us-gaap:EquitySecuritiesMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 us-gaap:EquitySecuritiesMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:SubordinatedDebtSecondLienMember 2024-09-30 0001737924 ncdlc:SubordinatedDebtMezzanineDebtMember 2024-09-30 0001737924 ncdlc:StructuredDebtMember 2024-09-30 0001737924 ncdlc:SubordinatedDebtSecondLienMember 2023-12-31 0001737924 ncdlc:SubordinatedDebtMezzanineDebtMember 2023-12-31 0001737924 ncdlc:StructuredDebtMember 2023-12-31 0001737924 ncdlc:AerospaceDefenseMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:AerospaceDefenseMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:AutomotiveMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:AutomotiveMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:BankingFinanceInsuranceRealEstateMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:BankingFinanceInsuranceRealEstateMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:BeverageFoodTobaccoMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:BeverageFoodTobaccoMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:CapitalEquipmentMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:CapitalEquipmentMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ChemicalsPlasticsRubberMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ChemicalsPlasticsRubberMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ConstructionBuildingMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ConstructionBuildingMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ConsumerGoodsDurableMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ConsumerGoodsDurableMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ConsumerGoodsNonDurableMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ConsumerGoodsNonDurableMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ContainersPackagingGlassMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ContainersPackagingGlassMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:EnergyElectricityMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:EnergyElectricityMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:EnvironmentalIndustriesMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:EnvironmentalIndustriesMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:HealthcarePharmaceuticalsMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:HealthcarePharmaceuticalsMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:HighTechIndustriesMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:HighTechIndustriesMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:MediaAdvertisingPrintingPublishingMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:MediaAdvertisingPrintingPublishingMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:MediaDiversifiedProductionMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:MediaDiversifiedProductionMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 us-gaap:RetailSectorMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 us-gaap:RetailSectorMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ServicesBusinessMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ServicesBusinessMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:ServicesConsumerMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:ServicesConsumerMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:SovereignPublicFinanceMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:SovereignPublicFinanceMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:TelecommunicationsMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:TelecommunicationsMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:TransportationCargoMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:TransportationCargoMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:TransportationConsumerMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:TransportationConsumerMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:UtilitiesElectricMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:UtilitiesElectricMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:UtilitiesWaterMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:UtilitiesWaterMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:WholesaleMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:WholesaleMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 country:US 2024-09-30 0001737924 country:US ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 country:CA 2024-09-30 0001737924 country:CA ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 country:DE 2024-09-30 0001737924 country:DE ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 country:GB 2024-09-30 0001737924 country:GB ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 country:US 2023-12-31 0001737924 country:US ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 country:CA 2023-12-31 0001737924 country:CA ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 country:GB 2023-12-31 0001737924 country:GB ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:DebtSecuritiesVariableRateMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtSecuritiesVariableRateMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 ncdlc:DebtSecuritiesFixedRateMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtSecuritiesFixedRateMember ncdlc:InvestmentTypeConcentrationRiskMember ncdlc:InvestmentOwnedAtFairValueMember 2023-01-01 2023-12-31 0001737924 us-gaap:FairValueInputsLevel1Member ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel2Member ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel1Member us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel2Member us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel1Member us-gaap:CashEquivalentsMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel2Member us-gaap:CashEquivalentsMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member us-gaap:CashEquivalentsMember 2024-09-30 0001737924 us-gaap:CashEquivalentsMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel1Member 2024-09-30 0001737924 us-gaap:FairValueInputsLevel2Member 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member 2024-09-30 0001737924 us-gaap:FairValueInputsLevel1Member ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel2Member ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel1Member us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel2Member us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel1Member us-gaap:CashEquivalentsMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel2Member us-gaap:CashEquivalentsMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member us-gaap:CashEquivalentsMember 2023-12-31 0001737924 us-gaap:CashEquivalentsMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001737924 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2024-06-30 0001737924 us-gaap:SubordinatedDebtMember 2024-06-30 0001737924 us-gaap:EquitySecuritiesMember 2024-06-30 0001737924 us-gaap:InvestmentsMember 2024-06-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2024-07-01 2024-09-30 0001737924 us-gaap:SubordinatedDebtMember 2024-07-01 2024-09-30 0001737924 us-gaap:EquitySecuritiesMember 2024-07-01 2024-09-30 0001737924 us-gaap:InvestmentsMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:SubordinatedDebtMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:EquitySecuritiesMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:InvestmentsMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:SubordinatedDebtMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:EquitySecuritiesMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:InvestmentsMember 2024-07-01 2024-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:InvestmentsMember 2024-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 us-gaap:InvestmentsMember 2023-12-31 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2024-01-01 2024-09-30 0001737924 us-gaap:SubordinatedDebtMember 2024-01-01 2024-09-30 0001737924 us-gaap:EquitySecuritiesMember 2024-01-01 2024-09-30 0001737924 us-gaap:InvestmentsMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:SubordinatedDebtMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:EquitySecuritiesMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:InvestmentsMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:SubordinatedDebtMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:EquitySecuritiesMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:InvestmentsMember 2024-01-01 2024-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-06-30 0001737924 us-gaap:SubordinatedDebtMember 2023-06-30 0001737924 us-gaap:EquitySecuritiesMember 2023-06-30 0001737924 us-gaap:InvestmentsMember 2023-06-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-07-01 2023-09-30 0001737924 us-gaap:SubordinatedDebtMember 2023-07-01 2023-09-30 0001737924 us-gaap:EquitySecuritiesMember 2023-07-01 2023-09-30 0001737924 us-gaap:InvestmentsMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:SubordinatedDebtMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:EquitySecuritiesMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:InvestmentsMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:SubordinatedDebtMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:EquitySecuritiesMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:InvestmentsMember 2023-07-01 2023-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-09-30 0001737924 us-gaap:SubordinatedDebtMember 2023-09-30 0001737924 us-gaap:EquitySecuritiesMember 2023-09-30 0001737924 us-gaap:InvestmentsMember 2023-09-30 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2022-12-31 0001737924 us-gaap:SubordinatedDebtMember 2022-12-31 0001737924 us-gaap:EquitySecuritiesMember 2022-12-31 0001737924 us-gaap:InvestmentsMember 2022-12-31 0001737924 ncdlc:DebtSecuritiesFirstLienMember 2023-01-01 2023-09-30 0001737924 us-gaap:SubordinatedDebtMember 2023-01-01 2023-09-30 0001737924 us-gaap:EquitySecuritiesMember 2023-01-01 2023-09-30 0001737924 us-gaap:InvestmentsMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:SubordinatedDebtMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:EquitySecuritiesMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesRealizedGainLossMember us-gaap:InvestmentsMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember ncdlc:DebtSecuritiesFirstLienMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:SubordinatedDebtMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:EquitySecuritiesMember 2023-01-01 2023-09-30 0001737924 ncdlc:DebtAndEquitySecuritiesUnrealizedGainLossMember us-gaap:InvestmentsMember 2023-01-01 2023-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 srt:MinimumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 srt:MaximumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 srt:WeightedAverageMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 srt:MinimumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:MaximumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:WeightedAverageMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 srt:MinimumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 srt:MaximumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 srt:WeightedAverageMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 srt:MinimumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:MaximumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:WeightedAverageMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationBlackScholesMember us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 srt:MinimumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationBlackScholesMember 2024-09-30 0001737924 srt:MaximumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationBlackScholesMember 2024-09-30 0001737924 srt:WeightedAverageMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationBlackScholesMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:RevenueMultipleMember ncdlc:ValuationMarketApproachMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:RevenueMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:RevenueMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:RevenueMultipleMember ncdlc:ValuationMarketApproachMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:ValuationRecentTransactionsMember ncdlc:DebtSecuritiesFirstLienMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:ValuationRecentTransactionsMember us-gaap:SubordinatedDebtMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:ValuationRecentTransactionsMember us-gaap:EquitySecuritiesMember 2024-09-30 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 srt:MinimumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 srt:MaximumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 srt:WeightedAverageMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 srt:MinimumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:MaximumMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:WeightedAverageMember ncdlc:DebtSecuritiesFirstLienMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 srt:MinimumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 srt:MaximumMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 srt:WeightedAverageMember us-gaap:SubordinatedDebtMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:MarketYieldDiscountRatesMember ncdlc:ValuationYieldMethodMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:EBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:BlendedEBITDAMultipleMember ncdlc:ValuationMarketApproachMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:BlendedEBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:BlendedEBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:BlendedEBITDAMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:MinimumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:BlendedRevenueMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:MaximumMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:BlendedRevenueMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member ncdlc:BlendedRevenueMultipleMember ncdlc:ValuationMarketApproachMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:ValuationRecentTransactionsMember ncdlc:DebtSecuritiesFirstLienMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:ValuationRecentTransactionsMember us-gaap:SubordinatedDebtMember 2023-12-31 0001737924 us-gaap:FairValueInputsLevel3Member ncdlc:ValuationRecentTransactionsMember us-gaap:EquitySecuritiesMember 2023-12-31 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementsMember 2019-12-31 2019-12-31 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementsMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementsMember 2023-10-27 2023-10-27 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementCompensationOfTheAdviserManagementFeeFirstFiveQuartersMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementCompensationOfTheAdviserManagementFeeThereafterMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementIncentiveRateQuarterlyHurdleRateMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementIncentiveRateAnnualizedHurdleRateMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementIncentiveRatePreIncentiveFeeNetInvestmentIncomeBelowCatchUpThresholdMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementIncentiveRateQuarterlyCatchUpThresholdMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementIncentiveRatePreIncentiveFeeNetInvestmentIncomeExceedsCatchUpThresholdMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementCumulativePreIncentiveFeeNetReturnMember 2024-01-29 2024-01-29 0001737924 us-gaap:RelatedPartyMember ncdlc:InvestmentAdvisoryAgreementIncentiveRateRealizedCapitalGainsMember 2024-01-29 2024-01-29 0001737924 ncdlc:ExpenseSupportAgreementMember 2019-12-31 2019-12-31 0001737924 us-gaap:RelatedPartyMember ncdlc:ExpenseSupportAgreementMember 2024-01-01 2024-09-30 0001737924 us-gaap:RelatedPartyMember ncdlc:AdvisorAndAdministratorMember 2024-09-30 0001737924 us-gaap:RelatedPartyMember ncdlc:AdvisorAndAdministratorMember 2023-12-31 0001737924 ncdlc:SubscriptionFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2020-09-10 0001737924 ncdlc:SubscriptionFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-07-01 2024-09-30 0001737924 ncdlc:SubscriptionFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-07-01 2023-09-30 0001737924 ncdlc:SubscriptionFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-01-01 2024-09-30 0001737924 ncdlc:SubscriptionFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-08-26 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-08-27 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-03-14 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2022-05-05 2022-05-05 0001737924 ncdlc:WellsFargoFinancingFacilityDailyUndrawnAmountsDuringThePeriodMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-03-14 2024-03-14 0001737924 ncdlc:WellsFargoFinancingFacilityForNextSixMonthsAndThereafterMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-03-14 2024-03-14 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-03-14 2024-03-14 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-01-01 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-01-01 2023-12-31 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-07-01 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-07-01 2023-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-01-01 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-11-20 2023-11-20 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-11-20 2023-11-20 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2023-11-21 2023-11-21 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-11-21 2023-11-21 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-11-20 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-11-21 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-11-20 2023-11-20 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-11-21 2023-11-21 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-01-01 2023-12-31 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-01-01 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-12-07 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-12-06 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-07-01 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-07-01 2023-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-01-01 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-04-08 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-04-09 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-06-23 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:BridgeLoanMember us-gaap:LineOfCreditMember 2023-06-23 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-06-23 2023-06-23 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-01-01 2023-12-31 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-01-01 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-07-01 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-07-01 2023-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-01-01 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AAAClassA12022NotesMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AAAClassA12022NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2022-05-20 2022-05-20 0001737924 ncdlc:AAAClassA1F2022NotesMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AAAClassA1F2022NotesMember us-gaap:SecuredDebtMember 2022-05-20 2022-05-20 0001737924 ncdlc:AAClassB2022NotesMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AAClassB2022NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2022-05-20 2022-05-20 0001737924 ncdlc:AClassC2022NotesMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AClassC2022NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2022-05-20 2022-05-20 0001737924 ncdlc:BBBClassD2022NotesMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:BBBClassD2022NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2022-05-20 2022-05-20 0001737924 ncdlc:Subordinated2022NotesMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AAAClassAL2022LoansToCLOIMember us-gaap:SecuredDebtMember 2022-05-20 0001737924 ncdlc:AAAClassAL2022LoansToCLOIMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2022-05-20 2022-05-20 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-07-01 2024-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-07-01 2023-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-01-01 2024-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-01-01 2023-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAAClassX2023NotesMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAAClassX2023NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-12-07 2023-12-07 0001737924 ncdlc:AAAClassA12023NotesMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAAClassA12023NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-12-07 2023-12-07 0001737924 ncdlc:AAClassB2023NotesMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAClassB2023NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-12-07 2023-12-07 0001737924 ncdlc:Subordinated2023NotesMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAAClassALA2023ToCLOIIMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAAClassALB2023LoansToCLOIIMember us-gaap:SecuredDebtMember 2023-12-07 0001737924 ncdlc:AAAClassALA2023ToCLOIIMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-12-07 2023-12-07 0001737924 ncdlc:AAAClassALB2023LoansToCLOIIMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-12-07 2023-12-07 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-07-01 2024-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-07-01 2023-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-01-01 2024-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-01-01 2023-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-03-14 0001737924 ncdlc:AAAClassX2024NotesMember us-gaap:SecuredDebtMember 2024-03-14 0001737924 ncdlc:AAAClassX2024NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-03-14 2024-03-14 0001737924 ncdlc:AAAClassA2024NotesMember us-gaap:SecuredDebtMember 2024-03-14 0001737924 ncdlc:AAAClassA2024NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-03-14 2024-03-14 0001737924 ncdlc:AAClassB2024NotesMember us-gaap:SecuredDebtMember 2024-03-14 0001737924 ncdlc:AAClassB2024NotesMember us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-03-14 2024-03-14 0001737924 ncdlc:Subordinated2024NotesMember us-gaap:SecuredDebtMember 2024-03-14 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-07-01 2024-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-07-01 2023-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-01-01 2024-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-01-01 2023-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:A2024DebtSecuritizationMember us-gaap:SecuredDebtMember 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-12-31 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-12-31 0001737924 ncdlc:A2022DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:A2023DebtSecuritizationMember us-gaap:SecuredDebtMember 2023-12-31 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2023-12-31 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 ncdlc:WellsFargoFinancingFacilityMember us-gaap:LineOfCreditMember 2023-12-31 0001737924 ncdlc:SMBCFinancingFacilityMember us-gaap:LineOfCreditMember 2023-12-31 0001737924 ncdlc:SeniorSecuredRevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2023-12-31 0001737924 360 Training - Delayed Draw Loan 2024-09-30 0001737924 360 Training - Delayed Draw Loan 2023-12-31 0001737924 Action Behavior Centers - Delayed Draw Loan 2024-09-30 0001737924 Action Behavior Centers - Delayed Draw Loan 2023-12-31 0001737924 Allstar Holdings - Delayed Draw Loan 2024-09-30 0001737924 Allstar Holdings - Delayed Draw Loan 2023-12-31 0001737924 Alternative Logistics Technologies Buyer, LLC - Delayed Draw Loan 2024-09-30 0001737924 Alternative Logistics Technologies Buyer, LLC - Delayed Draw Loan 2023-12-31 0001737924 AmerCareRoyal - Delayed Draw Loan 2024-09-30 0001737924 AmerCareRoyal - Delayed Draw Loan 2023-12-31 0001737924 Anne Arundel - Delayed Draw Loan 2024-09-30 0001737924 Anne Arundel - Delayed Draw Loan 2023-12-31 0001737924 Apex Companies - Delayed Draw Loan 2024-09-30 0001737924 Apex Companies - Delayed Draw Loan 2023-12-31 0001737924 Apex Services - Delayed Draw Loan 2024-09-30 0001737924 Apex Services - Delayed Draw Loan 2023-12-31 0001737924 Apex Services - First Lien Term Loan 2024-09-30 0001737924 Apex Services - First Lien Term Loan 2023-12-31 0001737924 Apex Services - Revolving Loan 2024-09-30 0001737924 Apex Services - Revolving Loan 2023-12-31 0001737924 ARMstrong - Delayed Draw Loan 2024-09-30 0001737924 ARMstrong - Delayed Draw Loan 2023-12-31 0001737924 Ascend - Delayed Draw Loan 2024-09-30 0001737924 Ascend - Delayed Draw Loan 2023-12-31 0001737924 ASTP Holdings Co-Investment - Units 2024-09-30 0001737924 ASTP Holdings Co-Investment - Units 2023-12-31 0001737924 Bounteous - Delayed Draw Loan 2024-09-30 0001737924 Bounteous - Delayed Draw Loan 2023-12-31 0001737924 BTX Precision - Delayed Draw Loan 2024-09-30 0001737924 BTX Precision - Delayed Draw Loan 2023-12-31 0001737924 BusinesSolver - Delayed Draw Loan 2024-09-30 0001737924 BusinesSolver - Delayed Draw Loan 2023-12-31 0001737924 Chroma Color - Delayed Draw Loan 2024-09-30 0001737924 Chroma Color - Delayed Draw Loan 2023-12-31 0001737924 ClaimLogiq - Delayed Draw Loan 2024-09-30 0001737924 ClaimLogiq - Delayed Draw Loan 2023-12-31 0001737924 Classic Collision - Delayed Draw Loan 2024-09-30 0001737924 Classic Collision - Delayed Draw Loan 2023-12-31 0001737924 CMP Ren Partners I-A LP 2024-09-30 0001737924 CMP Ren Partners I-A LP 2023-12-31 0001737924 Coding Solutions Acquisition Inc. - Delayed Draw Loan 2024-09-30 0001737924 Coding Solutions Acquisition Inc. - Delayed Draw Loan 2023-12-31 0001737924 Coding Solutions Acquisition Inc. - Revolving Loan 2024-09-30 0001737924 Coding Solutions Acquisition Inc. - Revolving Loan 2023-12-31 0001737924 Contract Land Staff - Delayed Draw Loan 2024-09-30 0001737924 Contract Land Staff - Delayed Draw Loan 2023-12-31 0001737924 Covercraft - Delayed Draw Loan 2024-09-30 0001737924 Covercraft - Delayed Draw Loan 2023-12-31 0001737924 CRCI Holdings Inc - Revolving Loan 2024-09-30 0001737924 CRCI Holdings Inc - Revolving Loan 2023-12-31 0001737924 CRCI Holdings Inc - Delayed Draw Loan 2024-09-30 0001737924 CRCI Holdings Inc - Delayed Draw Loan 2023-12-31 0001737924 Crete - Delayed Draw Loan 2024-09-30 0001737924 Crete - Delayed Draw Loan 2023-12-31 0001737924 CrossCountry Consulting - Delayed Draw Loan 2024-09-30 0001737924 CrossCountry Consulting - Delayed Draw Loan 2023-12-31 0001737924 D&H United Fueling Solutions - Delayed Draw Loan 2024-09-30 0001737924 D&H United Fueling Solutions - Delayed Draw Loan 2023-12-31 0001737924 Diligent Corporation - Delayed Draw Loan 2024-09-30 0001737924 Diligent Corporation - Delayed Draw Loan 2023-12-31 0001737924 DMC Power - Delayed Draw Loan 2024-09-30 0001737924 DMC Power - Delayed Draw Loan 2023-12-31 0001737924 E78 - Delayed Draw Loan 2024-09-30 0001737924 E78 - Delayed Draw Loan 2023-12-31 0001737924 Elevation Labs - Delayed Draw Loan 2024-09-30 0001737924 Elevation Labs - Delayed Draw Loan 2023-12-31 0001737924 Eliassen Group, LLC - Delayed Draw Loan 2024-09-30 0001737924 Eliassen Group, LLC - Delayed Draw Loan 2023-12-31 0001737924 Engage - Delayed Draw Loan 2024-09-30 0001737924 Engage - Delayed Draw Loan 2023-12-31 0001737924 Ergotech (INS) - Delayed Draw Loan 2024-09-30 0001737924 Ergotech (INS) - Delayed Draw Loan 2023-12-31 0001737924 Evergreen Services Group II - Delayed Draw Loan 2024-09-30 0001737924 Evergreen Services Group II - Delayed Draw Loan 2023-12-31 0001737924 Excel Fitness - Delayed Draw Loan 2024-09-30 0001737924 Excel Fitness - Delayed Draw Loan 2023-12-31 0001737924 EyeSouth - Delayed Draw Loan 2024-09-30 0001737924 EyeSouth - Delayed Draw Loan 2023-12-31 0001737924 Fairway Lawns - Delayed Draw Loan 2024-09-30 0001737924 Fairway Lawns - Delayed Draw Loan 2023-12-31 0001737924 Firstcall Mechanical Group - Delayed Draw 2024-09-30 0001737924 Firstcall Mechanical Group - Delayed Draw 2023-12-31 0001737924 Gannett Fleming - Revolving Loan 2024-09-30 0001737924 Gannett Fleming - Revolving Loan 2023-12-31 0001737924 GHR Healthcare - Delayed Draw 2024-09-30 0001737924 GHR Healthcare - Delayed Draw 2023-12-31 0001737924 Health Management Associates - Delayed Draw 2024-09-30 0001737924 Health Management Associates - Delayed Draw 2023-12-31 0001737924 Heartland Paving Partners - Delayed Draw 2024-09-30 0001737924 Heartland Paving Partners - Delayed Draw 2023-12-31 0001737924 Heartland Veterinary Partners - Delayed Draw 2024-09-30 0001737924 Heartland Veterinary Partners - Delayed Draw 2023-12-31 0001737924 High Bar Brands - Delayed Draw 2024-09-30 0001737924 High Bar Brands - Delayed Draw 2023-12-31 0001737924 Impact Environmental Group - Delayed Draw 2024-09-30 0001737924 Impact Environmental Group - Delayed Draw 2023-12-31 0001737924 Infobase - Delayed Draw 2024-09-30 0001737924 Infobase - Delayed Draw 2023-12-31 0001737924 Insulation Technology Group - Delayed Draw 2024-09-30 0001737924 Insulation Technology Group - Delayed Draw 2023-12-31 0001737924 Integrated Power Services - Delayed Draw 2024-09-30 0001737924 Integrated Power Services - Delayed Draw 2023-12-31 0001737924 ITSavvy - Delayed Draw 2024-09-30 0001737924 ITSavvy - Delayed Draw 2023-12-31 0001737924 Kenco - Delayed Draw 2024-09-30 0001737924 Kenco - Delayed Draw 2023-12-31 0001737924 Legacy Service Partners - Delayed Draw 2024-09-30 0001737924 Legacy Service Partners - Delayed Draw 2023-12-31 0001737924 Leo Facilities - Delayed Draw 2024-09-30 0001737924 Leo Facilities - Delayed Draw 2023-12-31 0001737924 Liberty Group - Delayed Draw 2024-09-30 0001737924 Liberty Group - Delayed Draw 2023-12-31 0001737924 Market Performance Group - Delayed Draw 2024-09-30 0001737924 Market Performance Group - Delayed Draw 2023-12-31 0001737924 MEI Buyer LLC - Delayed Draw 2024-09-30 0001737924 MEI Buyer LLC - Delayed Draw 2023-12-31 0001737924 MGM Transformer Company - Delayed Draw 2024-09-30 0001737924 MGM Transformer Company - Delayed Draw 2023-12-31 0001737924 Mobile Communications America Inc - Delayed Draw 2024-09-30 0001737924 Mobile Communications America Inc - Delayed Draw 2023-12-31 0001737924 Mosaic Dental - Delayed Draw 2024-09-30 0001737924 Mosaic Dental - Delayed Draw 2023-12-31 0001737924 National Power - Delayed Draw 2024-09-30 0001737924 National Power - Delayed Draw 2023-12-31 0001737924 NearU - Delayed Draw 2024-09-30 0001737924 NearU - Delayed Draw 2023-12-31 0001737924 NJEye, LLC - Delayed Draw 2024-09-30 0001737924 NJEye, LLC - Delayed Draw 2023-12-31 0001737924 North Haven Spartan US Holdco LLC - Delayed Draw 2024-09-30 0001737924 North Haven Spartan US Holdco LLC - Delayed Draw 2023-12-31 0001737924 Online Labels Group - Delayed Draw 2024-09-30 0001737924 Online Labels Group - Delayed Draw 2023-12-31 0001737924 Options IT - Delayed Draw 2024-09-30 0001737924 Options IT - Delayed Draw 2023-12-31 0001737924 Options IT - Revolving Loan 2024-09-30 0001737924 Options IT - Revolving Loan 2023-12-31 0001737924 Ovation Holdings - Delayed Draw 2024-09-30 0001737924 Ovation Holdings - Delayed Draw 2023-12-31 0001737924 Palmetto Exterminators - Delayed Draw 2024-09-30 0001737924 Palmetto Exterminators - Delayed Draw 2023-12-31 0001737924 Pinnacle Supply Partners, LLC - Delayed Draw 2024-09-30 0001737924 Pinnacle Supply Partners, LLC - Delayed Draw 2023-12-31 0001737924 Precision Aviation Group - Delayed Draw 2024-09-30 0001737924 Precision Aviation Group - Delayed Draw 2023-12-31 0001737924 Prompt Care - Delayed Draw 2024-09-30 0001737924 Prompt Care - Delayed Draw 2023-12-31 0001737924 Propark Mobility - Delayed Draw 2024-09-30 0001737924 Propark Mobility - Delayed Draw 2023-12-31 0001737924 PT Intermediate Holdings III, LLC - Delayed Draw 2024-09-30 0001737924 PT Intermediate Holdings III, LLC - Delayed Draw 2023-12-31 0001737924 Randy's Worldwide Automotive - Delayed Draw 2024-09-30 0001737924 Randy's Worldwide Automotive - Delayed Draw 2023-12-31 0001737924 Repipe Specialists - Delayed Draw 2024-09-30 0001737924 Repipe Specialists - Delayed Draw 2023-12-31 0001737924 Rhino Tool House - Delayed Draw 2024-09-30 0001737924 Rhino Tool House - Delayed Draw 2023-12-31 0001737924 Riveron - Delayed Draw 2024-09-30 0001737924 Riveron - Delayed Draw 2023-12-31 0001737924 RMA Companies - Delayed Draw 2024-09-30 0001737924 RMA Companies - Delayed Draw 2023-12-31 0001737924 RoadOne - Delayed Draw 2024-09-30 0001737924 RoadOne - Delayed Draw 2023-12-31 0001737924 RoadOne- Common 2024-09-30 0001737924 RoadOne- Common 2023-12-31 0001737924 S&S Truck Parts - Delayed Draw 2024-09-30 0001737924 S&S Truck Parts - Delayed Draw 2023-12-31 0001737924 Sciens Building Solutions, LLC - Delayed Draw 2024-09-30 0001737924 Sciens Building Solutions, LLC - Delayed Draw 2023-12-31 0001737924 SI Solutions - Delayed Draw 2024-09-30 0001737924 SI Solutions - Delayed Draw 2023-12-31 0001737924 Sunny Sky Products - Delayed Draw 2024-09-30 0001737924 Sunny Sky Products - Delayed Draw 2023-12-31 0001737924 Tech24 - Delayed Draw 2024-09-30 0001737924 Tech24 - Delayed Draw 2023-12-31 0001737924 Technical Safety Services - Delayed Draw 2024-09-30 0001737924 Technical Safety Services - Delayed Draw 2023-12-31 0001737924 The Facilities Group - Delayed Draw 2024-09-30 0001737924 The Facilities Group - Delayed Draw 2023-12-31 0001737924 TIDI Products - Delayed Draw 2024-09-30 0001737924 TIDI Products - Delayed Draw 2023-12-31 0001737924 Trilon Group - Delayed Draw 2024-09-30 0001737924 Trilon Group - Delayed Draw 2023-12-31 0001737924 USA Water - Delayed Draw 2024-09-30 0001737924 USA Water - Delayed Draw 2023-12-31 0001737924 Velosio - Delayed Draw 2024-09-30 0001737924 Velosio - Delayed Draw 2023-12-31 0001737924 Vensure - Delayed Draw 2024-09-30 0001737924 Vensure - Delayed Draw 2023-12-31 0001737924 Vessco - Delayed Draw 2024-09-30 0001737924 Vessco - Delayed Draw 2023-12-31 0001737924 Vessco - Revolving Loan 2024-09-30 0001737924 Vessco - Revolving Loan 2023-12-31 0001737924 Watermill Express - Delayed Draw 2024-09-30 0001737924 Watermill Express - Delayed Draw 2023-12-31 0001737924 Wellspring - Delayed Draw 2024-09-30 0001737924 Wellspring - Delayed Draw 2023-12-31 0001737924 Wpromote - Delayed Draw 2024-09-30 0001737924 Wpromote - Delayed Draw 2023-12-31 0001737924 WSB / EST - Delayed Draw 2024-09-30 0001737924 WSB / EST - Delayed Draw 2023-12-31 0001737924 Young Innovations - Delayed Draw 2024-09-30 0001737924 Young Innovations - Delayed Draw 2023-12-31 0001737924 us-gaap:IPOMember 2024-01-29 2024-01-29 0001737924 us-gaap:IPOMember 2024-01-29 0001737924 2024-01-29 0001737924 2024-01-29 2024-01-29 0001737924 2024-01-05 0001737924 2024-01-05 2024-01-05 0001737924 2023-11-03 0001737924 2023-11-03 2023-11-03 0001737924 2023-07-17 0001737924 2023-07-17 2023-07-17 0001737924 2023-04-20 0001737924 2023-04-20 2023-04-20 0001737924 2022-12-21 0001737924 2022-12-21 2022-12-21 0001737924 2022-08-01 0001737924 2022-08-01 2022-08-01 0001737924 2022-04-25 0001737924 2022-04-25 2022-04-25 0001737924 2022-01-21 0001737924 2022-01-21 2022-01-21 0001737924 2021-12-09 0001737924 2021-12-09 2021-12-09 0001737924 2021-11-01 0001737924 2021-11-01 2021-11-01 0001737924 2021-08-23 0001737924 2021-08-23 2021-08-23 0001737924 2021-07-26 0001737924 2021-07-26 2021-07-26 0001737924 2021-06-22 0001737924 2021-06-22 2021-06-22 0001737924 2021-04-23 0001737924 2021-04-23 2021-04-23 0001737924 2021-03-11 0001737924 2021-03-11 2021-03-11 0001737924 2020-11-06 0001737924 2020-11-06 2020-11-06 0001737924 2020-10-16 0001737924 2020-10-16 2020-10-16 0001737924 2020-08-06 0001737924 2020-08-06 2020-08-06 0001737924 2020-05-07 0001737924 2020-05-07 2020-05-07 0001737924 2019-12-31 0001737924 2019-12-31 2019-12-31 0001737924 2019-12-19 0001737924 2019-12-19 2019-12-19 0001737924 ncdlc:O2024Q4DividendsMember 2024-01-01 2024-09-30 0001737924 ncdlc:O2024Q3DividendsMember 2024-01-01 2024-09-30 0001737924 ncdlc:O2025Q2DividendsMember 2024-01-01 2024-09-30 0001737924 ncdlc:O2025Q1DividendsMember 2024-01-01 2024-09-30 0001737924 ncdlc:O2024Q2DividendsMember 2024-01-01 2024-09-30 0001737924 ncdlc:O2024Q1DividendsMember 2024-01-01 2024-09-30 0001737924 ncdlc:O2023Q4DividendsMember 2023-01-01 2023-12-31 0001737924 ncdlc:O2023Q3DividendsMember 2023-01-01 2023-12-31 0001737924 ncdlc:O2023Q2DividendsMember 2023-01-01 2023-12-31 0001737924 ncdlc:O2023Q1DividendsMember 2023-01-01 2023-12-31 0001737924 ncdlc:O2022Q4DividendsMember 2022-01-01 2022-12-31 0001737924 ncdlc:O2022Q3DividendsMember 2022-01-01 2022-12-31 0001737924 ncdlc:O2022Q2DividendsMember 2022-01-01 2022-12-31 0001737924 ncdlc:O2022Q1DividendsMember 2022-01-01 2022-12-31 0001737924 ncdlc:O2021Q4DividendsMember 2021-01-01 2021-12-31 0001737924 ncdlc:O2021Q3DividendsMember 2021-01-01 2021-12-31 0001737924 ncdlc:O2021Q2DividendsMember 2021-01-01 2021-12-31 0001737924 ncdlc:O2021Q1DividendsMember 2021-01-01 2021-12-31 0001737924 ncdlc:O2020Q4DividendsMember 2020-01-01 2020-12-31 0001737924 ncdlc:O2020Q3DividendsMember 2020-01-01 2020-12-31 0001737924 ncdlc:O2020Q2DividendsMember 2020-01-01 2020-12-31 0001737924 2024-07-29 2024-07-29 0001737924 ncdlc:O2024Q3DividendsMember 2024-07-29 2024-07-29 0001737924 2024-04-29 2024-04-29 0001737924 2024-01-10 2024-01-10 0001737924 2023-10-12 2023-10-12 0001737924 2023-07-12 2023-07-12 0001737924 2023-04-12 2023-04-12 0001737924 2023-01-17 2023-01-17 0001737924 2022-10-11 2022-10-11 0001737924 2022-07-12 2022-07-12 0001737924 2022-04-12 2022-04-12 0001737924 2022-01-18 2022-01-18 0001737924 2021-10-11 2021-10-11 0001737924 2021-07-12 2021-07-12 0001737924 2021-04-19 2021-04-19 0001737924 2021-01-18 2021-01-18 0001737924 2020-11-11 2020-11-11 0001737924 2020-08-11 2020-08-11 0001737924 ncdlc:ShareRepurchasePlanMember 2024-03-05 0001737924 2024-04-01 2024-04-30 0001737924 2024-04-30 0001737924 2024-05-01 2024-05-31 0001737924 2024-05-31 0001737924 2024-06-01 2024-06-30 0001737924 2024-07-01 2024-07-31 0001737924 2024-07-31 0001737924 2024-08-01 2024-08-31 0001737924 2024-08-31 0001737924 2024-09-01 2024-09-30 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-09-30 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember 2024-10-04 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember 2024-01-01 2024-09-30 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember us-gaap:SubsequentEventMember 2024-10-04 2024-10-04 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember ncdlc:ThreeMonthSOFRMember 2024-01-01 2024-09-30 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember ncdlc:ThreeMonthSOFRMember us-gaap:SubsequentEventMember 2024-10-04 2024-10-04 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember ncdlc:SixMonthSOFRMember 2024-01-01 2024-09-30 0001737924 us-gaap:SecuredDebtMember us-gaap:LineOfCreditMember ncdlc:SixMonthSOFRMember us-gaap:SubsequentEventMember 2024-10-04 2024-10-04 0001737924 us-gaap:SubsequentEventMember ncdlc:O2024Q4RegularDividendsMember 2024-11-04 2024-11-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2024
OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 000-56133
NUVEEN CHURCHILL DIRECT LENDING CORP.
(Exact name of registrant as specified in its charter)
Maryland 84-3613224
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
375 Park Avenue, 9th Floor , New York , NY
10152
(Address of principal executive offices) (Zip Code)
( 212 ) 478-9200
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.01
NCDL
New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
¨
Accelerated filer
¨
Non-accelerated filer
ý
Smaller reporting company
¨
Emerging growth company
ý
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨ No ý

As of November 5, 2024, the registrant had 54,485,518 shares of common stock, $0.01 par value, outstanding.




TABLE OF CONTENTS



FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on our current expectations and estimates, our current and prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
our future operating results;
our business prospects and the prospects of our portfolio companies;
the dependence of our future success on the general economy and its impact on the industries in which we invest;
the impact of a protracted decline in the liquidity of credit markets on our business;
the impact of increased competition;
an economic downturn and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us;
the impact of interest rate volatility on our business and our portfolio companies;
the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;
the level of inflation, and its impact on our portfolio companies and on the industries in which we invest;
the impact of geopolitical conditions, including the conflict between Ukraine and Russia and in the Middle East, and their impact on financial market volatility, global economic markets, and various sectors, industries and markets for commodities globally, such as oil and natural gas;
our contractual arrangements and relationships with third parties;
the valuation of our investments in portfolio companies, particularly those having no liquid trading market;
actual and potential conflicts of interest with the Advisers, and/or their respective affiliates;
the ability of our portfolio companies to achieve their objectives;
the use of borrowed money to finance a portion of our investments;
the adequacy of our financing sources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies;
the ability of the Advisers; to locate suitable investments for us and to monitor and administer our investments;
the ability of the Advisers or their respective affiliates to attract and retain highly talented professionals;
our ability to qualify and maintain our qualification as a regulated investment company (a “RIC”) and operate as a business development company ("BDC"); and
the impact of future legislation and regulation on our business and our portfolio companies.

1


Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include our ability to originate new loans and investments, certain margins and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of forward-looking statements in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These forward-looking statements apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements except as otherwise provided by law.

2


PART I. FINANCIAL INFORMATION
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(dollars in thousands, except share and per share data)
September 30, 2024 December 31, 2023
Assets
(Unaudited)
Investments
Non-controlled/non-affiliated company investments, at fair value (amortized cost of $ 2,075,365 and $ 1,666,169 , respectively)
$ 2,046,887 $ 1,641,686
Cash and cash equivalents 69,304 67,395
Restricted cash 50 50
Interest receivable 18,127 17,674
Receivable for investments sold 5,657 3,919
Prepaid expenses 85 13
Other assets 127
Total assets $ 2,140,110 $ 1,730,864
Liabilities
Secured borrowings (net of $ 7,503 and $ 7,941 deferred financing costs, respectively) (See Note 6 )
$ 1,094,461 $ 943,936
Payable for investments purchased 2,545
Interest payable 15,462 9,837
Due to adviser for expense support (See Note 5 )
632
Management fees payable 3,873 3,006
Distributions payable 30,037 22,683
Directors’ fees payable 128 96
Accounts payable and accrued expenses 2,995 2,789
Total liabilities $ 1,149,501 $ 982,979
Commitments and contingencies (See Note 7 )
Net Assets: (See Note 8 )
Common shares, $ 0.01 par value, 500,000,000 and 500,000,000 shares authorized, 54,571,650 and 41,242,105 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively
$ 546 $ 412
Paid-in-capital in excess of par value 1,017,248 776,719
Total distributable earnings (loss) ( 27,185 ) ( 29,246 )
Total net assets $ 990,609 $ 747,885
Total liabilities and net assets $ 2,140,110 $ 1,730,864
Net asset value per share (See Note 10 )
$ 18.15 $ 18.13

See Notes to Consolidated Financial Statements
3


NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(dollars in thousands, except share and per share data)
Three Months Ended September 30,
Nine Months Ended September 30,
2024 2023 2024 2023
Investment income:
Non-controlled/non-affiliated company investments:
Interest income $ 57,317 $ 40,370 $ 159,413 $ 110,049
Payment-in-kind interest income 2,503 951 6,024 1,823
Dividend income 16 16 357 56
Other income 444 409 1,170 879
Total investment income 60,280 41,746 166,964 112,807
Expenses:
Interest and debt financing expenses 23,198 16,048 58,860 43,089
Management fees (See Note 5 )
3,873 2,722 10,727 7,503
Incentive fees on net investment income
5,496 13,030
Professional fees
912 730 2,315 2,284
Directors' fees 128 96 383 287
Administration fees (See Note 5 )
535 370 1,561 1,029
Other general and administrative expenses 145 125 888 653
Total expenses before expense support and incentive fees waived
34,287 20,091 87,764 54,845
Expense support (See Note 5 )
( 158 )
Incentive fees waived (See Note 5 )
( 5,496 ) ( 13,030 )
Net Expenses after expense support
28,791 20,091 74,734 54,687
Net investment income 31,489 21,655 92,230 58,120
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments 1,086 ( 13,107 ) ( 1,522 ) ( 6,408 )
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated company investments
4,050 11,574 ( 3,995 ) ( 3,805 )
Income tax (provision) benefit 18 27 159 ( 735 )
Total net change in unrealized gain (loss)
4,068 11,601 ( 3,836 ) ( 4,540 )
Total net realized and unrealized gain (loss) on investments 5,154 ( 1,506 ) ( 5,358 ) ( 10,948 )
Net increase (decrease) in net assets resulting from operations $ 36,643 $ 20,149 $ 86,872 $ 47,172
Per share data:
Net investment income per share - basic and diluted $ 0.58 $ 0.62 $ 1.71 $ 1.85
Net increase (decrease) in net assets resulting from operations per share - basic and diluted $ 0.67 $ 0.58 $ 1.61 $ 1.50
Weighted average common shares outstanding - basic and diluted 54,688,860 34,812,720 54,080,979 31,409,296
See Notes to Consolidated Financial Statements
4


NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)
(dollars in thousands, except share and per share data)
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Increase (decrease) in net assets resulting from operations:
Net investment income $ 31,489 $ 21,655 $ 92,230 $ 58,120
Net realized gain (loss) on investments 1,086 ( 13,107 ) ( 1,522 ) ( 6,408 )
Net change in unrealized appreciation (depreciation) on investments 4,068 11,601 ( 3,836 ) ( 4,540 )
Net increase (decrease) in net assets resulting from operations 36,643 20,149 86,872 47,172
Shareholder distributions:
Distributions declared from net investment income ( 30,036 ) ( 19,572 ) ( 84,811 ) ( 58,523 )
Net increase (decrease) in net assets resulting from shareholder distributions ( 30,036 ) ( 19,572 ) ( 84,811 ) ( 58,523 )
Capital share transactions:
Issuance of common shares, net 78,565 241,657 118,542
Reinvestment of shareholder distributions
3,560 2,320 10,085 6,811
Repurchases of common stock
( 5,930 ) ( 11,079 )
Net increase (decrease) in net assets resulting from capital share transactions ( 2,370 ) 80,885 240,663 125,353
Total increase (decrease) in net assets 4,237 81,462 242,724 114,002
Net assets, beginning of period
986,372 557,497 747,885 524,957
Net assets, end of period
$ 990,609 $ 638,959 $ 990,609 $ 638,959

See Notes to Consolidated Financial Statements
5


NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(dollars in thousands, except share and per share data)
Nine Months Ended September 30,
2024 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations $ 86,872 $ 47,172
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments ( 712,464 ) ( 352,883 )
Proceeds from principal repayments and sales of investments 310,489 65,851
Payment-in-kind interest ( 6,024 ) ( 1,823 )
Amortization of (premium)/accretion of discount, net
( 2,719 ) ( 1,994 )
Net realized (gain) loss on investments 1,522 6,408
Net change in unrealized (appreciation) depreciation on investments 3,995 3,805
Amortization of deferred financing costs 2,638 1,424
Amortization of offering costs ( 23 )
Changes in operating assets and liabilities:
Due from adviser for expense support
515
Interest receivable ( 453 ) ( 3,888 )
Receivable for investments sold ( 1,738 ) ( 4,399 )
Prepaid expenses ( 72 ) ( 16 )
Other assets 127
Payable for investments purchased 2,545 ( 56 )
Interest payable 5,625 3,808
Due to adviser for expense support
( 632 ) ( 282 )
Management fees payable 867 511
Directors’ fees payable 32
Accounts payable and accrued expenses 206 1,053
Net cash provided by (used in) operating activities ( 309,184 ) ( 234,817 )
Cash flows from financing activities:
Proceeds from issuance of common shares 241,657 118,988
Shareholder distributions ( 67,372 ) ( 46,464 )
Repurchases of common shares ( 11,079 )
Proceeds from secured borrowings 717,750 340,600
Repayments of secured borrowings ( 567,663 ) ( 179,500 )
Payments of deferred financing costs ( 2,200 ) ( 2,106 )
Net cash provided by (used in) financing activities 311,093 231,518
Net increase (decrease) in Cash and Cash Equivalents and Restricted Cash 1,909 ( 3,299 )
Cash and Cash Equivalents and Restricted Cash, beginning of period 67,445 39,320
Cash and Cash Equivalents and Restricted Cash, end of period $ 69,354 $ 36,021
Supplemental disclosure of cash flow information:
Cash paid during the period for interest $ 50,597 $ 37,857
Cash paid during the period for excise taxes
$ 6 $
Supplemental disclosure of non-cash flow financing activity:
Reinvestment of shareholder distributions $ 10,085 $ 6,811
See Notes to Consolidated Financial Statements
6



The following tables provide a reconciliation of cash and cash equivalents and restricted cash reported on the consolidated statements of assets and liabilities to comparable amounts on the consolidated statements of cash flows (dollars in thousands):
September 30, 2024 September 30, 2023
Cash
$ 6,824 $ 1,771
Cash equivalents
62,480 34,200
Restricted cash 50 50
Total cash and cash equivalents and restricted cash shown on the Consolidated Statements of Cash Flows $ 69,354 $ 36,021


See Notes to Consolidated Financial Statements
7

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Investments
Debt Investments
Aerospace & Defense
AEgis Technologies (6) (12) (13) First Lien Term Loan
S + 6.00 %
10.70 % 10/31/2025 $ 14,548 $ 14,510 $ 14,352 1.45 %
AEgis Technologies (6) (12) (13) First Lien Term Loan
S + 6.00 %
10.70 % 10/31/2025 3,022 2,998 2,982 0.30 %
Arotech Corporation (6) (13) First Lien Term Loan
S + 6.25 %
11.20 % 10/22/2026 15,004 14,437 15,004 1.51 %
Arotech Corporation (Delayed Draw) (6) (12) First Lien Term Loan
S + 6.25 %
11.29 % 10/22/2026 730 704 730 0.07 %
BTX Precision (12) First Lien Term Loan
S + 5.00 %
9.85 % 7/25/2030 1,571 1,551 1,552 0.16 %
BTX Precision (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 7/25/2030 539 ( 3 ) ( 6 ) %
BTX Precision (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 7/25/2030 359 ( 4 ) %
Precision Aviation Group (6) (12) (13) First Lien Term Loan
S + 5.25 %
9.85 % 12/21/2029 14,927 14,654 14,775 1.50 %
Precision Aviation Group (Delayed Draw) (12) First Lien Term Loan
S + 5.25 %
9.97 % 12/21/2029 4,948 4,905 4,898 0.49 %
Prime Buyer, L.L.C. (6) First Lien Term Loan
S + 5.25 %
10.20 % 12/22/2026 6,501 6,458 6,501 0.66 %
Turbine Engine Specialists (12) Subordinated Debt
S + 9.50 %
14.25 % 3/1/2029 2,537 2,482 2,533 0.26 %
Valkyrie / Hill Technical Solutions (12) Subordinated Debt N/A
10.50 % (Cash) 1.00 % (PIK)
11/17/2027 2,858 2,821 2,813 0.28 %
Total Aerospace & Defense 65,517 66,130 6.68 %
Automotive
Covercraft (12) Subordinated Debt
N/A
10.00 % (Cash) 0.75 % (PIK)
2/20/2028 7,520 7,432 6,886 0.70 %
High Bar Brands (12) Subordinated Debt
N/A
13.00 %
6/19/2030 2,088 2,041 2,060 0.21 %
High Bar Brands (Delayed Draw) (11) (12) Subordinated Debt N/A 13.00 % 6/19/2030 596 ( 7 ) ( 8 ) %
JEGS Automotive (6) (16) First Lien Term Loan
S + 6.00 %
11.43 % 12/22/2027 3,988 3,965 2,556 0.26 %
PGW Auto Glass (6) (13) First Lien Term Loan
S + 5.00 %
10.43 % 4/18/2028 12,563 12,482 12,493 1.26 %
PGW Auto Glass (12) First Lien Term Loan
S + 5.00 %
10.25 % 4/18/2028 2,431 2,408 2,418 0.24 %
Randy's Worldwide Automotive (6) (9) (12) (13) First Lien Term Loan
S + 6.25 %
11.54 % 11/1/2028 11,053 10,886 10,928 1.10 %
Randy's Worldwide Automotive (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.25 %
11.51 % 11/1/2028 3,747 1,111 1,069 0.11 %
S&S Truck Parts (6) First Lien Term Loan
S + 5.00 %
10.39 % 3/1/2029 6,806 6,757 6,737 0.68 %
S&S Truck Parts (6) First Lien Term Loan
S + 5.00 %
10.39 % 3/1/2029 1,150 1,142 1,139 0.11 %
S&S Truck Parts (Delayed Draw) (6) First Lien Term Loan
S + 5.00 %
9.95 % 3/1/2029 98 98 97 0.01 %
S&S Truck Parts (Delayed Draw) (6) First Lien Term Loan
S + 5.00 %
10.35 % 3/1/2029 1,712 1,712 1,694 0.17 %
S&S Truck Parts (6) (12) (13) First Lien Term Loan
S + 5.00 %
9.95 % 3/1/2029 20,084 19,894 19,882 2.01 %
Total Automotive 69,921 67,951 6.86 %
See Notes to Consolidated Financial Statements
8

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Banking, Finance, Insurance, Real Estate
Ascend (12) (13) First Lien Term Loan
S + 4.50 %
9.35 % 8/11/2031 7,358 7,285 7,288 0.74 %
Ascend (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.50 %
9.35 % 8/11/2031 12,642 ( 62 ) ( 120 ) ( 0.01 %)
Long Term Care Group (6) (9) (12) First Lien Term Loan
S + 1.00 %
6.54 % (Cash) 6.00 % (PIK)
9/8/2027 7,162 7,140 6,465 0.65 %
Patriot Growth (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.00 %
9.75 % 10/16/2028 7,118 7,068 7,040 0.71 %
RSC Acquisition Inc (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 4.75 %
9.69 % 11/1/2029 9,769 9,769 9,720 0.98 %
Vensure (9) (12) First Lien Term Loan
S + 5.00 %
9.64 % 9/27/2031 2,570 2,545 2,546 0.26 %
Vensure (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.64 % 9/27/2031 730 ( 4 ) ( 7 ) %
World Insurance Associates, LLC (6) (9) (12) First Lien Term Loan
S + 6.00 %
10.60 % 4/3/2028 14,769 14,759 14,755 1.48 %
Total Banking, Finance, Insurance, Real Estate 48,500 47,687 4.81 %
Beverage, Food & Tobacco
AmerCareRoyal (6) First Lien Term Loan
S + 5.00 %
9.85 % 9/10/2030 720 713 713 0.07 %
AmerCareRoyal (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 9/10/2030 165 ( 2 ) %
AmerCareRoyal (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 9/10/2030 115 ( 1 ) ( 1 ) %
Bardstown Bourbon Company (12) Subordinated Debt
S + 7.75 %
12.96 % 8/30/2027 9,300 9,178 9,214 0.93 %
Commercial Bakeries (6) (7) (10) (13) First Lien Term Loan
S + 5.50 %
10.10 % 9/25/2029 17,152 16,858 16,936 1.71 %
Commercial Bakeries (6) (7) (10) First Lien Term Loan
S + 5.50 %
10.60 % 9/25/2029 2,029 2,013 2,004 0.20 %
Death Wish Coffee (6) (9) (13) First Lien Term Loan
S + 4.75 %
9.45 % 9/28/2027 9,725 9,673 9,725 0.98 %
Dessert Holdings (6) (9) (12) Subordinated Debt
S + 7.25 %
12.21 % 6/8/2029 9,000 8,888 8,014 0.81 %
Dessert Holdings (10) (13) (14) First Lien Term Loan
S + 4.00 %
8.96 % 6/9/2028 5,545 5,408 5,263 0.53 %
Fresh Edge (12) Subordinated Debt
S + 4.50 %
9.92 % (Cash) 5.13 % (PIK)
4/3/2029 4,006 3,934 3,924 0.40 %
Fresh Edge (12) Subordinated Debt
S + 4.50 %
9.92 % (Cash) 5.13 % (PIK)
4/3/2029 800 784 783 0.08 %
Fresh Edge (12) Subordinated Debt
S + 4.50 %
9.92 % (Cash) 5.13 % (PIK)
4/3/2029 947 926 927 0.09 %
Handgards, LLC (6) (12) (13) First Lien Term Loan
S + 5.50 %
9.86 %
4/10/2031 29,925 29,636 30,218 3.05 %
KSLB Holdings LLC (13) First Lien Term Loan
S + 4.50 %
9.90 % 7/30/2025 2,828 2,820 2,743 0.28 %
Rise Baking (6) (9) (13) First Lien Term Loan
S + 6.25 %
11.41 % 8/13/2027 14,588 14,465 14,588 1.47 %
Rise Baking (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.50 %
10.66 % 8/13/2027 4,421 4,403 4,421 0.45 %
Rise Baking (6) (9) (12) (13) First Lien Term Loan
S + 5.50 %
10.66 % 8/13/2027 10,819 10,767 10,819 1.09 %
Summit Hill Foods (6) First Lien Term Loan
S + 5.75 %
10.81 % 11/29/2029 8,944 8,822 8,910 0.90 %
Sunny Sky Products (6) (12) (13) First Lien Term Loan
S + 4.75 %
9.35 % 12/23/2028 7,040 6,979 6,976 0.70 %
See Notes to Consolidated Financial Statements
9

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Sunny Sky Products (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.75 %
9.35 % 12/23/2028 1,773 ( 16 ) %
Tech24 (6) (12) (13) First Lien Term Loan
S + 5.75 %
10.35 % 9/18/2029 13,214 13,011 13,008 1.31 %
Tech24 (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
10.64 % 9/18/2029 4,828 2,194 2,135 0.22 %
Watermill Express (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
10.50 % 7/5/2029 2,376 574 580 0.06 %
Watermill Express (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
10.60 % 7/5/2029 3,170 3,170 3,170 0.32 %
Watermill Express (6) (9) (13) First Lien Term Loan
S + 5.75 %
10.50 % 7/5/2029 6,327 6,270 6,327 0.64 %
Watermill Express (6) (9) First Lien Term Loan
S + 5.75 %
10.50 % 7/5/2029 3,229 3,213 3,229 0.33 %
Watermill Express (Delayed Draw) (6) (9) First Lien Term Loan
S + 5.75 %
10.50 % 7/5/2029 312 312 312 0.03 %
Total Beverage, Food & Tobacco 165,010 164,920 16.65 %
Capital Equipment
Clean Solutions Buyer (6) First Lien Term Loan
S + 4.50 %
9.35 % 9/9/2030 1,000 990 990 0.10 %
Crete (6) First Lien Term Loan
S + 4.75 %
9.35 % 5/19/2028 4,786 4,755 4,805 0.49 %
Crete (Delayed Draw) (6) First Lien Term Loan
S + 4.75 %
9.87 % 5/19/2028 2,823 2,791 2,834 0.29 %
Crete (Delayed Draw) (12) First Lien Term Loan
S + 4.75 %
9.36 %
5/19/2028 7,097 7,097 7,125 0.72 %
EFC International (12) Subordinated Debt
N/A
11.00 % (Cash) 2.50 % (PIK)
5/1/2028 3,248 3,175 3,245 0.33 %
E-Technologies / Superior (6) (13) First Lien Term Loan
S + 5.50 %
10.35 % 4/9/2030 7,295 7,226 7,149 0.72 %
Firstcall Mechanical Group (12) (13) First Lien Term Loan
S + 4.75 %
9.35 % 6/27/2030 9,975 9,878 9,876 1.00 %
Firstcall Mechanical Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.75 %
9.61 % 6/27/2030 20,000 ( 24 ) ( 198 ) ( 0.02 %)
Helios Buyer, Inc. (6) (9) (13) First Lien Term Loan
S + 6.00 %
10.70 % 12/15/2026 6,417 6,387 6,080 0.61 %
Helios Buyer, Inc. (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 6.00 %
10.70 % 12/15/2026 5,565 5,550 5,272 0.53 %
Helios Buyer, Inc. (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 6.00 %
10.70 % 12/15/2026 2,552 2,552 2,417 0.24 %
Hyperion (12) (13) (14) First Lien Term Loan
S + 4.50 %
9.46 % 8/30/2028 2,634 2,630 2,458 0.25 %
Ovation Holdings (6) (13) First Lien Term Loan
S + 5.00 %
10.40 % 2/5/2029 7,974 7,838 7,967 0.80 %
Ovation Holdings (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
10.40 % 2/5/2029 1,887 1,526 1,543 0.16 %
Precision Surfacing Solutions (12) First Lien Term Loan
N/A
15.00 % 11/30/2024 713 713 713 0.07 %
PT Intermediate Holdings III, LLC (6) (9) (12) (13) First Lien Term Loan
S + 3.25 %
5.33 % (Cash) 3.25 % (PIK)
4/9/2030 12,222 12,183 12,240 1.24 %
PT Intermediate Holdings III, LLC (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 3.25 %
5.33 % (Cash) 3.25 % (PIK)
4/9/2030 1,106 ( 1 ) 2 %
Rhino Tool House (6) (12) (13) First Lien Term Loan
S + 5.25 %
10.43 % 4/4/2029 8,737 8,604 8,670 0.88 %
Rhino Tool House (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.61 % 4/4/2029 1,871 1,829 1,821 0.18 %
Service Logic (6) (9) First Lien Term Loan
S + 3.50 %
8.31 % 10/29/2027 7,939 7,956 7,939 0.80 %
See Notes to Consolidated Financial Statements
10

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Vessco (6) (9) (12) (13) First Lien Term Loan
S + 5.25 %
10.22 % 7/24/2031 13,706 13,570 13,577 1.37 %
Vessco (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.25 %
9.54 % 7/24/2031 4,569 648 627 0.06 %
Vessco (9) (11) (12) Revolving Loan
S + 5.25 %
10.39 % 7/24/2031 1,726 ( 17 ) ( 16 ) %
Total Capital Equipment 107,856 107,136 10.82 %
Chemicals, Plastics, & Rubber
Ascensus (6) (9) (13) First Lien Term Loan
S + 4.25 %
9.20 % 6/30/2028 9,656 9,535 8,234 0.83 %
Boulder Scientific Company LLC (6) First Lien Term Loan
S + 5.00 %
10.38 % 12/28/2025 2,046 2,055 1,973 0.20 %
Chroma Color (6) First Lien Term Loan
S + 6.00 %
11.28 % 4/23/2029 6,266 6,165 6,220 0.63 %
Chroma Color (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.28 % 4/23/2029 1,379 ( 11 ) ( 10 ) %
Spartech (6) (9) (12) (13) (14) First Lien Term Loan
S + 4.75 %
10.05 % 5/6/2028 14,655 14,598 11,458 1.15 %
Total Chemicals, Plastics, & Rubber 32,342 27,875 2.81 %
Construction & Building
Allstar Holdings (12) Subordinated Debt N/A
10.00 % (Cash) 3.00 % (PIK)
4/26/2030 2,162 2,109 2,107 0.21 %
Allstar Holdings (Delayed Draw) (12) Subordinated Debt N/A
10.00 % (Cash) 3.00 % (PIK)
4/26/2030 4,115 4,065 4,010 0.40 %
Allstar Holdings (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 3.00 % (PIK)
4/26/2030 6,212 5,142 5,062 0.51 %
Erie Construction (6) (13) First Lien Term Loan
S + 4.75 %
10.09 % 7/30/2027 9,741 9,688 9,741 0.98 %
Gannett Fleming (9) (12) (13) First Lien Term Loan
S + 4.50 %
9.67 % 8/5/2030 17,869 17,605 17,606 1.78 %
Gannett Fleming (9) (11) (12) Revolving Loan
S + 4.50 %
9.67 % 8/5/2030 2,131 ( 31 ) ( 31 ) %
Heartland Paving Partners (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.60 % 8/9/2030 5,714 ( 14 ) ( 54 ) ( 0.01 %)
Heartland Paving Partners (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.60 % 8/9/2030 5,714 ( 14 ) ( 54 ) ( 0.01 %)
Heartland Paving Partners (6) First Lien Term Loan
S + 5.00 %
9.60 % 8/9/2030 8,571 8,486 8,490 0.87 %
ICE USA Infrastructure LLC (6) (13) First Lien Term Loan
S + 5.25 %
9.85 % 3/15/2030 6,588 6,526 6,524 0.66 %
MEI Buyer LLC (6) (12) (13) First Lien Term Loan
S + 5.00 %
9.85 % 6/29/2029 11,345 11,151 11,347 1.15 %
MEI Buyer LLC (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 6/29/2029 1,814 ( 7 ) %
RMA Companies (Delayed Draw) (6) (10) (12) First Lien Term Loan
S + 5.75 %
10.70 % 12/30/2027 4,593 4,586 4,568 0.46 %
RMA Companies (Delayed Draw) (10) (11) (12) First Lien Term Loan
S + 5.75 %
10.70 % 12/30/2027 3,133 1,184 1,173 0.12 %
RMA Companies (6) (10) First Lien Term Loan
S + 5.75 %
10.70 % 12/30/2027 3,095 3,057 3,078 0.31 %
Sciens Building Solutions, LLC (6) (9) First Lien Term Loan
S + 5.75 %
10.79 % 12/15/2027 9,243 9,132 9,243 0.94 %
Sciens Building Solutions, LLC (Delayed Draw) (6) (9) (12) (13) First Lien Term Loan
S + 5.75 %
11.04 % 12/15/2027 4,882 4,855 4,882 0.49 %
See Notes to Consolidated Financial Statements
11

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
WSB / EST (6) (12) First Lien Term Loan
S + 6.00 %
11.06 % 8/31/2029 6,470 6,387 6,384 0.64 %
WSB / EST (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.25 % 8/31/2029 4,334 3,000 2,969 0.30 %
Total Construction & Building 96,907 97,045 9.80 %
Consumer Goods: Durable
Halo Buyer, Inc. (6) (14) First Lien Term Loan
S + 4.50 %
9.45 % 6/30/2025 5,622 5,608 5,171 0.52 %
SmartSign (6) (13) First Lien Term Loan
S + 5.50 %
10.55 % 9/7/2028 9,800 9,732 9,800 0.99 %
SmartSign (6) First Lien Term Loan
S + 5.75 %
10.78 % 9/7/2028 4,987 4,907 4,987 0.50 %
Total Consumer Goods: Durable 20,247 19,958 2.01 %
Consumer Goods: Non-durable
ACP Tara Holdings, Inc. (6) (9) (13) First Lien Term Loan
S + 4.50 %
9.20 % 9/10/2027 12,507 12,440 12,507 1.26 %
ACP Tara Holdings, Inc. (6) (9) First Lien Term Loan
S + 5.75 %
10.45 % 9/10/2027 1,816 1,790 1,834 0.19 %
Elevation Labs (6) (13) First Lien Term Loan
S + 5.25 %
10.60 % 6/30/2028 6,738 6,692 6,724 0.68 %
Elevation Labs (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.45 % 6/30/2028 3,120 913 927 0.09 %
FoodScience LLC (6) (12) First Lien Term Loan
S + 5.25 %
10.20 % 3/1/2027 14,512 14,411 14,512 1.46 %
Market Performance Group (6) (13) First Lien Term Loan
S + 5.25 %
9.85 % 1/8/2030 12,556 12,442 12,682 1.28 %
Market Performance Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.51 % 1/8/2030 3,083 1,231 1,262 0.13 %
PIP (6) (13) First Lien Term Loan
S + 4.00 %
8.96 % 12/29/2027 9,075 9,059 9,054 0.91 %
Ultima (12) Subordinated Debt N/A
11.00 % (Cash) 1.50 % (PIK)
3/12/2029 1,754 1,728 1,754 0.18 %
Total Consumer Goods: Non-durable 60,706 61,256 6.18 %
Containers, Packaging & Glass
B2B/AMW Acquisition Company, Inc. (6) (13) First Lien Term Loan
S + 6.75 %
12.31 % 10/7/2026 14,584 14,562 13,809 1.39 %
B2B/AMW Acquisition Company, Inc. (6) First Lien Term Loan
S + 6.75 %
12.33 % 10/7/2026 115 114 109 0.01 %
Five Star Packaging (6) (13) (14) First Lien Term Loan
S + 4.25 %
9.19 % 5/5/2029 7,519 7,436 7,365 0.74 %
Good2Grow (6) (13) First Lien Term Loan
S + 4.50 %
9.71 % 12/1/2027 8,699 8,648 8,624 0.87 %
Good2Grow (6) (12) (13) First Lien Term Loan
S + 5.50 %
10.71 % 12/1/2027 6,314 6,238 6,314 0.64 %
Good2Grow (6) (13) First Lien Term Loan
S + 4.75 %
9.96 % 12/1/2027 14,302 14,173 14,277 1.44 %
Oliver Inc (12) Subordinated Debt N/A
10.00 % (Cash) 1.00 % (PIK)
1/6/2029 2,510 2,477 2,359 0.24 %
Oliver Inc (12) Subordinated Debt N/A 12.50 % 1/6/2029 465 456 460 0.05 %
Online Labels Group (13) First Lien Term Loan
S + 5.25 %
9.85 % 12/19/2029 3,304 3,274 3,304 0.33 %
Online Labels Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
9.85 % 12/19/2029 403 %
See Notes to Consolidated Financial Statements
12

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Online Labels Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
9.85 % 12/19/2029 403 %
Specialized Packaging Group (SPG) (6) (7) (10) (13) First Lien Term Loan
S + 5.50 %
10.80 % 12/17/2025 2,960 2,950 2,924 0.30 %
Specialized Packaging Group (SPG) (6) (7) (10) (13) First Lien Term Loan
S + 5.50 %
10.80 % 12/17/2025 7,219 7,190 7,131 0.72 %
Specialized Packaging Group (SPG) (7) (10) (13) First Lien Term Loan
S + 6.25 %
11.55 % 12/17/2025 4,376 4,340 4,360 0.44 %
Specialized Packaging Group (SPG) (6) (7) (10) (12) (13) First Lien Term Loan
S + 6.25 %
11.55 % 12/17/2025 6,843 6,780 6,818 0.69 %
Specialized Packaging Group (SPG) (7) (10) (12) First Lien Term Loan
S + 5.75 %
10.70 % 12/17/2025 3,299 3,273 3,263 0.33 %
Total Containers, Packaging & Glass 81,911 81,117 8.19 %
Energy: Electricity
Insulation Technology Group (6) (7) (10) (12) (13) First Lien Term Loan
S + 5.50 %
10.35 % 6/25/2030 22,410 22,192 22,196 2.24 %
Insulation Technology Group (Delayed Draw) (7) (10) (11) (12) First Lien Term Loan
S + 5.50 %
10.35 % 6/25/2030 5,912 ( 57 ) ( 0.01 %)
MGM Transformer Company (6) (12) (13) First Lien Term Loan
S + 5.50 %
10.82 % 10/31/2029 23,435 23,276 23,237 2.34 %
MGM Transformer Company (Delayed Draw) (12) First Lien Term Loan
S + 5.50 %
10.10 % 10/31/2029 6,372 6,358 6,318 0.64 %
National Power (6) (12) First Lien Term Loan
S + 5.75 %
10.60 % 10/22/2029 5,632 5,557 5,609 0.57 %
National Power (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
10.60 % 10/22/2029 3,051 ( 6 ) ( 12 ) %
Total Energy: Electricity 57,377 57,291 5.78 %
Environmental Industries
101 Inc (6) First Lien Term Loan
S + 5.25 %
10.60 % 8/31/2028 6,598 6,554 6,038 0.61 %
Contract Land Staff (6) (13) First Lien Term Loan
S + 4.75 %
9.35 % 3/27/2030 7,526 7,453 7,454 0.75 %
Contract Land Staff (Delayed Draw) (6) First Lien Term Loan
S + 4.75 %
9.86 % 3/27/2030 3,025 3,018 2,996 0.30 %
Contract Land Staff (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
10.28 % 3/27/2030 4,999 ( 12 ) ( 48 ) %
Impact Environmental Group (6) (12) First Lien Term Loan
S + 5.00 %
9.70 % 3/23/2029 6,725 6,612 6,724 0.68 %
Impact Environmental Group (Delayed Draw) (6) First Lien Term Loan
S + 5.00 %
9.70 % 3/23/2029 3,142 3,128 3,142 0.32 %
Impact Environmental Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.71 % 3/23/2029 6,800 3,117 3,145 0.32 %
Impact Environmental Group (6) First Lien Term Loan
S + 5.00 %
9.70 % 3/23/2029 1,723 1,694 1,723 0.17 %
Leo Facilities (6) (12) First Lien Term Loan
S + 5.50 %
10.76 % 7/3/2029 8,486 8,374 8,375 0.85 %
Leo Facilities (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.48 % 7/3/2029 6,417 4,732 4,661 0.47 %
Leo Facilities (6) First Lien Term Loan
S + 5.50 %
9.75 % 7/3/2029 1,593 1,577 1,572 0.16 %
Leo Facilities (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.76 % 7/3/2029 13,446 ( 176 ) ( 0.02 %)
SI Solutions (6) First Lien Term Loan
S + 4.75 %
9.60 % 8/15/2030 11,902 11,785 11,788 1.19 %
See Notes to Consolidated Financial Statements
13

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
SI Solutions (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.75 %
9.60 % 8/15/2030 5,601 ( 14 ) ( 54 ) ( 0.01 %)
The Facilities Group (6) (9) First Lien Term Loan
S + 5.75 %
11.10 % 11/30/2027 4,835 4,809 4,793 0.48 %
The Facilities Group (6) (9) (13) First Lien Term Loan
S + 5.75 %
10.96 % 11/30/2027 8,975 8,903 8,899 0.91 %
The Facilities Group (Delayed Draw) (6) (9) First Lien Term Loan
S + 5.75 %
10.64 % 11/30/2027 4,914 4,914 4,873 0.49 %
The Facilities Group (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
10.59 % 11/30/2027 5,027 166 124 0.01 %
Total Environmental Industries 76,810 76,029 7.68 %
Healthcare & Pharmaceuticals
Action Behavior Centers (12) (13) First Lien Term Loan
S + 5.25 %
10.57 % 7/2/2031 15,673 15,518 15,529 1.58 %
Action Behavior Centers (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.57 % 7/2/2031 2,850 ( 7 ) ( 26 ) %
Affinity Hospice (6) (12) First Lien Term Loan
S + 4.75 %
9.45 % 12/17/2027 7,812 7,764 6,881 0.69 %
Anne Arundel (12) (16) Subordinated Debt
N/A
12.75 % (PIK)
10/16/2026 3,282 3,261 540 0.05 %
Anne Arundel (12) (16) Subordinated Debt N/A
13.25 % (PIK)
4/16/2026 1,972 1,963 746 0.08 %
Anne Arundel (12) First Lien Term Loan N/A
4.71 % (PIK)
1/15/2026 516 516 516 0.05 %
Anne Arundel (Delayed Draw) (11) (12) (16) Subordinated Debt N/A
13.25 % (PIK)
4/16/2026 2,396 2,025 539 0.05 %
Coding Solutions Acquisition Inc. (9) (12) (13) First Lien Term Loan
S + 5.00 %
9.25 % 8/7/2031 11,995 11,913 11,881 1.20 %
Coding Solutions Acquisition Inc. (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
10.01 % 8/7/2031 2,165 ( 5 ) ( 21 ) %
Coding Solutions Acquisition Inc. (9) (11) (12) Revolving Loan
S + 5.00 %
10.01 % 8/7/2031 1,246 299 300 0.03 %
EyeSouth (6) (13) First Lien Term Loan
S + 5.50 %
10.45 % 10/5/2029 7,417 7,358 7,275 0.73 %
EyeSouth (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.46 % 10/5/2029 2,431 1,546 1,500 0.15 %
Forefront Dermatology (6) (9) (14) First Lien Term Loan
S + 4.25 %
9.10 % 3/30/2029 3,289 3,249 3,143 0.32 %
Genesee Scientific LLC (6) (9) First Lien Term Loan
S + 5.75 %
10.10 % 9/30/2027 5,913 5,882 5,329 0.54 %
Genesee Scientific LLC (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
10.10 % 9/30/2027 1,548 1,548 1,395 0.14 %
GHR Healthcare (6) (9) First Lien Term Loan
S + 5.00 %
9.95 % 12/9/2027 6,352 6,315 6,205 0.63 %
GHR Healthcare (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 5.00 %
9.95 % 12/9/2027 1,987 1,987 1,941 0.20 %
GHR Healthcare (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.25 %
10.20 % 12/9/2027 1,946 ( 45 ) %
GHR Healthcare (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.25 %
10.20 % 12/9/2027 648 ( 15 ) %
GHR Healthcare (6) (9) (13) First Lien Term Loan
S + 5.00 %
9.95 % 12/9/2027 4,945 4,878 4,830 0.49 %
GHR Healthcare (9) (12) (13) First Lien Term Loan
S + 5.00 %
9.95 % 12/9/2027 8,068 7,993 7,881 0.80 %
GHR Healthcare (6) (9) (13) First Lien Term Loan
S + 5.25 %
10.20 % 12/9/2027 3,751 3,716 3,664 0.37 %
Health Management Associates (6) (12) (13) First Lien Term Loan
S + 6.25 %
11.37 % 3/30/2029 8,264 8,128 8,242 0.83 %
Health Management Associates (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.22 % 3/30/2029 1,497 715 738 0.07 %
Heartland Veterinary Partners (Delayed Draw) (11) (12) Subordinated Debt
N/A
14.50 % 12/10/2027 3,600 1,400 1,371 0.14 %
See Notes to Consolidated Financial Statements
14

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Heartland Veterinary Partners (Delayed Draw) (12) Subordinated Debt N/A
7.50 % (Cash) 7.00 % (PIK)
12/10/2027 9,841 9,841 9,760 0.99 %
Heartland Veterinary Partners (12) Subordinated Debt N/A
7.50 % (Cash) 7.00 % (PIK)
12/10/2027 1,968 1,946 1,952 0.20 %
HemaSource (12) Subordinated Debt
N/A
8.50 % (Cash) 5.00 % (PIK)
2/28/2030 5,292 5,165 5,276 0.53 %
Infucare (6) (13) First Lien Term Loan
S + 4.25 %
8.95 % 1/4/2028 6,942 6,900 6,942 0.70 %
Midwest Eye Services, LLC (6) (13) First Lien Term Loan
S + 4.50 %
9.45 % 8/20/2027 8,952 8,906 8,946 0.90 %
Mosaic Dental (12) Subordinated Debt
N/A
10.00 % (Cash) 2.25 % (PIK)
2/7/2030 1,779 1,745 1,725 0.17 %
Mosaic Dental (Delayed Draw) (11) (12) Subordinated Debt
N/A
10.00 % (Cash) 2.25 % (PIK)
2/7/2030 728 468 452 0.05 %
Prime Time Healthcare (6) (12) (13) First Lien Term Loan
S + 6.00 %
11.36 % 9/19/2028 7,833 7,657 7,803 0.79 %
Prime Time Healthcare (12) (13) First Lien Term Loan
S + 6.00 %
11.21 % 9/19/2028 9,738 9,571 9,700 0.98 %
Prompt Care (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
10.95 % 9/1/2027 2,871 1,434 1,425 0.14 %
Prompt Care (6) (9) First Lien Term Loan
S + 6.00 %
11.02 % 9/1/2027 8,141 8,087 8,117 0.82 %
Prompt Care (Delayed Draw) (6) (9) First Lien Term Loan
S + 6.00 %
11.02 % 9/1/2027 1,268 1,264 1,264 0.13 %
QHR Holdco, Inc. (6) (10) (13) First Lien Term Loan
S + 5.25 %
10.20 % 5/28/2027 7,621 7,577 7,678 0.78 %
QHR Holdco, Inc. (Delayed Draw) (6) First Lien Term Loan
S + 5.25 %
10.20 % 5/28/2027 3,223 3,217 3,247 0.33 %
QHR Holdco, Inc. (6) (13) First Lien Term Loan
S + 5.25 %
10.20 % 5/28/2027 3,223 3,185 3,247 0.33 %
Smile Brands (12) Subordinated Debt
S + 9.62 %
14.69 % (PIK)
4/12/2028 11,139 11,087 9,428 0.95 %
Solis Mammography (6) (12) (13) First Lien Term Loan
S + 4.50 %
10.01 % 4/17/2028 13,056 12,989 12,925 1.30 %
Southern Veterinary Partners (9) (13) (14) First Lien Term Loan
S + 3.75 %
8.00 % 10/5/2027 4,760 4,755 4,775 0.48 %
Team Services Group (6) (14) First Lien Term Loan
S + 5.00 %
10.51 % 12/20/2027 6,616 6,585 6,554 0.66 %
Thorne HealthTech (6) (13) First Lien Term Loan
S + 5.50 %
10.35 %
10/16/2030 10,572 10,477 10,592 1.07 %
TIDI Products (6) (9) (12) (13) First Lien Term Loan
S + 5.50 %
10.35 % 12/19/2029 15,406 15,268 15,450 1.56 %
TIDI Products (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
10.35 % 12/19/2029 4,085 12 %
US Fertility (12) Subordinated Debt
N/A
4.00 % (Cash) 9.75 % (PIK)
6/21/2028 13,475 13,211 13,411 1.35 %
VMG Health (6) (13) First Lien Term Loan
S + 5.00 %
9.60 % 4/16/2030 15,932 15,779 15,777 1.59 %
Wellspring (6) (12) (13) First Lien Term Loan
S + 5.00 %
9.70 %
8/22/2028 7,330 7,283 7,259 0.73 %
Wellspring (6) First Lien Term Loan
S + 5.00 %
10.36 % 8/22/2028 3,353 3,305 3,320 0.34 %
Wellspring (Delayed Draw) (12) First Lien Term Loan
S + 5.00 %
9.70 % 8/22/2028 1,559 1,551 1,544 0.16 %
Wellspring (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.70 % 8/22/2028 3,756 2,553 2,530 0.26 %
Wellspring (6) (12) (13) First Lien Term Loan
S + 5.00 %
9.70 % 8/22/2028 1,236 1,217 1,224 0.12 %
Young Innovations (6) (9) (13) First Lien Term Loan
S + 5.75 %
10.87 % 12/3/2029 16,428 16,283 16,276 1.64 %
Young Innovations (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
10.87 % 12/3/2029 3,448 ( 32 ) %
Total Healthcare & Pharmaceuticals 297,268 288,918 29.19 %
See Notes to Consolidated Financial Statements
15

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
High Tech Industries
AQ Holdco Inc. (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.15 % 4/15/2027 4,210 4,203 3,962 0.40 %
AQ Holdco Inc. (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 5.75 %
11.15 % 4/15/2027 1,081 1,076 1,018 0.10 %
AQ Holdco Inc. (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
11.15 % 4/15/2027 244 243 230 0.02 %
Diligent Corporation (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
10.09 % 8/2/2030 3,830 ( 18 ) %
Diligent Corporation (6) (9) (12) (13) First Lien Term Loan
S + 5.00 %
10.09 % 8/2/2030 3,830 3,811 3,830 0.39 %
Diligent Corporation (6) (9) (12) (13) First Lien Term Loan
S + 5.00 %
10.09 % 8/2/2030 22,340 22,230 22,342 2.25 %
Eliassen Group, LLC (6) (9) (13) First Lien Term Loan
S + 5.75 %
10.35 % 4/14/2028 11,978 11,898 11,978 1.21 %
Eliassen Group, LLC (Delayed Draw) (6) (9) First Lien Term Loan
S + 5.75 %
10.88 % 4/14/2028 862 861 862 0.09 %
Evergreen Services Group II (6) (9) (12) (13) First Lien Term Loan
S + 5.75 %
10.35 % 10/4/2030 16,034 15,815 16,243 1.64 %
Evergreen Services Group II (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
10.35 % 10/4/2030 12,963 12,936 13,132 1.33 %
Exterro, Inc. (6) (13) First Lien Term Loan
S + 5.50 %
10.67 % 6/1/2027 9,474 9,474 9,593 0.97 %
FineLine (12) Subordinated Debt
S + 8.75 %
13.62 % 8/19/2028 2,453 2,430 2,453 0.25 %
Go Engineer (6) (9) (13) First Lien Term Loan
S + 5.00 %
9.60 % 12/21/2027 11,484 11,453 11,355 1.15 %
Go Engineer (Delayed Draw) (6) (9) First Lien Term Loan
S + 5.00 %
9.60 % 12/21/2027 3,128 3,109 3,092 0.31 %
Go Engineer (9) (13) First Lien Term Loan
S + 5.00 %
9.60 % 12/21/2027 5,351 5,300 5,291 0.53 %
Infobase (6) First Lien Term Loan
S + 5.50 %
11.01 % 6/14/2028 4,298 4,268 4,298 0.43 %
ITSavvy (6) First Lien Term Loan
S + 5.25 %
10.20 % 8/8/2028 7,735 7,682 7,735 0.78 %
North Haven CS Acquisition Inc (6) First Lien Term Loan
S + 5.50 %
10.93 % 1/23/2025 5,734 5,734 5,792 0.58 %
North Haven CS Acquisition Inc (6) (12) (13) First Lien Term Loan
S + 5.50 %
10.93 % 1/22/2027 22,243 22,062 22,465 2.26 %
Options IT (9) (12) First Lien Term Loan
S + 4.75 %
9.35 % 9/30/2031 685 678 678 0.07 %
Options IT (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 4.75 %
9.35 % 9/30/2031 236 ( 1 ) ( 2 ) %
Options IT (9) (11) (12) Revolving Loan
S + 4.75 %
9.35 % 3/31/2031 79 11 11 %
Prosci, Inc. (6) First Lien Term Loan
S + 4.50 %
9.45 % 10/21/2026 4,733 4,711 4,733 0.48 %
Quickbase (12) (13) First Lien Term Loan
S + 4.00 %
8.85 % 10/2/2028 6,320 6,295 6,291 0.64 %
SmartWave (6) (12) First Lien Term Loan
S + 6.00 %
11.40 % 11/5/2026 8,869 8,817 7,486 0.76 %
Solve Industrial (12) Subordinated Debt N/A
10.00 % (Cash) 2.00 % (PIK)
6/30/2028 1,878 1,855 1,772 0.18 %
Solve Industrial (12) Subordinated Debt N/A
10.00 % (Cash) 2.50 % (PIK)
6/30/2028 806 794 772 0.08 %
See Notes to Consolidated Financial Statements
16

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Solve Industrial (Delayed Draw) (12) Subordinated Debt N/A
10.00 % (Cash) 2.00 % (PIK)
6/30/2028 2,151 2,151 2,029 0.20 %
Velosio (6) (9) (13) First Lien Term Loan
S + 5.25 %
10.56 % 3/1/2030 6,216 6,160 6,223 0.63 %
Velosio (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.25 %
10.56 % 3/1/2030 1,284 1 %
Total High Tech Industries 176,038 175,665 17.73 %
Media: Advertising, Printing & Publishing
Tinuiti Inc. (6) (9) (12) First Lien Term Loan
S + 5.25 %
9.95 % 12/10/2026 2,925 2,909 2,872 0.29 %
Tinuiti Inc. (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 5.25 %
9.95 % 12/10/2026 1,912 1,911 1,877 0.19 %
Tinuiti Inc. (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.25 %
9.95 % 12/10/2026 9,788 9,788 9,609 0.97 %
Wpromote (6) (13) First Lien Term Loan
S + 5.75 %
11.05 % 10/23/2028 4,346 4,280 4,351 0.44 %
Wpromote (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.05 % 10/23/2028 588 ( 3 ) 1 %
Total Media: Advertising, Printing & Publishing 18,885 18,710 1.89 %
Media: Diversified & Production
BroadcastMed (12) Subordinated Debt
N/A
10.00 % (Cash) 3.75 % (PIK)
11/12/2027 3,615 3,565 3,466 0.35 %
CVI Parent, Inc. (6) First Lien Term Loan
S + 4.50 %
9.20 % 8/12/2027 2,525 2,502 2,188 0.22 %
CVI Parent, Inc. (6) First Lien Term Loan
S + 4.50 %
9.20 % 8/12/2027 2,872 2,856 2,489 0.25 %
Spectrio (6) (9) (12) (13) First Lien Term Loan
S + 6.00 %
11.06 % 12/9/2026 8,184 8,152 7,427 0.75 %
Spectrio (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 6.00 %
11.06 % 12/9/2026 2,907 2,891 2,638 0.27 %
Spectrio (Delayed Draw) (9) (13) First Lien Term Loan
S + 6.00 %
11.06 % 12/9/2026 443 442 400 0.04 %
Total Media: Diversified & Production 20,408 18,608 1.88 %
Retail
Syndigo (6) First Lien Term Loan
S + 4.50 %
9.46 % 12/15/2027 5,790 5,801 5,776 0.58 %
Total Retail 5,801 5,776 0.58 %
Services: Business
ALKU (12) (13) First Lien Term Loan
S + 6.25 %
10.50 % 5/23/2029 4,485 4,410 4,526 0.46 %
ARMstrong (6) (13) First Lien Term Loan
S + 5.75 %
10.45 % 10/8/2029 11,361 11,209 11,316 1.13 %
ARMstrong (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.13 % 10/8/2029 3,846 281 290 0.03 %
Bounteous (12) (13) First Lien Term Loan
S + 4.75 %
9.91 % 8/2/2027 5,306 5,277 5,306 0.54 %
Bounteous (12) First Lien Term Loan
S + 4.75 %
9.91 % 8/2/2027 2,172 2,160 2,172 0.22 %
Bounteous (Delayed Draw) (12) First Lien Term Loan
S + 4.75 %
9.91 % 8/2/2027 2,746 2,733 2,746 0.28 %
See Notes to Consolidated Financial Statements
17

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Bounteous (Delayed Draw) (12) First Lien Term Loan
S + 4.75 %
9.91 % 8/2/2027 3,550 3,550 3,550 0.36 %
Bullhorn (6) (9) (12) (13) First Lien Term Loan
S + 5.00 %
9.85 % 10/1/2029 13,671 13,600 13,632 1.37 %
BusinesSolver (6) (9) First Lien Term Loan
S + 5.50 %
10.20 % 12/1/2027 7,682 7,636 7,682 0.78 %
BusinesSolver (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
10.20 % 12/1/2027 1,147 271 274 0.03 %
Caldwell & Gregory (12) Subordinated Debt
S + 9.25 %
13.85 % (PIK)
3/29/2030 1,000 980 980 0.10 %
Career Now (12) Subordinated Debt
N/A
13.00 % (PIK)
3/30/2027 3,621 3,588 2,560 0.26 %
Cornerstone Advisors of Arizona, LLC (6) First Lien Term Loan
S + 5.50 %
9.85 % 9/24/2026 306 304 306 0.03 %
Cornerstone Advisors of Arizona, LLC (6) First Lien Term Loan
S + 5.50 %
9.85 % 9/24/2026 2,277 2,268 2,277 0.23 %
Cornerstone Advisors of Arizona, LLC (Delayed Draw) (6) First Lien Term Loan
S + 5.50 %
9.85 % 9/24/2026 209 208 209 0.02 %
Cornerstone Advisors of Arizona, LLC (6) First Lien Term Loan
S + 5.50 %
9.85 % 9/24/2026 3,432 3,404 3,432 0.35 %
CrossCountry Consulting (6) (9) First Lien Term Loan
S + 4.75 %
9.85 % 6/1/2029 8,112 7,991 8,151 0.82 %
CrossCountry Consulting (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 4.75 %
9.85 % 6/1/2029 3,320 ( 22 ) 16 %
D&H United Fueling Solutions (6) (13) First Lien Term Loan
S + 5.50 %
10.51 % 9/15/2028 7,434 7,327 7,322 0.74 %
D&H United Fueling Solutions (Delayed Draw) (6) First Lien Term Loan
S + 5.50 %
10.67 % 9/15/2028 2,366 2,350 2,330 0.24 %
D&H United Fueling Solutions (Delayed Draw) (6) First Lien Term Loan
S + 6.00 %
11.42 % 9/15/2028 1,559 1,553 1,561 0.16 %
D&H United Fueling Solutions (6) (13) First Lien Term Loan
S + 6.00 %
10.75 % 9/15/2028 3,439 3,382 3,443 0.35 %
D&H United Fueling Solutions (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
10.90 % 9/15/2028 5,153 1,617 1,563 0.16 %
E78 (12) First Lien Term Loan
S + 5.50 %
10.45 % 12/1/2027 5,557 5,524 5,531 0.56 %
E78 (13) First Lien Term Loan
S + 5.50 %
10.45 % 12/1/2027 1,427 1,418 1,420 0.14 %
E78 (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.51 % 12/1/2027 15,233 ( 71 ) ( 0.01 %)
E78 (Delayed Draw) (12) (13) First Lien Term Loan
S + 5.50 %
10.45 % 12/1/2027 4,178 4,154 4,159 0.42 %
E78 (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.51 % 12/1/2027 3,531 3,126 3,109 0.31 %
Engage (6) (9) (13) First Lien Term Loan
S + 5.00 %
9.85 % 8/1/2029 9,594 9,467 9,502 0.96 %
Engage (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 8/1/2029 9,295 4,136 4,066 0.41 %
Engage (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 8/1/2029 1,074 ( 3 ) ( 10 ) %
Esquire Deposition Services (12) Subordinated Debt
N/A
14.00 % (PIK)
6/30/2029 1,738 1,698 1,696 0.17 %
Evergreen Services Group (6) (9) (12) (13) First Lien Term Loan
S + 6.25 %
10.96 % 6/15/2029 11,875 11,694 11,875 1.20 %
Evergreen Services Group (Delayed Draw) (9) (12) First Lien Term Loan
S + 6.25 %
10.96 % 6/15/2029 2,841 2,820 2,841 0.29 %
Gabriel Partners, LLC (6) (9) (13) First Lien Term Loan
S + 6.25 %
11.46 % 9/21/2026 9,120 9,085 9,120 0.92 %
Gabriel Partners, LLC (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 6.25 %
11.46 % 9/21/2026 1,519 1,519 1,519 0.15 %
Gabriel Partners, LLC (6) (9) (13) First Lien Term Loan
S + 6.25 %
11.46 % 9/21/2026 3,765 3,749 3,765 0.38 %
See Notes to Consolidated Financial Statements
18

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Image First (6) (12) (13) First Lien Term Loan
S + 4.25 %
8.85 % 4/27/2028 7,771 7,756 7,771 0.78 %
Integrated Power Services (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.50 %
9.46 % 11/22/2028 5,112 ( 13 ) %
Integrated Power Services (12) First Lien Term Loan
S + 4.50 %
9.46 % 11/22/2028 2,045 2,042 2,045 0.21 %
Lion Merger Sub, Inc. (9) (13) First Lien Term Loan
S + 6.50 %
11.20 % 12/17/2025 7,265 7,242 7,124 0.72 %
Lion Merger Sub, Inc. (9) (12) (13) First Lien Term Loan
S + 6.50 %
11.20 % 12/17/2025 7,241 7,198 7,101 0.72 %
LSCS Holdings, Inc. (Dohmen) (6) (12) (13) First Lien Term Loan
S + 4.50 %
9.46 % 12/16/2028 9,936 9,897 9,891 1.00 %
LYNX FRANCHISING, LLC (6) (9) First Lien Term Loan
S + 6.25 %
11.46 % 12/23/2026 9,725 9,656 9,713 0.98 %
LYNX FRANCHISING, LLC (9) (12) (13) First Lien Term Loan
S + 6.25 %
11.46 % 12/23/2026 6,740 6,616 6,798 0.69 %
Output Services Group, Inc. (10) (12) First Lien Term Loan
S + 8.00 %
13.75 % 5/30/2028 155 155 155 0.02 %
Output Services Group, Inc. (12) First Lien Term Loan
S + 6.25 %
12.00 % 11/30/2028 837 837 837 0.08 %
Phaidon (6) (7) (10) (13) First Lien Term Loan
S + 5.50 %
10.45 % 8/22/2029 13,448 13,348 13,194 1.33 %
PLZ Aeroscience (12) Subordinated Debt
S + 7.50 %
12.46 % 7/7/2028 13,500 13,242 12,399 1.25 %
Press Ganey (9) (12) (13) (14) First Lien Term Loan
S + 3.50 %
8.35 % 4/30/2031 5,855 5,798 5,849 0.59 %
Propark Mobility (6) First Lien Term Loan
S + 5.00 %
9.85 % 1/31/2029 6,772 6,670 6,766 0.68 %
Propark Mobility (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.80 % 1/31/2029 3,114 2,647 2,690 0.27 %
Propark Mobility (Delayed Draw) (12) First Lien Term Loan
S + 6.25 %
10.31 % 1/31/2029 10,198 10,173 10,190 1.03 %
Province (12) (13) First Lien Term Loan
S + 5.25 %
10.10 % 7/1/2030 5,194 5,143 5,146 0.52 %
Riveron (6) (12) (13) First Lien Term Loan
S + 6.25 %
11.10 % 7/6/2029 10,683 10,425 10,576 1.07 %
Riveron (Delayed Draw) (12) First Lien Term Loan
S + 6.25 %
11.04 % 7/6/2029 1,603 1,586 1,586 0.16 %
Safety Infrastructure Services (12) (13) First Lien Term Loan
S + 4.75 %
9.35 % 7/21/2028 7,103 7,034 7,035 0.71 %
Scaled Agile (6) (9) First Lien Term Loan
S + 5.50 %
10.20 % 12/15/2028 7,875 7,820 7,048 0.71 %
Scaled Agile (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.50 %
10.89 % 12/15/2028 387 387 347 0.04 %
System One (6) (12) First Lien Term Loan
S + 3.75 %
8.50 % 3/2/2028 3,212 3,212 3,212 0.32 %
Technical Safety Services (6) First Lien Term Loan
S + 5.50 %
10.45 % 6/22/2029 6,720 6,669 6,720 0.68 %
Technical Safety Services (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.45 % 6/22/2029 6,371 4,677 4,740 0.48 %
Technical Safety Services (6) (12) First Lien Term Loan
S + 5.50 %
10.45 % 6/22/2029 1,876 1,851 1,876 0.19 %
Trilon Group (6) (12) (13) First Lien Term Loan
S + 5.50 %
10.95 % 5/27/2029 27,826 27,663 27,561 2.77 %
Trilon Group (Delayed Draw) (12) First Lien Term Loan
S + 5.50 %
10.90 % 5/29/2029 1,875 1,866 1,857 0.19 %
Vistage (6) (9) First Lien Term Loan
S + 4.75 %
9.35 % 7/13/2029 4,952 4,929 4,959 0.50 %
Vital Records Control (6) (9) First Lien Term Loan
S + 5.50 %
11.01 % 6/29/2027 4,547 4,517 4,547 0.46 %
Vital Records Control (6) (9) First Lien Term Loan
S + 5.75 %
10.88 % 6/29/2027 331 328 331 0.03 %
Total Services: Business 335,835 334,230 33.74 %
Services: Consumer
360 Training (13) First Lien Term Loan
S + 5.00 %
9.85 % 8/2/2028 3,447 3,416 3,447 0.35 %
See Notes to Consolidated Financial Statements
19

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
360 Training (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 8/2/2028 3,093 %
All My Sons (6) First Lien Term Loan
S + 4.75 %
9.71 % 10/25/2028 5,219 5,185 5,186 0.52 %
Apex Services (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.86 % 10/24/2030 154 16 16 %
Apex Services (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.86 % 10/24/2030 156 ( 1 ) ( 2 ) %
Apex Services (9) (11) (12) Revolving Loan
S + 5.00 %
9.86 % 10/24/2029 55 ( 1 ) ( 1 ) %
Apex Services (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.86 % 10/24/2030 635 ( 6 ) ( 6 ) %
Excel Fitness (6) (13) First Lien Term Loan
S + 5.25 %
9.85 % 4/27/2029 9,850 9,763 9,761 0.99 %
Excel Fitness (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.10 % 4/27/2029 2,371 ( 16 ) %
Fairway Lawns (12) Subordinated Debt
N/A
8.00 % (Cash) 5.00 % (PIK)
5/17/2029 2,871 2,813 2,804 0.28 %
Fairway Lawns (Delayed Draw) (12) Subordinated Debt N/A
8.00 % (Cash) 5.00 % (PIK)
5/17/2029 6,597 6,597 6,443 0.65 %
Fairway Lawns (Delayed Draw) (11) (12) Subordinated Debt N/A
8.00 % (Cash) 5.00 % (PIK)
5/17/2029 6,234 2,874 2,729 0.28 %
Legacy Service Partners (6) (12) (13) First Lien Term Loan
S + 5.25 %
10.00 % 1/9/2029 10,085 9,927 10,037 1.02 %
Legacy Service Partners (Delayed Draw) (6) First Lien Term Loan
S + 5.25 %
10.14 % 1/9/2029 4,700 4,683 4,678 0.47 %
Liberty Group (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.12 % 6/15/2028 3,899 3,872 3,899 0.39 %
Liberty Group (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
10.93 % 6/15/2028 742 293 293 0.03 %
NearU (6) (9) (12) (13) First Lien Term Loan
S + 6.00 %
11.03 % 8/16/2028 8,673 8,633 8,270 0.83 %
NearU (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
11.54 % 8/16/2028 1,220 ( 57 ) ( 0.01 %)
NearU (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
11.54 % 8/16/2028 1,427 ( 66 ) ( 0.01 %)
NearU (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
11.54 % 8/16/2028 145 ( 7 ) %
NJEye, LLC (6) First Lien Term Loan
S + 4.75 %
10.25 % 3/14/2025 5,298 5,291 5,298 0.53 %
NJEye, LLC (Delayed Draw) (6) First Lien Term Loan
S + 4.75 %
10.23 % 3/14/2025 694 694 694 0.07 %
NJEye, LLC (Delayed Draw) (12) First Lien Term Loan
S + 4.75 %
10.03 % 3/14/2025 884 883 884 0.09 %
NJEye, LLC (6) First Lien Term Loan
S + 4.75 %
10.31 % 3/14/2025 883 883 883 0.09 %
North Haven Spartan US Holdco LLC (6) First Lien Term Loan
S + 5.75 %
10.69 % 6/8/2026 2,483 2,482 2,483 0.25 %
North Haven Spartan US Holdco LLC (Delayed Draw) (6) First Lien Term Loan
S + 5.75 %
10.85 % 6/8/2026 215 215 215 0.02 %
North Haven Spartan US Holdco LLC (Delayed Draw) (11) (13) First Lien Term Loan
S + 5.75 %
11.00 % 6/8/2026 3,260 ( 8 ) %
One World Fitness PFF, LLC (6) First Lien Term Loan
S + 5.25 %
9.95 % (Cash) 1.00 % (PIK)
11/26/2025 3,879 3,880 3,670 0.37 %
Palmetto Exterminators (12) Subordinated Debt
N/A
9.00 % (Cash) 4.00 % (PIK)
1/28/2030 864 844 843 0.09 %
Palmetto Exterminators (Delayed Draw) (12) Subordinated Debt
N/A
9.00 % (Cash) 4.00 % (PIK)
1/28/2030 660 652 644 0.07 %
Perennial Services Group (6) First Lien Term Loan
S + 5.50 %
10.66 % 9/7/2029 6,682 6,598 6,749 0.68 %
Perennial Services Group (Delayed Draw) (6) (12) First Lien Term Loan
S + 5.50 %
10.66 % 9/7/2029 5,980 5,971 6,040 0.61 %
See Notes to Consolidated Financial Statements
20

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Repipe Specialists (12) Subordinated Debt N/A
3.33 % (Cash) 9.17 % (PIK)
3/18/2029 2,552 2,516 2,005 0.20 %
Repipe Specialists (Delayed Draw) (12) Subordinated Debt N/A
3.33 % (Cash) 9.17 % (PIK)
3/18/2029 221 221 173 0.02 %
Total Services: Consumer 89,170 88,005 8.88 %
Sovereign & Public Finance
LMI (6) (12) (13) First Lien Term Loan
S + 5.50 %
10.36 % 7/18/2028 12,163 12,058 12,216 1.23 %
Total Sovereign & Public Finance 12,058 12,216 1.23 %
Telecommunications
BCM One (6) First Lien Term Loan
S + 4.50 %
9.08 % 11/17/2027 5,729 5,729 5,729 0.58 %
BCM One (Delayed Draw) (6) First Lien Term Loan
S + 4.50 %
9.45 % 11/17/2027 1,813 1,813 1,813 0.18 %
MBS Holdings, Inc. (6) (9) First Lien Term Loan
S + 6.25 %
11.09 % 4/16/2027 1,814 1,790 1,832 0.18 %
MBS Holdings, Inc. (6) (9) (13) First Lien Term Loan
S + 5.75 %
10.59 % 4/16/2027 9,976 9,930 9,976 1.01 %
MBS Holdings, Inc. (6) (9) First Lien Term Loan
S + 6.50 %
11.34 % 4/16/2027 1,305 1,285 1,318 0.13 %
Mobile Communications America Inc (6) (12) (13) First Lien Term Loan
S + 5.25 %
10.26 % 10/16/2029 18,367 18,148 18,530 1.87 %
Mobile Communications America Inc (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.44 % 10/16/2029 5,968 763 854 0.09 %
Sapphire Telecom Inc (6) (12) (13) First Lien Term Loan
S + 5.00 %
9.60 % 6/27/2029 19,091 18,905 19,051 1.92 %
Tyto Athene (6) (12) First Lien Term Loan
S + 4.75 %
10.23 % 4/3/2028 7,157 7,112 6,863 0.69 %
Total Telecommunications 65,475 65,966 6.65 %
Transportation: Cargo
Armstrong Transport Group (12) Subordinated Debt N/A
17.00 % (PIK)
6/30/2027 1,062 1,043 1,043 0.11 %
Armstrong Transport Group (12) Subordinated Debt N/A
7.00 % (Cash) 7.00 % (PIK)
6/30/2027 7,484 7,349 7,350 0.74 %
Kamps Pallets (6) (13) First Lien Term Loan
S + 6.00 %
11.41 % 12/23/2026 9,800 9,686 9,503 0.95 %
Kenco (6) (12) (13) First Lien Term Loan
S + 4.25 %
8.99 % 11/15/2029 21,939 21,773 22,140 2.24 %
Kenco (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.25 %
8.99 % 11/15/2029 3,839 ( 27 ) 35 %
Kenco (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.25 %
8.99 % 11/15/2029 4,111 ( 39 ) 38 %
Quantix SCS, LLC (6) (9) First Lien Term Loan
S + 6.75 %
12.22 % 8/3/2026 256 255 242 0.02 %
Quantix SCS, LLC (6) (9) First Lien Term Loan
S + 6.75 %
12.22 % 8/3/2026 888 886 840 0.08 %
Quantix SCS, LLC (6) (9) First Lien Term Loan
S + 6.75 %
12.22 % 8/3/2026 180 179 170 0.02 %
Quantix SCS, LLC (6) (9) First Lien Term Loan
S + 6.75 %
12.22 % 8/3/2026 4,333 4,324 4,102 0.41 %
Quantix SCS, LLC (9) (13) First Lien Term Loan
S + 6.75 %
12.22 % 8/3/2026 1,348 1,341 1,277 0.13 %
RoadOne (12) Subordinated Debt
N/A
8.75 % (Cash) 5.00 % (PIK)
6/30/2029 4,882 4,772 4,749 0.48 %
See Notes to Consolidated Financial Statements
21

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Seko Global Logistics LLC (12) (16) Subordinated Debt
S + 9.62 %
10.48 % (Cash) 5.50 % (PIK)
6/30/2027 5,905 5,844 973 0.10 %
Seko Global Logistics LLC (12) (16) Subordinated Debt
S + 9.62 %
10.48 % (Cash) 5.50 % (PIK)
6/30/2027 4,098 4,051 675 0.07 %
Seko Global Logistics LLC (6) (16) First Lien Term Loan
S + 8.00 %
13.43 % 12/30/2026 1,122 1,117 788 0.08 %
Seko Global Logistics LLC (Delayed Draw) (12) (16) Subordinated Debt
S + 8.00 %
7.93 % (Cash) 5.50 % (PIK)
6/30/2027 923 923 152 0.02 %
Seko Global Logistics LLC (Delayed Draw) (6) (12) (16) First Lien Term Loan
S + 8.00 %
13.43 % 12/30/2026 4,473 4,473 3,143 0.32 %
Seko Global Logistics LLC (6) (16) First Lien Term Loan
S + 8.00 %
13.43 % 12/30/2026 1,513 1,505 1,063 0.11 %
TI Acquisition NC, LLC (6) First Lien Term Loan
S + 4.75 %
9.35 % 3/19/2027 2,759 2,708 2,729 0.28 %
Total Transportation: Cargo 72,163 61,012 6.16 %
Transportation: Consumer
Alternative Logistics Technologies Buyer, LLC (6) (9) (12) (13) First Lien Term Loan
S + 5.25 %
10.10 % 2/14/2031 10,586 10,490 10,484 1.05 %
Alternative Logistics Technologies Buyer, LLC (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.25 %
10.10 % 2/14/2031 3,040 ( 29 ) %
American Student Transportation Partners (12) Subordinated Debt N/A
6.00 % (Cash) 8.50 % (PIK)
9/11/2029 2,216 2,168 2,161 0.22 %
Total Transportation: Consumer 12,658 12,616 1.27 %
Utilities: Electric
CRCI Holdings Inc (9) (12) (13) First Lien Term Loan
S + 5.00 %
9.85 % 8/27/2031 10,460 10,356 10,359 1.05 %
CRCI Holdings Inc (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.00 %
9.85 % 8/27/2031 2,615 ( 13 ) ( 25 ) %
CRCI Holdings Inc (9) (11) (12) Revolving Loan
S + 5.00 %
9.85 % 8/27/2031 1,925 944 944 0.10 %
DMC Power (6) First Lien Term Loan
S + 5.75 %
11.05 % 7/13/2029 4,962 4,899 4,992 0.50 %
DMC Power (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.05 % 7/13/2029 1,671 ( 3 ) 10 %
Pinnacle Supply Partners, LLC (6) First Lien Term Loan
S + 6.25 %
11.37 % 4/3/2030 6,284 6,178 6,243 0.63 %
Pinnacle Supply Partners, LLC (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.68 % 4/3/2030 3,629 1,364 1,363 0.14 %
Total Utilities: Electric 23,725 23,886 2.42 %
Utilities: Water
USA Water (6) (12) First Lien Term Loan
S + 4.75 %
9.60 % 2/21/2031 7,857 7,786 7,849 0.79 %
USA Water (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.75 %
10.01 % 2/21/2031 3,037 334 331 0.04 %
Total Utilities: Water 8,120 8,180 0.83 %
Wholesale
Ergotech (INS) (6) (13) First Lien Term Loan
S + 6.50 %
11.91 % 1/19/2029 7,885 7,766 7,895 0.80 %
See Notes to Consolidated Financial Statements
22

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Ergotech (INS) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.50 %
11.91 % 1/19/2029 1,979 ( 29 ) 3 %
Industrial Service Group (6) First Lien Term Loan
S + 5.75 %
11.00 % 12/7/2028 6,476 6,376 6,405 0.65 %
Industrial Service Group (Delayed Draw) (6) First Lien Term Loan
S + 5.75 %
11.00 % 12/7/2028 3,372 3,359 3,335 0.34 %
Micronics (12) Subordinated Debt
S + 5.25 %
10.12 % 2/17/2027 2,450 2,412 2,409 0.24 %
TPC Wire & Cable Corp (12) Subordinated Debt N/A
11.00 % (Cash) 1.50 % (PIK)
2/16/2028 2,261 2,244 2,225 0.22 %
TPC Wire & Cable Corp (Delayed Draw) (12) Subordinated Debt N/A
11.00 % (Cash) 1.50 % (PIK)
2/16/2028 925 924 911 0.09 %
TPC Wire & Cable Corp (Delayed Draw) (12) Subordinated Debt N/A
11.00 % (Cash) 1.50 % (PIK)
2/16/2028 1,723 1,723 1,696 0.17 %
Total Wholesale 24,775 24,879 2.51 %
Total Debt Investments 2,045,483 2,013,062 203.23 %
Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Equity Investments
Aerospace & Defense
Turbine Engine Specialists (8) (12) (15) Class A-1 Units 9/1/2023 1,530,000 1,530 1,728 0.17 %
Total Aerospace & Defense 1,530 1,728 0.17 %
Automotive
Covercraft (8) (12) LP Interests 8/20/2021 768 768 299 0.03 %
High Bar Brands (8) (10) (12) Class A Units 12/19/2023 303,000 303 396 0.04 %
S&S Truck Parts (8) (12) Partnership Units 3/1/2022 4 378 343 0.03 %
S&S Truck Parts (8) (12) Common Units 8/1/2022 78,543 290 71 0.01 %
S&S Truck Parts (8) (10) (12) Partnership Interests 6/3/2024 1,000 1,000 977 0.10 %
S&S Truck Parts (8) (12) Warrants 6/3/2024 1,000 1 %
Total Automotive 2,740 2,086 0.21 %
Beverage, Food & Tobacco
Bardstown Bourbon Company (8) (10) (12) Common Units 7/13/2022 14,777 1,860 2,016 0.20 %
Fresh Edge (8) (12) Class B Common Units 10/3/2022 698 5 71 0.01 %
Fresh Edge (8) (12) Class A Preferred Units 10/3/2022 698 698 801 0.08 %
Tech24 (8) (12) Company Unit 10/5/2023 954 954 1,005 0.10 %
Total Beverage, Food & Tobacco 3,517 3,893 0.39 %
See Notes to Consolidated Financial Statements
23

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Capital Equipment
Crete (8) (12) Equity Co-Investment 5/7/2022 24 249 843 0.09 %
EFC International (8) (10) (12) Class A Common Units 2/28/2023 148 60 146 0.01 %
EFC International (8) (10) (12) Series A Preferred Units 2/28/2023 148 148 168 0.02 %
E-Technologies / Superior (8) (12) Partnership Interests 5/22/2024 1,000,000 1,000 806 0.08 %
Precision Surfacing Solutions (8) (10) (12) Common Units 10/3/2022 3,750,000 3,750 6,000 0.61 %
Total Capital Equipment 5,207 7,963 0.81 %
Construction & Building
Erie Construction (8) (12) Common Units 7/27/2021 166 166 528 0.05 %
Gannett Fleming (8) (12) Series F Units 5/26/2023 1,272,139 1,272 1,622 0.17 %
Gannett Fleming (8) (12) (15) Limited Partnership Interests 12/20/2022 894,607 895 1,141 0.12 %
Total Construction & Building 2,333 3,291 0.34 %
Consumer Goods: Non-durable
FoodScience LLC (8) (12) Class B Units 3/1/2021 5,168 5 112 0.01 %
FoodScience LLC (8) (12) Class A Units 3/1/2021 98 98 137 0.01 %
Ultima (8) (12) Preferred Units 9/12/2022 15 170 226 0.02 %
Total Consumer Goods: Non-durable 273 475 0.04 %
Containers, Packaging & Glass
Oliver Inc (8) (12) Class A Common Units 7/6/2022 11,916 1,131 742 0.07 %
Specialized Packaging Group (SPG) (7) (8) (10) (12) Class A Units 12/17/2020 147,708 148 168 0.02 %
Total Containers, Packaging & Glass 1,279 910 0.09 %
Healthcare & Pharmaceuticals
Anne Arundel (8) (12) AA Equity Co-Invest 9/14/2023 12,175 880 %
Health Management Associates (8) (12) Class A Common Units 3/31/2023 399,904 400 485 0.05 %
HemaSource (8) (12) LP Interests 8/31/2023 577,000 577 726 0.07 %
Mosaic Dental (8) (10) (12) Class A2 Units 2/7/2023 245 245 212 0.02 %
Total Healthcare & Pharmaceuticals 2,102 1,423 0.14 %
See Notes to Consolidated Financial Statements
24

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
High Tech Industries
ITSavvy (8) (12) Class A Common Units 8/8/2022 522 522 1,791 0.18 %
Solve Industrial (8) (12) LP Interests 6/30/2021 313 313 140 0.01 %
Total High Tech Industries 835 1,931 0.19 %
Media: Diversified & Production
BroadcastMed (8) (12) Series A-3 Preferred Units 10/4/2022 56,899 853 741 0.07 %
Total Media: Diversified & Production 853 741 0.07 %
Services: Business
Apex Companies (8) (10) (12) Class A Membership Interests 1/31/2023 1,173 117 139 0.01 %
Career Now (8) (12) Common Equity 9/30/2021 624 624 %
Career Now (8) (12) Series B Limited Partnership Units 10/14/2023 222 22 %
E78 (8) (12) Class A Common Units 12/1/2021 816 860 900 0.09 %
Esquire Deposition Services (8) (12) Class A Limited Partnership Units 7/1/2024 2,424 320 242 0.02 %
Output Services Group, Inc. (8) (10) (12) Class A Units 11/30/2023 47,021 833 907 0.10 %
Riveron (8) (12) Class A Units 7/17/2023 790 790 776 0.08 %
Total Services: Business 3,566 2,964 0.30 %
Services: Consumer
Legacy Service Partners (8) (12) Class B Units 1/9/2023 4,907 491 606 0.06 %
NearU (8) (9) (12) Limited Partnership Interests 8/8/2022 2,432 243 186 0.02 %
Palmetto Exterminators (8) (12) Class A Units 7/31/2023 997,000 1,117 1,202 0.13 %
Perennial Services Group (8) (10) (12) Class A Units 9/8/2023 7,784 778 1,125 0.11 %
Repipe Specialists (8) (10) (12) Purchased Units 3/18/2022 253 253 12 %
Total Services: Consumer 2,882 3,131 0.32 %
Sovereign & Public Finance
LMI (8) (12) Limited Partnership Interests 7/18/2022 633,980 634 1,295 0.13 %
Total Sovereign & Public Finance 634 1,295 0.13 %
See Notes to Consolidated Financial Statements
25

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Transportation: Cargo
RoadOne (8) (12) Partnership Units 12/29/2022 1,173,220 939 1,093 0.11 %
Seko Global Logistics LLC (8) (12) Equity Co-Invest 12/30/2020 671,203 332 %
Total Transportation: Cargo 1,271 1,093 0.11 %
Transportation: Consumer
American Student Transportation Partners (8) (12) Limited Partnership Interest 9/11/2023 102,475 102 94 0.01 %
Total Transportation: Consumer 102 94 0.01 %
Utilities: Electric
Pinnacle Supply Partners, LLC (8) (12) Subject Partnership Units 4/3/2023 279,687 280 251 0.03 %
Total Utilities: Electric 280 251 0.03 %
Utilities: Water
USA Water (8) (10) (12) Common Units 2/21/2024 4,781 478 556 0.06 %
Total Utilities: Water 478 556 0.06 %
Total Equity Investments 29,882 33,825 3.41 %
Portfolio Company (1) (2)
Interest Rate Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Cash Equivalents
BlackRock Liquidity Funds T-Fund - Institutional Class 4.76 % 62,452 62,452 62,452 6.30 %
First American Government Obligations Fund - Class Z 4.75 % 28 28 28 %
Total Cash Equivalents $ 62,480 $ 62,480 6.30 %
Total Investments and Cash Equivalents $ 2,137,845 $ 2,109,367 212.94 %
_______________
(1) All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a portfolio company is generally presumed to be “non-controlled” when the Company owns 25% or less of the portfolio company’s voting securities and “controlled” when the Company owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Company owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Company owns 5% or more of a portfolio company’s voting securities.
(2) Unless otherwise indicated, issuers of debt and equity held by the Company are domiciled in the United States.
(3) The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at September 30, 2024. As of September 30, 2024, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 4.85 %, 4.59 %, 4.25 %, and 3.78 % respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.
(4) Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.
(5) Percentage is based on net assets of $ 990,609 as of September 30, 2024.
See Notes to Consolidated Financial Statements
26

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
September 30, 2024
(dollar amounts in thousands)

(6) Denotes that all or a portion of the assets are owned by CLO-I, CLO-II and/or CLO-III (each as defined in Note 1 "Organization"), which serve as collateral for the 2022 Debt Securitization, the 2023 Debt Securitization, and 2024 Debt Securitization (each as defined in the Notes). See Note 6 "Secured Borrowings".
(7) This portfolio company is not domiciled in the United States. The principal place of business for Specialized Packing Group and Commercial Bakeries is Canada. The principal place of business for Phaidon International is the United Kingdom. The principal place of business for Insulation Technology Group is Germany.
(8) Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of September 30, 2024, the Company held forty-nine restricted securities with an aggregate fair value of $ 33,825 , or 3.41 % of the Company’s net assets.
(9) Investment is a unitranche position.
(10) The investment is considered a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70 % of the Company's total assets. As of September 30, 2024, total non-qualifying assets at fair value represented 5.30 % of the Company's total assets calculated in accordance with the 1940 Act.
(11) Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.
(12) Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.
(13) Denotes that all or a portion of the assets are owned by SPV IV and/or SPV V (each as defined in Note 1 "Organization"). SPV IV has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV IV. Accordingly, such assets are not available to other creditors of the Company. SPV V has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV V. Accordingly, such assets are not available to other creditors of the Company.
(14) Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.
(15) Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.
(16) Loan was on non-accrual status as of September 30, 2024.


See Notes to Consolidated Financial Statements
27

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Investments
Debt Investments
Aerospace & Defense
AEgis Technologies (6) (12) (13) First Lien Term Loan
S + 6.50 %
12.04 % 10/31/2025 $ 14,657 $ 14,592 $ 14,311 1.91 %
Arotech (6) (12) First Lien Term Loan
S + 6.25 %
11.70 % 10/22/2026 9,202 9,127 8,945 1.20 %
Arotech (Delayed Draw) (6) (12) (13) First Lien Term Loan
S + 6.25 %
11.70 % 10/22/2026 448 446 435 0.06 %
Loc Performance Products (6) (12) First Lien Term Loan
S + 5.25 %
10.71 % 12/22/2026 6,557 6,502 6,270 0.84 %
Precision Aviation Group (6) (12) (13) First Lien Term Loan
S + 5.75 %
11.12 % 12/21/2029 15,039 14,740 14,740 1.97 %
Precision Aviation Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.12 % 12/21/2029 4,961 ( 49 ) ( 99 ) ( 0.01 %)
Turbine Engine Specialist, Inc (12) Subordinated Debt
S + 9.50 %
14.96 % 3/1/2029 2,556 2,494 2,509 0.33 %
Valkyrie (12) Subordinated Debt N/A
10.50 % (Cash) 1.00 % (PIK)
11/17/2027 2,836 2,792 2,740 0.37 %
Total Aerospace & Defense 50,644 49,851 6.67 %
Automotive
American Auto Auction Group (6) (12) First Lien Term Loan
S + 5.00 %
10.50 % 12/30/2027 10,520 10,443 10,266 1.37 %
Classic Collision (Delayed Draw) (Incremental Tranche A-4) (11) (12) First Lien Term Loan
S + 5.75 %
11.29 % 1/14/2026 25,225 3,304 3,016 0.40 %
Classic Collision (Delayed Draw) (Incremental) (6) (12) (13) First Lien Term Loan
S + 5.75 %
11.29 % 1/14/2026 6,941 6,941 6,847 0.92 %
Classic Collision (Incremental) (6) (12) First Lien Term Loan
S + 5.75 %
11.29 % 1/14/2026 7,751 7,707 7,646 1.02 %
Collision Right (6) (12) (13) First Lien Term Loan
S + 5.25 %
10.50 % 4/14/2028 5,294 5,269 5,282 0.71 %
Collision Right (12) Subordinated Debt N/A
9.00 % (Cash) 3.75 % (PIK)
10/14/2028 1,411 1,380 1,371 0.18 %
Collision Right (Delayed Draw) (12) Subordinated Debt N/A
9.00 % (Cash) 3.75 % (PIK)
10/14/2028 996 985 968 0.13 %
Covercraft (12) Subordinated Debt N/A
10.00 % (Cash) 0.75 % (PIK)
2/20/2028 7,478 7,373 6,892 0.92 %
Covercraft (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 0.75 % (PIK)
2/20/2028 4,386 ( 344 ) ( 0.04 %)
High Bar Brands (12) Subordinated Debt N/A
9.00 % (Cash) 4.00 % (PIK)
6/19/2030 2,088 2,035 2,036 0.27 %
High Bar Brands (Delayed Draw) (11) (12) Subordinated Debt N/A
9.00 % (Cash) 4.00 % (PIK)
6/19/2030 596 ( 7 ) ( 15 ) %
JEGS Automotive (6) First Lien Term Loan
S + 6.00 %
11.46 % 12/22/2027 3,999 3,970 3,381 0.45 %
See Notes to Consolidated Financial Statements
28

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
OEP Glass Purchaser (6) (12) (13) First Lien Term Loan
S + 5.25 %
10.55 % 4/18/2028 12,563 12,467 12,508 1.67 %
Randys Holdings, Inc (6) (9) (12) (13) First Lien Term Loan
S + 6.50 %
11.88 % 11/1/2028 11,138 10,943 10,997 1.47 %
Randys Holdings, Inc (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.50 %
11.88 % 11/1/2028 3,750 ( 47 ) ( 0.01 %)
S&S Truck Parts (6) First Lien Term Loan
S + 5.00 %
10.19 % 3/1/2029 6,858 6,803 6,779 0.91 %
S&S Truck Parts (13) First Lien Term Loan
S + 5.00 %
10.19 % 3/1/2029 1,159 1,150 1,146 0.15 %
S&S Truck Parts (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
10.19 % 3/1/2029 98 ( 1 ) %
S&S Truck Parts (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
10.19 % 3/1/2029 1,724 1,576 1,556 0.21 %
Total Automotive 82,339 80,284 10.73 %
Banking, Finance, Insurance, Real Estate
Coding Solutions Acquisitions (6) (9) First Lien Term Loan
S + 5.75 %
11.11 % 5/11/2028 6,432 6,380 6,304 0.84 %
Coding Solutions Acquisitions (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
11.11 % 5/11/2028 1,966 1,966 1,927 0.26 %
Long Term Care Group (6) (9) (12) First Lien Term Loan
S + 1.00 %
6.66 % (Cash) 6.00 % (PIK)
9/8/2027 6,858 6,812 5,916 0.79 %
Patriot Growth Insurance Service (Delayed Draw) (Incremental) (9) (12) First Lien Term Loan
S + 5.75 %
11.25 % 10/14/2028 7,166 7,109 7,003 0.94 %
Risk Strategies (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.50 %
11.00 % 11/2/2026 14,869 14,869 14,606 1.95 %
Vensure Employer Services (6) (13) First Lien Term Loan
S + 4.75 %
10.12 % 3/26/2027 14,656 14,628 14,326 1.92 %
World Insurance Associates (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 6.00 %
11.35 % 4/3/2028 14,881 14,869 14,841 1.98 %
Total Banking, Finance, Insurance, Real Estate 66,633 64,923 8.68 %
Beverage, Food & Tobacco
Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries) (6) (7) (10) (12) (13) First Lien Term Loan
S + 6.25 %
11.60 % 9/25/2029 17,282 16,958 16,940 2.27 %
Bardstown PPC Holdings LLC (12) Subordinated Debt
S + 7.75 %
13.18 % 8/28/2027 9,300 9,154 9,154 1.22 %
Death Wish Coffee (6) (9) (13) First Lien Term Loan
S + 4.75 %
10.20 % 9/28/2027 9,800 9,739 9,800 1.31 %
Dessert Holdings Subordinated Debt
S + 7.25 %
12.72 % 6/10/2029 9,000 8,874 7,628 1.02 %
Fresh Edge (12) Subordinated Debt
S + 4.50 %
10.07 % (Cash) 5.13 % (PIK)
4/3/2029 3,853 3,772 3,765 0.50 %
See Notes to Consolidated Financial Statements
29

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Fresh Edge (Incremental) (12) Subordinated Debt
S + 4.50 %
9.98 % (Cash) 5.13 % (PIK)
4/3/2029 914 891 893 0.12 %
Fresh Edge (Incremental) (12) Subordinated Debt
S + 4.50 %
9.76 % (Cash) 5.13 % (PIK)
4/3/2029 769 752 752 0.10 %
Handgards (6) (13) First Lien Term Loan
S + 7.00 %
12.54 % 10/14/2026 14,513 14,364 14,513 1.94 %
Harvest Hill Beverage Company (12) Subordinated Debt
S + 9.00 %
14.46 % 2/28/2029 3,640 3,540 3,573 0.48 %
KSLB Holdings LLC (13) First Lien Term Loan
S + 4.50 %
10.03 % 7/30/2025 2,858 2,844 2,712 0.36 %
Palmetto Acquisitionco, Inc. (6) (12) (13) First Lien Term Loan
S + 5.75 %
11.10 % 9/18/2029 13,314 13,091 13,085 1.74 %
Palmetto Acquisitionco, Inc. (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.10 % 9/18/2029 4,842 1,169 1,103 0.15 %
Rise Baking (6) (9) (13) First Lien Term Loan
S + 6.25 %
11.71 % 8/13/2027 14,700 14,554 14,852 1.99 %
Rise Baking (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.50 %
10.96 % 8/13/2027 4,454 4,432 4,400 0.59 %
Summit Hill Foods (6) First Lien Term Loan
S + 6.00 %
11.39 % 11/29/2029 9,835 9,689 9,690 1.30 %
Sunny Sky Products (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.60 % 12/23/2028 1,773 ( 17 ) %
Sunny Sky Products (12) (13) First Lien Term Loan
S + 5.25 %
10.60 % 12/23/2028 7,093 7,025 7,026 0.94 %
Watermill Express, LLC (6) (9) First Lien Term Loan
S + 5.00 %
10.50 % 4/20/2027 3,256 3,236 3,241 0.43 %
Watermill Express, LLC (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.00 %
10.50 % 4/20/2027 314 315 313 0.04 %
Total Beverage, Food & Tobacco 124,399 123,423 16.50 %
Capital Equipment
Crete Mechanical Group (6) First Lien Term Loan
S + 5.00 %
10.37 % 5/19/2028 4,823 4,785 4,708 0.63 %
Crete Mechanical Group (Delayed Draw) (6) First Lien Term Loan
S + 5.00 %
10.37 % 5/19/2028 2,846 2,807 2,778 0.37 %
Crete Mechanical Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
10.37 % 5/19/2028 7,153 5,710 5,539 0.74 %
EFC Holdings, LLC (12) Subordinated Debt N/A
11.00 % (Cash) 2.50 % (PIK)
5/1/2028 3,167 3,083 3,137 0.42 %
Heartland Home Services (6) (9) (13) First Lien Term Loan
S + 6.00 %
11.36 % 12/15/2026 6,467 6,428 6,382 0.85 %
Heartland Home Services (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 6.00 %
11.36 % 12/15/2026 5,608 5,589 5,533 0.74 %
Heartland Home Services (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 6.00 %
11.36 % 12/15/2026 2,571 2,571 2,537 0.34 %
Ovation Holdings, Inc. (6) (13) First Lien Term Loan
S + 6.25 %
11.78 % 2/3/2029 8,035 7,876 7,949 1.06 %
Ovation Holdings, Inc. (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.78 % 2/3/2029 1,899 1,535 1,536 0.21 %
Precision Surfacing (12) First Lien Term Loan
N/A
15.00 % 6/30/2024 713 713 713 0.09 %
PT Intermediate Holdings III, LLC (6) (9) (13) First Lien Term Loan
S + 5.98 %
11.52 % 11/1/2028 8,735 8,711 8,664 1.16 %
See Notes to Consolidated Financial Statements
30

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
PT Intermediate Holdings III, LLC (Incremental) (6) (9) (13) First Lien Term Loan
S + 5.98 %
11.47 % 11/1/2028 1,068 1,059 1,059 0.14 %
Repipe Specialists (12) Subordinated Debt N/A
10.00 % (Cash) 1.00 % (PIK)
3/18/2029 2,433 2,393 2,207 0.30 %
Repipe Specialists (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 1.00 % (PIK)
3/18/2029 901 210 126 0.01 %
RTH Buyer LLC (dba Rhino Tool House) (12) (13) First Lien Term Loan
S + 6.25 %
11.97 % 4/4/2029 8,052 7,902 7,986 1.07 %
RTH Buyer LLC (dba Rhino Tool House) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.97 % 4/4/2029 1,885 956 949 0.13 %
Total Capital Equipment 62,328 61,803 8.26 %
Chemicals, Plastics, & Rubber
Ascensus (12) (15) Subordinated Debt
S + 6.50 %
12.18 % 8/2/2029 9,000 8,935 8,691 1.16 %
Ascensus Specialties (6) (9) (13) First Lien Term Loan
S + 4.25 %
9.71 % 6/30/2028 9,731 9,589 8,776 1.17 %
Boulder Scientific Company LLC (6) First Lien Term Loan
S + 4.50 %
10.04 % 12/28/2025 2,064 2,073 1,996 0.27 %
Chroma Color Corporation (dba Chroma Color) (6) (13) First Lien Term Loan
S + 6.00 %
11.41 % 4/21/2029 6,314 6,197 6,199 0.83 %
Chroma Color Corporation (dba Chroma Color) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.41 % 4/21/2029 1,379 ( 12 ) ( 25 ) %
Spartech (6) (9) (12) (13) First Lien Term Loan
S + 4.75 %
10.16 % 5/6/2028 14,768 14,699 11,898 1.59 %
Total Chemicals, Plastics, & Rubber 41,481 37,535 5.02 %
Construction & Building
Allstar Holdings (12) Subordinated Debt N/A
10.00 % (Cash) 3.00 % (PIK)
4/26/2030 2,114 2,053 2,054 0.27 %
Allstar Holdings (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 3.00 % (PIK)
4/26/2030 4,043 2,803 2,745 0.37 %
Allstar Holdings (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 3.00 % (PIK)
4/26/2030 6,188 ( 88 ) ( 175 ) ( 0.02 %)
Erie Construction (6) (13) First Lien Term Loan
S + 4.75 %
10.21 % 7/30/2027 10,153 10,083 10,153 1.36 %
Gannett Fleming (6) (13) First Lien Term Loan
S + 6.60 %
11.95 % 12/20/2028 9,900 9,730 9,913 1.32 %
MEI Rigging & Crating (6) (12) (13) First Lien Term Loan
S + 6.50 %
11.86 % 6/30/2029 11,431 11,212 11,329 1.51 %
MEI Rigging & Crating (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.50 %
11.86 % 6/30/2029 1,814 ( 8 ) ( 16 ) %
Royal Holdco Corporation (Delayed Draw A) (11) (12) First Lien Term Loan
S + 5.75 %
11.21 % 12/30/2027 4,690 4,303 4,246 0.57 %
Royal Holdco Corporation (Delayed Draw B) (11) (12) First Lien Term Loan
S + 5.75 %
11.21 % 12/30/2027 3,134 ( 7 ) ( 45 ) ( 0.01 %)
See Notes to Consolidated Financial Statements
31

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Royal Holdco Corporation (Incremental) (10) (12) (13) First Lien Term Loan
S + 5.75 %
11.21 % 12/30/2027 3,118 3,074 3,073 0.41 %
Sciens Building Solutions, LLC (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.23 % 12/15/2027 9,315 9,183 9,128 1.22 %
Sciens Building Solutions, LLC (Delayed Draw) (6) (9) (11) (12) (13) First Lien Term Loan
S + 5.75 %
11.23 % 12/15/2027 4,915 3,259 3,193 0.43 %
WSB Engineering Holdings Inc. (12) (13) First Lien Term Loan
S + 6.00 %
11.39 % 8/31/2029 6,519 6,426 6,424 0.86 %
WSB Engineering Holdings Inc. (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.39 % 8/31/2029 4,357 ( 31 ) ( 64 ) ( 0.01 %)
Total Construction & Building 61,992 61,958 8.28 %
Consumer Goods: Durable
Halo Buyer Inc (6) (15) First Lien Term Loan
S + 4.50 %
9.96 % 6/28/2025 5,668 5,641 4,284 0.57 %
Petmate (6) (9) (12) First Lien Term Loan
S + 5.50 %
11.23 % 9/15/2028 9,825 9,753 5,846 0.78 %
Xpressmyself.com LLC (a/k/a SmartSign) (6) (13) First Lien Term Loan
S + 5.50 %
10.98 % 9/7/2028 9,875 9,796 9,701 1.30 %
Xpressmyself.com LLC (a/k/a SmartSign) (6) First Lien Term Loan
S + 5.75 %
11.22 % 9/7/2028 5,025 4,932 4,983 0.67 %
Total Consumer Goods: Durable 30,122 24,814 3.32 %
Consumer Goods: Non-durable
Arcadia Consumer Health (6) (9) (13) First Lien Term Loan
S + 4.50 %
9.98 % 9/10/2027 12,604 12,522 12,192 1.63 %
Arcadia Consumer Health (Incremental) (9) (12) (13) First Lien Term Loan
S + 5.75 %
11.23 % 9/10/2027 2,256 2,216 2,251 0.30 %
Badger Sportswear Acquisition Inc (6) First Lien Term Loan
S + 4.50 %
10.03 % 1/7/2024 3,800 3,800 3,800 0.51 %
FoodScience (6) (12) First Lien Term Loan
S + 6.00 %
11.73 % 3/1/2027 7,744 7,696 7,081 0.95 %
FoodScience (6) (12) First Lien Term Loan
S + 6.00 %
12.23 % 3/1/2027 6,880 6,831 6,291 0.84 %
Protective Industrial Products (“PIP”) (6) (9) (12) (13) First Lien Term Loan
S + 5.00 %
10.47 % 12/29/2027 4,860 4,684 4,909 0.66 %
Elevation Labs (6) (13) First Lien Term Loan
S + 5.75 %
11.23 % 6/30/2028 6,789 6,733 6,335 0.85 %
Elevation Labs (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.23 % 6/30/2028 3,125 ( 24 ) ( 209 ) ( 0.03 %)
Market Performance Group (6) (13) First Lien Term Loan
S + 5.50 %
11.03 % 12/29/2026 2,505 2,489 2,505 0.33 %
Market Performance Group (6) (13) First Lien Term Loan
S + 5.50 %
11.03 % 12/29/2026 7,275 7,256 7,275 0.97 %
Ultima Health Holdings, LLC (12) Subordinated Debt N/A
11.00 % (Cash) 1.50 % (PIK)
3/12/2029 1,734 1,706 1,704 0.23 %
Total Consumer Goods: Non-durable 55,909 54,134 7.24 %
See Notes to Consolidated Financial Statements
32

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Containers, Packaging & Glass
B2B Packaging (6) (13) First Lien Term Loan
S + 6.75 %
12.28 % 10/7/2026 14,696 14,663 14,398 1.93 %
B2B Packaging (Delayed Draw) (6) First Lien Term Loan
S + 6.75 %
12.29 % 10/7/2026 116 114 114 0.02 %
Five Star Packing (6) (13) (15) First Lien Term Loan
S + 4.25 %
9.63 % 5/6/2029 7,576 7,482 7,482 1.00 %
Good2Grow (12) (13) First Lien Term Loan
S + 5.50 %
11.04 % 12/1/2027 6,362 6,270 6,362 0.85 %
Good2Grow (6) (13) First Lien Term Loan
S + 4.50 %
10.04 % 12/1/2027 9,265 9,201 9,137 1.22 %
Oliver Packaging (12) Subordinated Debt N/A
10.00 % (Cash) 1.00 % (PIK)
1/6/2029 2,510 2,471 2,377 0.32 %
Online Labels Group (13) First Lien Term Loan
S + 5.25 %
10.61 % 12/19/2029 3,328 3,295 3,296 0.44 %
Online Labels Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.61 % 12/19/2029 403 ( 4 ) %
Online Labels Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.61 % 12/19/2029 403 ( 4 ) %
Specialized Packaging Group (6) (7) (10) (13) First Lien Term Loan
S + 5.50 %
11.23 % 12/17/2025 2,983 2,968 2,921 0.39 %
Specialized Packaging Group (6) (7) (10) (13) First Lien Term Loan
S + 5.50 %
11.23 % 12/17/2025 7,275 7,236 7,123 0.95 %
Specialized Packaging Group (Incremental) (7) (10) (13) First Lien Term Loan
S + 6.25 %
11.98 % 12/17/2025 4,409 4,354 4,375 0.58 %
Specialized Packaging Group (Incremental) (7) (10) (12) (13) First Lien Term Loan
S + 6.25 %
11.78 % 12/17/2025 6,894 6,798 6,751 0.90 %
Total Containers, Packaging & Glass 64,852 64,328 8.60 %
Energy: Electricity
MGM Transformer Company (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.38 % 10/31/2029 6,388 ( 16 ) ( 92 ) ( 0.01 %)
MGM Transformer Company (6) (12) (13) First Lien Term Loan
S + 6.00 %
11.38 % 10/31/2029 23,612 23,259 23,271 3.11 %
National Power (12) (13) First Lien Term Loan
S + 6.00 %
11.36 % 10/20/2029 5,674 5,589 5,593 0.75 %
National Power (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.36 % 10/20/2029 3,051 ( 7 ) ( 44 ) ( 0.01 %)
Total Energy: Electricity 28,825 28,728 3.84 %
Environmental Industries
Impact Environmental Group (12) (13) First Lien Term Loan
S + 6.00 %
11.28 % 3/23/2029 6,776 6,650 6,721 0.90 %
Impact Environmental Group (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.28 % 3/23/2029 3,166 2,770 2,759 0.37 %
Impact Environmental Group (Incremental) (12) First Lien Term Loan
S + 6.00 %
11.28 % 3/23/2029 1,736 1,703 1,722 0.23 %
See Notes to Consolidated Financial Statements
33

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Impact Environmental Group (Delayed Draw) (Incremental) (11) (12) First Lien Term Loan
S + 6.00 %
11.28 % 3/23/2029 6,822 ( 32 ) ( 55 ) ( 0.01 %)
Nutrition 101 Buyer LLC (a/k/a 101, Inc.) (6) (13) First Lien Term Loan
S + 5.25 %
10.73 % 8/31/2028 6,648 6,596 6,518 0.87 %
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (6) (12) (13) First Lien Term Loan
S + 6.25 %
11.65 % 7/1/2029 8,550 8,426 8,429 1.13 %
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.65 % 7/1/2029 6,429 ( 15 ) ( 91 ) ( 0.01 %)
The Facilities Group (6) (9) First Lien Term Loan
S + 5.75 %
11.23 % 11/30/2027 4,872 4,840 4,847 0.64 %
The Facilities Group (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
11.22 % 11/30/2027 5,028 ( 25 ) %
The Facilities Group (9) (13) First Lien Term Loan
S + 5.75 %
11.22 % 11/30/2027 9,051 8,963 9,006 1.20 %
The Facilities Group (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 5.75 %
11.22 % 11/30/2027 4,952 4,952 4,927 0.66 %
Total Environmental Industries 44,853 44,758 5.98 %
Healthcare & Pharmaceuticals
Affinity Hospice (6) (12) First Lien Term Loan
S + 4.75 %
10.20 % 12/17/2027 7,872 7,817 7,048 0.94 %
Anne Arundel (12) Subordinated Debt
N/A
12.75 % (PIK)
10/16/2026 3,282 3,247 2,656 0.36 %
Anne Arundel (12) Subordinated Debt N/A
11.00 % (PIK)
4/16/2026 1,972 1,957 1,776 0.24 %
Anne Arundel (Delayed Draw) (11) (12) Subordinated Debt N/A
11.00 % (PIK)
4/16/2026 2,396 2,022 1,790 0.24 %
Forefront Dermatology (6) (9) (12) (15) First Lien Term Loan
S + 4.25 %
9.63 % 4/1/2029 3,315 3,268 3,215 0.43 %
Genesee Scientific (6) (9) First Lien Term Loan
S + 5.50 %
10.95 % 9/30/2027 5,959 5,922 5,839 0.78 %
Genesee Scientific (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.50 %
10.95 % 9/30/2027 1,560 1,560 1,528 0.20 %
GHR Healthcare (6) (9) First Lien Term Loan
S + 5.00 %
10.50 % 12/8/2027 6,401 6,359 6,255 0.84 %
GHR Healthcare (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 5.00 %
10.50 % 12/9/2027 2,002 2,002 1,957 0.26 %
GHR Healthcare (Incremental) (13) First Lien Term Loan
S + 5.00 %
10.50 % 12/9/2027 4,983 4,904 4,869 0.65 %
Health Management Associates (12) (13) First Lien Term Loan
S + 6.50 %
11.73 % 3/31/2029 8,307 8,154 8,233 1.10 %
Health Management Associates (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.50 %
11.73 % 3/31/2029 1,499 444 460 0.06 %
Heartland Veterinary Partners LLC (Incremental) (12) Subordinated Debt
S + 7.50 %
12.96 % 12/10/2027 1,900 1,872 1,875 0.25 %
Heartland Veterinary Partners LLC (Incremental) (Delayed Draw) (12) Subordinated Debt
S + 7.50 %
12.96 % 12/10/2027 9,500 9,500 9,377 1.25 %
See Notes to Consolidated Financial Statements
34

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
HemaSource Inc. (12) Subordinated Debt N/A
8.50 % (Cash) 5.00 % (PIK)
2/28/2030 5,292 5,153 5,147 0.69 %
InfuCare RX (6) (12) (13) First Lien Term Loan
S + 4.50 %
9.95 % 1/4/2028 9,248 9,182 9,045 1.21 %
MDC Intermediate Holdings II, LLC (12) Subordinated Debt N/A
10.00 % (Cash) 2.25 % (PIK)
2/7/2030 1,749 1,711 1,690 0.23 %
MDC Intermediate Holdings II, LLC (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 2.25 % (PIK)
2/7/2030 721 160 143 0.02 %
Midwest Eye Consultants (6) (13) First Lien Term Loan
S + 4.50 %
10.04 % 8/20/2027 9,021 8,962 8,790 1.18 %
PromptCare (6) (9) (13) First Lien Term Loan
S + 6.00 %
11.46 % 9/1/2027 8,204 8,121 8,079 1.08 %
PromptCare (Delayed Draw) (6) (9) (12) (13) First Lien Term Loan
S + 6.00 %
11.46 % 9/1/2027 1,278 1,271 1,258 0.17 %
Quorum Health Resources, LLC (6) (13) First Lien Term Loan
S + 5.75 %
11.50 % 5/28/2027 7,680 7,627 7,552 1.01 %
Quorum Health Resources, LLC (Delayed Draw) (Incremental) (6) (10) (12) First Lien Term Loan
S + 6.25 %
11.68 % 5/28/2027 3,248 3,240 3,240 0.43 %
Quorum Health Resources, LLC (Incremental) (10) (12) (13) First Lien Term Loan
S + 6.25 %
11.68 % 5/28/2027 3,248 3,201 3,240 0.43 %
Sandlot Buyer, LLC (Prime Time Healthcare) (6) (12) (13) First Lien Term Loan
S + 6.00 %
11.28 % 9/19/2028 8,958 8,729 8,854 1.18 %
Sandlot Buyer, LLC (Prime Time Healthcare) (Incremental) (12) (13) First Lien Term Loan
S + 6.00 %
11.52 % 9/19/2028 10,122 9,924 10,004 1.34 %
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (6) (13) First Lien Term Loan
S + 5.75 %
11.21 % 10/7/2029 7,474 7,408 7,382 0.99 %
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.21 % 10/7/2029 2,443 1,558 1,528 0.21 %
SM Wellness Holdings, Inc (6) (12) (13) First Lien Term Loan
S + 4.75 %
10.14 % 4/15/2028 14,665 14,573 14,187 1.90 %
Thorne HealthTech (6) (12) (13) First Lien Term Loan
S + 5.75 %
11.10 % 10/16/2030 10,652 10,549 10,553 1.41 %
TIDI Products (6) (9) (12) (13) First Lien Term Loan
S + 5.50 %
10.86 % 12/19/2029 15,523 15,368 15,369 2.05 %
TIDI Products (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
10.86 % 12/19/2029 4,085 ( 40 ) ( 0.01 %)
US Fertility (12) Subordinated Debt
N/A
13.75 % (PIK)
6/21/2028 12,391 12,084 12,066 1.61 %
Wellspring Pharmaceutical (13) First Lien Term Loan
S + 5.75 %
11.03 % 8/22/2028 3,378 3,323 3,298 0.44 %
Wellspring Pharmaceutical (Delayed Draw) (12) First Lien Term Loan
S + 5.75 %
11.03 % 8/22/2028 1,571 1,561 1,534 0.21 %
Wellspring Pharmaceutical (Delayed Draw) (Incremental) (11) (12) First Lien Term Loan
S + 6.00 %
11.18 % 8/22/2028 3,756 ( 16 ) ( 55 ) ( 0.01 %)
Wellspring Pharmaceutical (Incremental) (12) (13) First Lien Term Loan
S + 6.00 %
11.18 % 8/22/2028 1,246 1,223 1,228 0.16 %
Young Innovations (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
11.09 % 12/1/2029 3,448 ( 34 ) %
See Notes to Consolidated Financial Statements
35

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Young Innovations (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.09 % 12/1/2029 16,552 16,386 16,391 2.19 %
Total Healthcare & Pharmaceuticals 210,326 207,327 27.72 %
High Tech Industries
Acclaim MidCo, LLC (dba ClaimLogiQ) (6) (12) (13) First Lien Term Loan
S + 6.00 %
11.35 % 6/13/2029 8,021 7,870 7,951 1.06 %
Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.35 % 6/13/2029 3,225 ( 15 ) ( 28 ) %
Argano, LLC (6) First Lien Term Loan
S + 5.50 %
11.69 % 6/10/2026 5,634 5,602 5,510 0.74 %
Argano, LLC (Delayed Draw) (6) (13) First Lien Term Loan
S + 5.50 %
11.69 % 6/10/2026 2,494 2,494 2,440 0.33 %
Argano, LLC (Delayed Draw) (Incremental) (6) First Lien Term Loan
S + 5.50 %
11.69 % 6/10/2026 1,705 1,676 1,667 0.22 %
Diligent Corporation (6) (9) (12) First Lien Term Loan
S + 6.25 %
11.78 % 7/31/2025 12,469 12,451 12,366 1.65 %
Diligent Corporation (9) (12) (13) First Lien Term Loan
S + 5.75 %
11.28 % 7/31/2025 3,387 3,372 3,334 0.45 %
Diligent Corporation (9) (12) First Lien Term Loan
S + 5.75 %
11.28 % 8/4/2025 1,476 1,469 1,453 0.19 %
Diligent Corporation (Delayed Draw) (9) (12) First Lien Term Loan
S + 6.25 %
11.78 % 7/31/2025 168 168 166 0.02 %
Diligent Corporation (Delayed Draw) (9) (12) First Lien Term Loan
S + 6.25 %
11.78 % 7/31/2025 106 106 105 0.01 %
Eliassen Group LLC (6) (9) (12) (13) First Lien Term Loan
S + 5.50 %
10.85 % 4/14/2028 12,069 11,976 12,083 1.62 %
Eliassen Group LLC (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
10.85 % 4/14/2028 2,771 864 872 0.11 %
Evergreen Services Group II (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
11.35 % 10/4/2030 13,014 8,495 8,342 1.11 %
Evergreen Services Group II (6) (9) (12) (13) First Lien Term Loan
S + 6.00 %
11.35 % 10/4/2030 16,156 15,917 15,926 2.13 %
Exterro (6) (9) (12) (13) First Lien Term Loan
S + 5.50 %
11.03 % 6/1/2027 9,474 9,462 9,503 1.27 %
Fineline Merger (12) Subordinated Debt
S + 9.26 %
14.61 % 8/22/2028 2,453 2,427 2,453 0.33 %
Go Engineer (6) (9) (13) First Lien Term Loan
S + 5.38 %
10.87 % 12/21/2027 11,572 11,490 11,409 1.53 %
Go Engineer (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.38 %
10.87 % 12/21/2027 3,152 3,130 3,107 0.42 %
Infinite Electronics (Incremental) (6) (9) (13) First Lien Term Loan
S + 6.25 %
11.88 % 3/2/2028 6,313 6,152 6,100 0.82 %
Infobase Acquisition, Inc. (6) (13) First Lien Term Loan
S + 5.50 %
10.93 % 6/14/2028 4,331 4,297 4,297 0.57 %
Infobase Acquisition, Inc. (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
10.93 % 6/14/2028 721 ( 6 ) %
ITSavvy LLC (6) (13) First Lien Term Loan
S + 5.25 %
10.89 % 8/8/2028 7,794 7,730 7,794 1.04 %
ITSavvy LLC (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.89 % 8/8/2028 1,049 883 891 0.12 %
See Notes to Consolidated Financial Statements
36

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
North Haven CS Acquisition Inc (6) First Lien Term Loan
S + 5.25 %
10.78 % 1/23/2025 5,787 5,787 5,787 0.77 %
Prosci, Inc. (6) First Lien Term Loan
S + 4.50 %
9.99 % 10/21/2026 4,733 4,704 4,708 0.63 %
Revalize (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.21 % 4/15/2027 4,243 4,232 4,064 0.54 %
Revalize (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 5.75 %
11.21 % 4/15/2027 1,090 1,083 1,044 0.14 %
Revalize (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
11.25 % 4/15/2027 244 243 234 0.03 %
SmartWave (6) (12) First Lien Term Loan
S + 6.00 %
11.53 % 11/5/2026 9,214 9,145 7,744 1.04 %
Solve Industrial Motion Group (12) Subordinated Debt
N/A
5.00 % (Cash) 8.00 % (PIK)
6/30/2028 1,786 1,760 1,700 0.23 %
Solve Industrial Motion Group (12) Subordinated Debt N/A
5.00 % (Cash) 8.00 % (PIK)
6/28/2028 763 749 739 0.10 %
Solve Industrial Motion Group (Delayed Draw) (12) Subordinated Debt N/A
5.00 % (Cash) 8.00 % (PIK)
6/30/2028 2,046 2,046 1,947 0.26 %
Total High Tech Industries 147,765 145,702 19.48 %
Media: Advertising, Printing & Publishing
Tinuiti (6) (9) First Lien Term Loan
S + 5.25 %
10.70 % 12/10/2026 2,948 2,928 2,823 0.38 %
Tinuiti (Delayed Draw) (6) (9) First Lien Term Loan
S + 5.25 %
10.70 % 12/10/2026 1,926 1,926 1,845 0.25 %
Tinuiti (Delayed Draw) (Incremental) (6) (12) First Lien Term Loan
S + 5.25 %
10.70 % 12/10/2026 9,863 9,863 9,445 1.26 %
Wpromote (13) First Lien Term Loan
S + 5.75 %
11.19 % 10/21/2028 4,379 4,304 4,344 0.58 %
Wpromote (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.19 % 10/21/2028 588 ( 4 ) ( 5 ) %
Total Media: Advertising, Printing & Publishing 19,017 18,452 2.47 %
Media: Diversified & Production
Corporate Visions (6) First Lien Term Loan
S + 4.50 %
9.96 % 8/12/2027 2,887 2,867 2,752 0.37 %
Corporate Visions (6) First Lien Term Loan
S + 4.50 %
9.96 % 8/12/2027 2,538 2,509 2,419 0.32 %
Spectrio II (6) (9) (12) (13) First Lien Term Loan
S + 6.00 %
6.50 % (Cash) 5.00 % (PIK)
12/9/2026 8,143 8,100 7,556 1.01 %
Spectrio II (Delayed Draw) (6) (9) (12) First Lien Term Loan
S + 6.00 %
6.50 % (Cash) 5.00 % (PIK)
12/9/2026 2,893 2,875 2,684 0.36 %
Spectrio II (Delayed Draw) (9) (13) First Lien Term Loan
S + 6.00 %
6.50 % (Cash) 5.00 % (PIK)
12/9/2026 441 440 407 0.06 %
Total Media: Diversified & Production 16,791 15,818 2.12 %
Retail
Syndigo (6) First Lien Term Loan
S + 4.50 %
9.97 % 12/14/2027 5,835 5,850 5,747 0.77 %
Total Retail 5,850 5,747 0.77 %
See Notes to Consolidated Financial Statements
37

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Services: Business
ALKU Intermediate Holdings, LLC (12) (13) First Lien Term Loan
S + 6.25 %
11.61 % 5/23/2029 4,519 4,434 4,480 0.60 %
Apex Companies Holdings, LLC (12) Subordinated Debt N/A
10.00 % (Cash) 2.50 % (PIK)
1/31/2029 3,964 3,879 3,953 0.53 %
Apex Companies Holdings, LLC (Delayed Draw) (11) (12) Subordinated Debt N/A
10.00 % (Cash) 2.50 % (PIK)
1/31/2029 1,197 69 79 0.01 %
ARMstrong (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.70 % 10/6/2029 3,847 ( 28 ) ( 55 ) ( 0.01 %)
ARMstrong (6) (12) (13) First Lien Term Loan
S + 6.25 %
11.70 % 10/6/2029 11,447 11,279 11,284 1.51 %
Big Truck Rental (12) Subordinated Debt
S + 8.00 %
13.47 % 9/30/2027 10,000 9,858 10,000 1.34 %
Big Truck Rental (12) Subordinated Debt
S + 8.00 %
13.47 % 9/30/2027 2,500 2,500 2,500 0.33 %
Bounteous (6) (12) (13) First Lien Term Loan
S + 5.25 %
10.74 % 8/2/2027 5,347 5,310 5,083 0.68 %
Bounteous (6) (12) First Lien Term Loan
S + 5.25 %
10.74 % 8/2/2027 2,189 2,173 2,080 0.28 %
Bounteous (Delayed Draw) (6) (12) First Lien Term Loan
S + 5.25 %
10.74 % 8/2/2027 2,768 2,750 2,631 0.35 %
Bounteous (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.25 %
10.74 % 8/2/2027 4,467 ( 221 ) ( 0.03 %)
BroadcastMed Holdco, LLC (12) Subordinated Debt N/A
10.00 % (Cash) 3.75 % (PIK)
11/12/2027 3,483 3,424 3,369 0.45 %
Bullhorn Inc (6) (9) (12) (13) First Lien Term Loan
S + 5.75 %
10.96 % 9/30/2026 13,706 13,609 13,706 1.83 %
BusinesSolver (6) (9) (12) First Lien Term Loan
S + 5.50 %
10.96 % 12/1/2027 7,741 7,686 7,738 1.03 %
BusinesSolver (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
10.96 % 12/1/2027 1,149 176 179 0.02 %
Career Now (12) Subordinated Debt N/A
13.00 % (PIK)
3/27/2027 3,277 3,237 2,425 0.32 %
Cornerstone Advisors of Arizona LLC (6) First Lien Term Loan
S + 5.50 %
11.07 % 9/24/2026 308 306 308 0.04 %
Cornerstone Advisors of Arizona LLC (6) First Lien Term Loan
S + 5.50 %
11.07 % 9/24/2026 2,295 2,283 2,295 0.31 %
Cornerstone Advisors of Arizona LLC (Delayed Draw) (6) First Lien Term Loan
S + 5.50 %
11.07 % 9/24/2026 210 210 210 0.03 %
CrossCountry Consulting (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.21 % 6/1/2029 8,174 8,037 8,217 1.10 %
CrossCountry Consulting (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.75 %
11.21 % 6/1/2029 3,320 ( 26 ) 17 %
D&H United Fueling Solutions (6) (13) First Lien Term Loan
S + 5.50 %
11.03 % 9/16/2028 7,491 7,368 7,290 0.97 %
D&H United Fueling Solutions (Delayed Draw) (6) First Lien Term Loan
S + 5.50 %
11.03 % 9/16/2028 2,384 2,365 2,320 0.31 %
D&H United Fueling Solutions (Delayed Draw) (Incremental) (11) (12) First Lien Term Loan
S + 6.00 %
11.50 % 9/16/2028 1,567 ( 7 ) ( 13 ) %
D&H United Fueling Solutions (Incremental) (6) (13) First Lien Term Loan
S + 6.00 %
11.50 % 9/16/2028 3,465 3,401 3,436 0.46 %
E78 (6) First Lien Term Loan
S + 5.75 %
11.21 % 12/1/2027 5,600 5,560 5,489 0.74 %
See Notes to Consolidated Financial Statements
38

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
E78 (13) First Lien Term Loan
S + 5.75 %
11.21 % 12/1/2027 1,438 1,426 1,409 0.19 %
E78 (Delayed Draw) (6) (13) First Lien Term Loan
S + 5.75 %
11.21 % 12/1/2027 4,210 4,180 4,127 0.55 %
E78 (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.75 %
11.21 % 12/1/2027 3,550 979 909 0.12 %
Evergreen Services Group (6) (9) (12) (13) First Lien Term Loan
S + 6.25 %
11.70 % 6/15/2029 11,966 11,766 11,733 1.57 %
Evergreen Services Group (Delayed Draw) (9) (12) First Lien Term Loan
S + 6.25 %
11.70 % 6/15/2029 2,863 2,839 2,807 0.38 %
Gabriel Partners LLC (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.53 % 9/21/2026 9,192 9,144 9,192 1.23 %
Gabriel Partners LLC (Delayed Draw) (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.53 % 9/21/2026 1,531 1,531 1,531 0.20 %
Gabriel Partners LLC (Incremental) (9) (13) First Lien Term Loan
S + 5.75 %
11.53 % 9/21/2026 3,794 3,771 3,794 0.51 %
Keng Acquisition, Inc. (Engage Group Holdings, LLC) (9) (12) (13) First Lien Term Loan
S + 6.25 %
11.60 % 8/1/2029 9,667 9,526 9,528 1.27 %
Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.25 %
11.60 % 8/1/2029 9,314 1,179 1,067 0.14 %
KRIV Acquisition, Inc (6) (12) (13) First Lien Term Loan
S + 6.50 %
11.85 % 7/6/2029 10,764 10,476 10,453 1.40 %
KRIV Acquisition, Inc (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.50 %
11.85 % 7/6/2029 1,607 ( 19 ) ( 46 ) ( 0.01 %)
Lion Merger Sub Inc (9) (13) First Lien Term Loan
S + 6.00 %
11.45 % 12/17/2025 7,342 7,308 7,259 0.97 %
Lion Merger Sub Inc (Incremental) (9) (12) (13) First Lien Term Loan
S + 6.00 %
11.45 % 12/17/2025 7,317 7,252 7,234 0.97 %
LSCS Holdings Inc. (6) (13) (15) First Lien Term Loan
S + 4.50 %
9.86 % 12/16/2028 9,800 9,762 9,675 1.30 %
LYNX FRANCHISING, LLC (6) (9) First Lien Term Loan
S + 6.75 %
12.47 % 12/23/2026 9,800 9,725 9,699 1.30 %
Micronics (12) Subordinated Debt
S + 5.25 %
10.00 % 2/17/2027 2,450 2,401 2,401 0.32 %
Output Services Group, Inc. (10) (12) First Lien Term Loan
S + 8.00 %
13.39 % 5/30/2028 155 155 155 0.02 %
Output Services Group, Inc. (12) First Lien Term Loan
S + 6.25 %
7.32 % (Cash) 4.75 % (PIK)
5/30/2028 837 837 837 0.11 %
Phaidon International (6) (7) (10) (12) (13) First Lien Term Loan
S + 5.50 %
10.96 % 8/22/2029 14,010 13,892 14,010 1.88 %
Plaze (12) Subordinated Debt
S + 7.50 %
12.97 % 7/7/2028 13,500 13,201 12,465 1.67 %
Scaled Agile (6) (9) First Lien Term Loan
S + 5.50 %
10.95 % 12/16/2028 7,936 7,875 7,623 1.02 %
Scaled Agile (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.50 %
10.95 % 12/16/2028 390 390 375 0.05 %
Smile Brands (12) Subordinated Debt
S + 8.50 %
14.99 % (PIK)
4/12/2028 9,947 9,866 8,665 1.16 %
Soliant Health (6) First Lien Term Loan
S + 4.00 %
9.47 % 4/1/2028 2,628 2,615 2,628 0.35 %
Technical Safety Services (6) (13) First Lien Term Loan
S + 5.50 %
11.00 % 6/22/2029 6,772 6,716 6,712 0.90 %
Technical Safety Services (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.50 %
11.00 % 6/22/2029 6,404 3,903 3,918 0.52 %
See Notes to Consolidated Financial Statements
39

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Technical Safety Services (Incremental) (12) First Lien Term Loan
S + 5.50 %
11.00 % 6/22/2029 1,890 1,863 1,873 0.25 %
TouchTunes Interactive (6) (13) (15) First Lien Term Loan
S + 5.00 %
10.35 % 4/2/2029 9,875 9,793 9,825 1.31 %
Transit Buyer LLC (dba“Propark”) (6) (13) First Lien Term Loan
S + 6.25 %
11.69 % 1/31/2029 6,823 6,705 6,801 0.91 %
Transit Buyer LLC (dba“Propark”) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.69 % 1/31/2029 3,125 1,275 1,318 0.18 %
Trilon Group, LLC (13) First Lien Term Loan
S + 6.25 %
11.78 % 5/27/2029 2,978 2,958 2,939 0.39 %
Trilon Group, LLC (6) (13) First Lien Term Loan
S + 6.25 %
11.75 % 5/27/2029 7,406 7,345 7,311 0.98 %
Trilon Group, LLC (12) (13) First Lien Term Loan
S + 6.25 %
11.78 % 5/27/2029 3,733 3,661 3,685 0.49 %
Trilon Group, LLC (Delayed Draw) (12) First Lien Term Loan
S + 6.25 %
11.78 % 5/27/2029 7,425 7,425 7,330 0.98 %
Trilon Group, LLC (Delayed Draw) (12) First Lien Term Loan
S + 6.25 %
11.78 % 5/27/2029 1,985 1,985 1,959 0.26 %
Trilon Group, LLC (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.25 %
11.78 % 5/27/2029 6,373 1,935 1,884 0.25 %
Vital Records Control (6) (9) First Lien Term Loan
S + 5.50 %
11.14 % 6/29/2027 4,582 4,544 4,515 0.60 %
Vital Records Control (9) (13) First Lien Term Loan
S + 5.75 %
11.12 % 6/29/2027 151 149 150 0.02 %
Vital Records Control (Delayed Draw) (9) (12) First Lien Term Loan
S + 5.75 %
11.12 % 6/29/2027 183 181 182 0.03 %
Total Services: Business 302,368 298,732 39.94 %
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU) (6) (9) (12) (13) First Lien Term Loan
S + 6.00 %
11.68 % 8/16/2028 8,474 8,474 7,920 1.06 %
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
11.68 % 8/16/2028 1,577 ( 103 ) ( 0.01 %)
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 6.00 %
11.68 % 8/16/2028 1,714 ( 112 ) ( 0.01 %)
All My Sons (6) First Lien Term Loan
S + 4.75 %
10.36 % 10/25/2028 5,261 5,222 5,206 0.69 %
COP Exterminators Acquisition, Inc. (12) Subordinated Debt
N/A
9.00 % (Cash) 4.00 % (PIK)
1/28/2030 838 816 816 0.11 %
COP Exterminators Acquisition, Inc. (Delayed Draw) (11) (12) Subordinated Debt
N/A
9.00 % (Cash) 4.00 % (PIK)
1/28/2030 652 ( 8 ) ( 17 ) 0.00 %
Excel Fitness (6) (13) First Lien Term Loan
S + 5.25 %
10.75 % 4/29/2029 9,875 9,778 9,616 1.29 %
Fairway Lawns (12) Subordinated Debt N/A
8.00 % (Cash) 5.00 % (PIK)
5/17/2029 2,730 2,662 2,659 0.35 %
Fairway Lawns (Delayed Draw) (11) (12) Subordinated Debt N/A
8.00 % (Cash) 5.00 % (PIK)
5/17/2029 6,287 5,867 5,704 0.76 %
Legacy Service Partners, LLC (“LSP”) (6) (12) (13) First Lien Term Loan
S + 6.50 %
12.00 % 1/9/2029 10,161 9,983 10,306 1.38 %
See Notes to Consolidated Financial Statements
40

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Legacy Service Partners, LLC (“LSP”) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.50 %
12.00 % 1/9/2029 4,734 3,949 4,037 0.54 %
Liberty Buyer (9) (13) First Lien Term Loan
S + 5.50 %
11.18 % 6/15/2028 3,929 3,898 3,945 0.53 %
Liberty Buyer (Delayed Draw) (9) (11) (12) First Lien Term Loan
S + 5.50 %
11.18 % 6/15/2028 744 295 298 0.04 %
NJEye LLC (6) First Lien Term Loan
S + 4.75 %
10.39 % 3/14/2025 5,340 5,331 5,283 0.71 %
NJEye LLC (Delayed Draw) (6) First Lien Term Loan
S + 4.75 %
10.39 % 3/14/2025 700 700 692 0.09 %
NJEye LLC (Delayed Draw) (11) (12) First Lien Term Loan
S + 4.75 %
10.39 % 3/14/2025 1,373 883 870 0.12 %
NJEye LLC (Delayed Draw) (12) First Lien Term Loan
S + 4.75 %
10.44 % 3/14/2025 890 890 881 0.12 %
North Haven Spartan US Holdco LLC (6) First Lien Term Loan
S + 6.25 %
11.63 % 6/6/2025 2,503 2,501 2,497 0.33 %
North Haven Spartan US Holdco LLC (Delayed Draw) (6) First Lien Term Loan
S + 6.25 %
11.63 % 6/6/2025 217 217 217 0.03 %
One World Fitness PFF LLC (6) First Lien Term Loan
S + 5.25 %
10.70 % (Cash) 1.00 % (PIK)
11/26/2025 3,872 3,873 3,637 0.48 %
Perennial Services, Group, LLC (6) (13) First Lien Term Loan
S + 6.00 %
11.49 % 9/8/2029 6,733 6,637 6,634 0.89 %
Perennial Services, Group, LLC (Delayed Draw) (12) First Lien Term Loan
S + 6.00 %
11.49 % 9/8/2029 6,025 6,011 5,937 0.79 %
Total Services: Consumer 77,979 76,923 10.29 %
Sovereign & Public Finance
LMI Consulting, LLC (LMI) (13) First Lien Term Loan
S + 6.50 %
11.90 % 7/18/2028 4,351 4,280 4,370 0.59 %
LMI Consulting, LLC (LMI) (Incremental) (6) First Lien Term Loan
S + 6.50 %
11.89 % 7/18/2028 4,938 4,938 4,959 0.66 %
Total Sovereign & Public Finance 9,218 9,329 1.25 %
Telecommunications
BCM One (6) First Lien Term Loan
S + 4.50 %
9.96 % 11/17/2027 6,074 6,074 5,966 0.80 %
BCM One (Delayed Draw) (6) First Lien Term Loan
S + 4.50 %
9.96 % 11/17/2027 1,827 1,827 1,794 0.24 %
MBS Holdings, Inc. (9) (13) First Lien Term Loan
S + 6.25 %
11.71 % 4/16/2027 1,828 1,797 1,824 0.24 %
Mobile Communications America Inc (6) (12) (13) First Lien Term Loan
S + 6.00 %
11.35 % 10/16/2029 18,505 18,232 18,241 2.44 %
Mobile Communications America Inc (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.35 % 10/16/2029 5,970 ( 43 ) ( 85 ) ( 0.01 %)
Momentum Telecom II (6) (9) (13) First Lien Term Loan
S + 5.75 %
11.21 % 4/16/2027 10,054 9,992 9,891 1.32 %
Momentum Telecom II (Incremental) (9) (12) First Lien Term Loan
S + 6.50 %
11.96 % 4/16/2027 1,314 1,290 1,320 0.18 %
Sapphire Telecom Inc (6) (9) First Lien Term Loan
S + 6.00 %
11.53 % 11/20/2025 6,650 6,627 6,650 0.89 %
See Notes to Consolidated Financial Statements
41

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Tyto Athene, LLC (6) (12) First Lien Term Loan
S + 5.50 %
11.04 % 4/1/2028 7,157 7,105 6,515 0.87 %
Total Telecommunications 52,901 52,116 6.97 %
Transportation: Cargo
FSK Pallet Holding Corp. (DBA Kamps Pallets) (6) (13) First Lien Term Loan
S + 6.00 %
11.53 % 12/23/2026 9,875 9,725 9,616 1.29 %
Kenco Group, Inc. (6) (13) First Lien Term Loan
S + 5.00 %
10.39 % 11/15/2029 8,498 8,349 8,498 1.14 %
Kenco Group, Inc. (Delayed Draw) (11) (12) First Lien Term Loan
S + 5.00 %
10.39 % 11/15/2029 1,416 ( 24 ) %
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) (6) (9) First Lien Term Loan
S + 6.50 %
12.04 % 5/3/2025 258 257 254 0.03 %
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) (6) (9) First Lien Term Loan
S + 6.00 %
11.54 % 5/3/2025 895 891 877 0.12 %
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) (6) (9) First Lien Term Loan
S + 6.50 %
12.04 % 5/3/2025 181 180 178 0.02 %
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) (6) (9) First Lien Term Loan
S + 6.50 %
12.04 % 5/3/2025 4,367 4,350 4,306 0.57 %
Quantix (f/k/a A&R Logistics Holdings, Inc.) (Incremental) (9) (13) First Lien Term Loan
S + 6.50 %
11.90 % 5/3/2025 1,359 1,343 1,340 0.18 %
RoadOne (Delayed Draw) (11) (12) Subordinated Debt N/A
8.75 % (Cash) 5.00 % (PIK)
6/30/2029 1,397 ( 18 ) ( 28 ) %
RoadOne (12) Subordinated Debt
N/A
8.75 % (Cash) 5.00 % (PIK)
6/30/2029 4,699 4,579 4,604 0.62 %
SEKO Global Logistics (12) Subordinated Debt
S + 9.00 %
6.04 % (Cash) 4.50 % (PIK)
6/30/2027 5,840 5,765 5,676 0.76 %
SEKO Global Logistics (12) Subordinated Debt
S + 9.00 %
9.86 % (Cash) 4.50 % (PIK)
6/30/2027 4,053 3,997 3,939 0.53 %
SEKO Global Logistics (6) First Lien Term Loan
S + 5.00 %
10.72 % 12/30/2026 1,125 1,118 1,115 0.15 %
SEKO Global Logistics (Delayed Draw) (12) Subordinated Debt
S + 9.00 %
6.04 % (Cash) 4.50 % (PIK)
6/30/2027 912 912 887 0.12 %
SEKO Global Logistics (Delayed Draw) (Incremental) (12) First Lien Term Loan
S + 5.00 %
10.72 % 12/30/2026 4,485 4,485 4,444 0.59 %
SEKO Global Logistics (Incremental) (6) (13) First Lien Term Loan
S + 5.00 %
10.72 % 12/30/2026 1,517 1,506 1,503 0.20 %
TI ACQUISITION NC LLC (6) First Lien Term Loan
S + 4.75 %
10.08 % 3/19/2027 2,780 2,719 2,642 0.35 %
Total Transportation: Cargo 50,134 49,851 6.67 %
Transportation: Consumer
American Student Transportaton Partners, Inc (12) Subordinated Debt N/A
10.00 % (Cash) 3.50 % (PIK)
9/11/2029 2,081 2,027 2,026 0.27 %
See Notes to Consolidated Financial Statements
42

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment
Spread Above Reference Rate (3)
Interest Rate (3)
Maturity Date Par Amount Amortized Cost
Fair Value (4)
% of Net Assets (5)
Total Transportation: Consumer 2,027 2,026 0.27 %
Utilities: Electric
DMC HoldCo LLC (DMC Power) (6) (12) (13) First Lien Term Loan
S + 6.00 %
11.39 % 7/13/2029 5,000 4,927 4,981 0.67 %
DMC HoldCo LLC (DMC Power) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.39 % 7/13/2029 1,671 ( 4 ) ( 7 ) %
Pinnacle Supply Partners, LLC (6) (13) First Lien Term Loan
S + 6.00 %
11.47 % 4/3/2030 6,332 6,214 6,287 0.84 %
Pinnacle Supply Partners, LLC (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.00 %
11.47 % 4/3/2030 3,636 ( 30 ) ( 26 ) %
TPC Wire & Cable (12) Subordinated Debt N/A
10.00 % (Cash) 1.00 % (PIK)
2/16/2028 2,240 2,220 2,215 0.29 %
TPC Wire & Cable (Delayed Draw) (12) Subordinated Debt N/A
11.00 % (Cash) 1.50 % (PIK)
2/16/2028 913 911 902 0.12 %
Total Utilities: Electric 14,238 14,352 1.92 %
Wholesale
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (6) (13) First Lien Term Loan
S + 6.50 %
12.03 % 1/20/2029 7,961 7,822 7,973 1.06 %
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw) (11) (12) First Lien Term Loan
S + 6.50 %
12.03 % 1/20/2029 1,979 ( 34 ) 3 %
ISG Merger Sub, LLC (dba Industrial Service Group) (6) (13) First Lien Term Loan
S + 6.25 %
11.60 % 12/7/2028 6,525 6,412 6,569 0.88 %
ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw) (12) First Lien Term Loan
S + 6.25 %
11.60 % 12/7/2028 3,397 3,383 3,420 0.46 %
Total Wholesale 17,583 17,965 2.40 %
Total Debt Investments 1,640,574 1,610,879 215.39 %

Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Equity Investments
Aerospace & Defense
BPC Kodiak LLC (Turbine Engine Specialist, Inc) (8) (12) (14) (16) Class A-1 Units 9/1/2023 1,530,000 1,530 1,614 0.22 %
Total Aerospace & Defense 1,530 1,614 0.22 %
See Notes to Consolidated Financial Statements
43

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Automotive
Covercraft (8) (12) (14) Covercraft Equity 8/20/2021 768 768 357 0.05 %
High Bar Brands (8) (10) (12) (14) Class A Units 12/19/2023 303,000 303 303 0.04 %
S&S Truck Parts (8) (12) (14) Partnership Units 3/31/2022 4 378 299 0.04 %
S&S Truck Parts (8) (12) (14) Pegasus Units 8/1/2022 78,541 79 62 0.01 %
Total Automotive 1,528 1,021 0.14 %
Beverage, Food & Tobacco
Bardstown PPC Holdings LLC (8) (10) (12) Common 7/13/2022 14,777 1,860 2,114 0.28 %
Fresh Edge - Common (8) (12) (14) Class B Common Units 10/3/2022 667 99 0.01 %
Fresh Edge - Preferred (8) (12) (14) Class A Preferred Units 10/3/2022 667 667 745 0.10 %
Tech24 (8) (12) (14) Company Unit 10/5/2023 954 954 954 0.13 %
Total Beverage, Food & Tobacco 3,481 3,912 0.52 %
Capital Equipment
Crete Mechanical Group (8) (12) (14) Equity Co-Investment 5/7/2022 23 230 534 0.07 %
EFC Holdings, LLC (8) (10) (12) (14) Class A Common Units 2/28/2023 148 60 113 0.02 %
EFC Holdings, LLC (8) (10) (12) (14) Series A Preferred Units 2/28/2023 148 148 158 0.02 %
Precision Surfacing - Common (8) (10) (12) (14) Common Units 10/3/2022 3,750,000 3,750 6,513 0.87 %
Repipe Specialists (8) (12) (14) Purchased Units 3/18/2022 239 239 6 %
Total Capital Equipment 4,427 7,324 0.98 %
Construction & Building
Erie Construction (8) (12) Common 7/27/2021 166 166 606 0.08 %
Gannett Fleming (8) (12) (14) Series F Units 5/26/2023 569,505 570 830 0.11 %
Gannett Fleming (8) (12) (14) (16) Limited Partnership Interests 12/20/2022 424,742 425 619 0.08 %
Total Construction & Building 1,161 2,055 0.27 %
Consumer Goods: Non-durable
FoodScience (8) (12) (14) Class B Units 3/1/2021 5,168 5 %
FoodScience (8) (12) (14) Class A Units 3/1/2021 98 98 51 0.01 %
Ultima Health Holdings, LLC (8) (12) (14) Preferred Units 9/12/2022 15 170 158 0.02 %
Total Consumer Goods: Non-durable 273 209 0.03 %
Containers, Packaging & Glass
Oliver Packaging (8) (12) (14) Class A Common Units 7/6/2022 10,230 1,023 640 0.09 %
See Notes to Consolidated Financial Statements
44

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
Specialized Packaging Group (7) (8) (10) (12) (14) Class A Units 12/17/2020 147,708 148 182 0.02 %
Total Containers, Packaging & Glass 1,171 822 0.11 %
Healthcare & Pharmaceuticals
AG MDC Holdings, Inc (8) (10) (12) (14) Class A2 Units (Common) 2/7/2023 245 245 177 0.02 %
Anne Arundel (8) (12) (14) AA Equity Co-Invest 9/14/2023 12,175 880 2 %
Health Management Associates (8) (12) (14) Class A Common Units 3/31/2023 399,904 400 427 0.06 %
REP HS Topco Holdings (HemaSource Inc.) (8) (12) (14) LP Interests 8/31/2023 577,000 577 645 0.09 %
Total Healthcare & Pharmaceuticals 2,102 1,251 0.17 %
High Tech Industries
ITSavvy LLC (8) (12) (14) Class A Common Units 8/8/2022 522 522 1,250 0.17 %
Solve Industrial Motion Group (8) (12) (14) Solve Industrial Equity 6/30/2021 313 313 210 0.03 %
Total High Tech Industries 835 1,460 0.20 %
Services: Business
Apex Companies Holdings, LLC (8) (10) (12) (14) Class A Membership Interests 1/31/2023 1,173 117 127 0.02 %
BroadcastMed Holdco, LLC (8) (12) Series A-3 Preferred Units 10/4/2022 56,899 853 888 0.12 %
Career Now (8) (12) (14) Series B Limited Partnership Units 10/14/2023 222 22 %
Career Now (8) (12) (14) Common Equity 9/30/2021 624 624 %
E78 (8) (12) (14) Class A Common Units 12/1/2021 816 860 835 0.11 %
KRIV Acquisition, Inc (8) (12) (14) Class A Units 7/17/2023 790 790 930 0.12 %
Output Services Group, Inc. (8) (10) (12) (14) Class A Units 11/30/2023 47,021 833 833 0.11 %
Total Services: Business 4,099 3,613 0.48 %
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU) (8) (9) (12) (14) Limited Partnership Interests 8/8/2022 2,432 243 156 0.02 %
COP Exterminators Investment, LLC (8) (12) (14) Class A Units 7/31/2023 997,000 1,117 1,163 0.16 %
Legacy Service Partners, LLC (“LSP”) (8) (12) (14) Class B Units 1/9/2023 4,907 491 544 0.07 %
Perennial Services Investors LLC (8) (10) (12) (14) Class A Units 9/8/2023 7,784 778 1,077 0.14 %
Total Services: Consumer 2,629 2,940 0.39 %
Sovereign & Public Finance
See Notes to Consolidated Financial Statements
45

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
Portfolio Company (1) (2)
Footnotes Investment Acquisition Date Shares/Units Amortized Cost
Fair Value (4)
% of Net Assets (5)
LMI Renaissance (8) (12) (14) Limited Partnership Interests 7/18/2022 633,980 634 1,370 0.18 %
Total Sovereign & Public Finance 634 1,370 0.18 %
Transportation: Cargo
RoadOne - Common (8) (12) (14) Partnership Units 12/29/2022 1,173,220 939 1,525 0.20 %
SEKO Global Logistics (8) (12) Seko Equity Co-Invest 12/30/2020 671,203 332 1,221 0.16 %
Total Transportation: Cargo 1,271 2,746 0.36 %
Transportation: Consumer
ASTP Holdings Co-Investment LP (8) (12) (14) Limited Partnership Interest 9/11/2023 173,844 174 189 0.03 %
Total Transportation: Consumer 174 189 0.03 %
Utilities: Electric
Pinnacle Supply Partners, LLC (8) (12) (14) Subject Partnership Units 4/3/2023 279,687 280 281 0.04 %
Total Utilities: Electric 280 281 0.04 %
Total Equity Investments 25,595 30,807 4.12 %

Portfolio Company (1) (2)
Interest Rate (3)
Shares/Units
Amortized Cost
Fair Value (4)
% of Net Assets (5)
Cash Equivalents
BlackRock Liquidity Funds Treasury 5.18 % 46,784 46,784 46,784 6.26 %
First American Government Obligations Fund 5.19 % 32 32 32 %
U.S. Bank National Association Money Market Deposit Account 2.05 % 17,661 17,661 17,661 2.36 %
Total Cash Equivalents $ 64,477 $ 64,477 8.62 %
Total Investments and Cash Equivalents $ 1,730,646 $ 1,706,163 228.13 %
_____________
(1) All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally presumed to be “non-controlled” when the Company owns 25% or less of the portfolio company’s voting securities and “controlled” when the Company owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Company maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Company owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Company owns 5% or more of a portfolio company’s voting securities.
(2) Unless otherwise indicated, issuers of debt and equity held by the Company are domiciled in the United States.
See Notes to Consolidated Financial Statements
46

NUVEEN CHURCHILL DIRECT LENDING CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(dollar amounts in thousands, including share data)
(3) The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“SOFR” or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at December 31, 2023. As of December 31, 2023, rate for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.35 %, 5.33 %, 5.16 %, and 4.77 % respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.
(4) Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.
(5) Percentage is based on net assets of $ 747,885 as of December 31, 2023.
(6) Denotes that all or a portion of the assets are owned by CLO-I and/or CLO-II (each as defined in the Note 1 "Organization"), which serve as collateral for the 2022 and 2023 Debt Securitization (as defined in the Notes). See Note 6 "Secured Borrowings".
(7) This portfolio company is not domiciled in the United States. The principal place of business for Specialized Packing Group is Canada. The principal place of business for Phaidon International is the United Kingdom.
(8) Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2023, the Company held forty-four restricted securities with an aggregate fair value of 30,807 , or 4.12 % of the Company’s net assets.
(9) Investment is a unitranche position.
(10) The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70 % of the Company's total assets. As of December 31, 2023, total non-qualifying assets at fair value represented 4.24 % of the Company's total assets calculated in accordance with the 1940 Act.
(11) Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 7 "Commitments and Contingencies". The investment may be subject to unused commitment fees.
(12) Denotes that all or a portion of the assets are owned by the Company or NCDL Equity Holdings (each as defined in Note 1 "Organization"). The Company entered into a senior secured revolving credit agreement (the “Revolving Credit Facility”). The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future.
(13) Denotes that all or a portion of the assets are owned by SPV II and/or SPV III (each as defined in Note 1 "Organization"). SPV II has entered into a senior secured revolving credit facility (the “SMBC Financing Facility”). The lenders of the SMBC Financing Facility have a first lien security interest in substantially all of the assets of SPV II. Accordingly, such assets are not available to other creditors of the Company. SPV III has entered into a senior secured revolving credit facility (the “Wells Fargo Financing Facility”). The lenders of the Wells Fargo Financing Facility have a first lien security interest in substantially all of the assets of SPV III. Accordingly, such assets are not available to other creditors of the Company.
(14) Equity investments are non-income producing securities unless otherwise noted.
(15) Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 4 "Fair Value Measurements" for more information.
(16) Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

See Notes to Consolidated Financial Statements
47

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)


1. ORGANIZATION
Nuveen Churchill Direct Lending Corp., a Maryland corporation (the “Company”, which refers to either Nuveen Churchill Direct Lending Corp. or Nuveen Churchill Direct Lending Corp. together with its consolidated subsidiaries, as the context may require), is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, the Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Effective June 1, 2020, the Company changed its name from “Nuveen Churchill BDC, Inc.” to “Nuveen Churchill Direct Lending Corp.”
The Company’s investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which the Company defines as companies with approximately $10 million to $250 million of annual earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Company primarily focuses on investing in U.S. middle market companies with $10 million to $100 million in EBITDA, which it considers the core middle market. The Company's portfolio is comprised primarily of first-lien senior secured debt and unitranche loans. Although it is not the Company's primary strategy, the Company also opportunistically invests in junior capital opportunities, including second-lien loans, subordinated debt, and equity co-investments and similar equity-related securities.
The Company entered into the Advisory Agreement with Churchill DLC Advisor LLC (f/k/a Nuveen Churchill Advisors LLC) (the “Adviser”), under which the Adviser has delegated substantially all of its day-to-day portfolio management obligations through the CAM Sub-Advisory Agreement with Churchill Asset Management LLC (“Churchill”). In addition, the Adviser and Churchill have entered into the NAM Sub-Advisory Agreement with Nuveen Asset Management, LLC (“Nuveen Asset Management” and, together with the Adviser and Churchill, the “Advisers”), pursuant to which Nuveen Asset Management may manage a portion of the Company's portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments, subject to the pace and amount of investment activity in the middle market investment program. Under the Administration Agreement, the Company is provided with certain services by an administrator, Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC) (the “Administrator”). The Advisers and Administrator are all affiliates and subsidiaries of Nuveen, LLC, a wholly owned subsidiary of Teachers Insurance and Annuity Association of America (“TIAA”). See Note 5 , Related Party Transactions.
Churchill NCDLC CLO-I, LLC (“CLO-I”), Churchill NCDLC CLO-II, LLC (“CLO-II”), Churchill NCDLC CLO-III, LLC (“CLO-III”), Nuveen Churchill BDC SPV IV, LLC (“SPV IV”), Nuveen Churchill BDC SPV V, LLC (“SPV V”) and NCDL Equity Holdings LLC ("NCDL Equity Holdings") are wholly owned subsidiaries of the Company and are consolidated in these financial statements commencing from the date of their respective formation, in accordance with the Company's consolidation policy discussed in Note 2 . CLO-I, CLO-II and CLO-III completed term debt securitizations in May 2022, December 2023 and March 2024, respectively. SPV IV and SPV V primarily invest in first-lien senior secured debt and unitranche loans. NCDL Equity Holdings was formed to hold certain equity-related securities.
Beginning with its initial closing in March 2020, the Company conducted private offerings ("Private Offerings") of its shares of common stock to accredited investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Company held its final closing on April 28, 2023.
On January 29, 2024, the Company closed its initial public offering (“IPO”). The Company’s common stock began trading on the New York Stock Exchange (“NYSE”) under the symbol “NCDL” on January 25, 2024.
48

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature and considered necessary for the fair statement of the consolidated financial statements for the periods presented have been included. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform to the current period presentation. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value, unless otherwise disclosed herein.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates based on assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash, Cash Equivalents and Restricted Cash
Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. The Company's cash held by SPV V is restricted, based on the terms of the Wells Fargo Financing Facility (as defined in Note 6 below). Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value.
Valuation of Portfolio Investments
Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”), and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.
ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:
Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.
Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.
49

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Company’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.
Pursuant to Rule 2a-5 under the 1940 Act, the Company's board of directors (the “Board”) has designated the Adviser as the Company's valuation designee (the “Valuation Designee”) to determine the fair value of the Company's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Company's valuation policy approved by the Board, a valuation committee comprised of employees of Churchill (the “Valuation Committee”) is responsible for determining the fair value of the Company’s assets for which market quotations are not readily available, subject to the oversight of the Board.
With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, defined further below in Note 5 , undertakes a multi-step valuation process each quarter, as follows:
i. the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;
ii. to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Company to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Company will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;
iii. the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Company’s valuation policy, subject to the oversight of the Board; and
iv. the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Company’s valuation policy in connection with each quarterly Board meeting, comply with the periodic board reporting requirements set forth in the Company’s valuation policy, and discuss with the Board its determination of the fair value of each investment in good faith.
The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company's credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent transactions of investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are discussed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.
The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such values do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

50

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Company’s assets for which market quotations are not readily available, taking into account the Company’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Company's investments.
Investment Transactions and Revenue Recognition
Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains or losses are measured by the difference between the net proceeds received from repayments and sales and the cost basis of the investment using the specific identification method without regard to unrealized appreciation or depreciation previously recognized are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Company accrues interest income if it expects that ultimately it will be able to collect such income.
The Company may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Company to maintain its tax treatment as a RIC, even though the Company has not yet collected cash. For the three and nine months ended September 30, 2024, the Company earned $ 2,503 and $ 6,024 , respectively, in PIK income provisions, representing 4.15 % and 3.61 % of total investment income, respectively. For the three and nine months ended September 30, 2023, the Company earned $ 951 and $ 1,823 , respectively, in PIK income provisions, representing 2.28 % and 1.62 % of total investment income, respectively.
Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three and nine months ended September 30, 2024, the Company earned $ 16 and $ 357 , respectively, of dividend income on its equity investments. For the three and nine months ended September 30, 2023, the Company earned $ 16 and $ 56 , respectively, of dividend income on its equity investments.
Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Company’s investment activities, as well as any fees for managerial assistance services rendered by the Company to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three and nine months ended September 30, 2024, the Company earned other income of $ 444 and $ 1,170 , respectively, primarily related to prepayment and amendment fees. For the three and nine months ended September 30, 2023, the Company earned other income of $ 409 and $ 879 , respectively, primarily related to prepayment and amendment fees.
Loans are generally placed on non-accrual status when a payment default occurs or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Company will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible. However, the Company remains contractually entitled to this interest. The Company may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. As of September 30, 2024, the Company had three portfolio companies on non-accrual status with an aggregate fair value of $ 11,175 which represented approximately 0.55 % of total investments at fair value. As of December 31, 2023, there were no portfolio companies on non-accrual.
51

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Deferred Financing Costs
Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations.
Offering Costs
Offering costs associated with the Private Offerings were recognized as a deferred charge on the consolidated statement of assets and liabilities and amortized on a straight-line basis over 12 months. These expenses consist primarily of legal fees and other costs incurred in connection with the Company’s continuous Private Offering of its shares. For the nine months ended September 30, 2024 and 2023, the Company incurred offering costs of $ 0 and $ 23 , respectively.
Deferred offering costs include registration expenses related to any shelf registration statement filed by the Company. These expenses consist primarily of SEC registration fees, legal fees and accounting fees incurred related thereto. Upon the completion of an equity offering or a debt offering, the deferred expenses are charged to additional paid-in capital or debt issuance costs, respectively. If there are any deferred offering costs remaining at the expiration of the shelf registration statement, these deferred costs are charged to expense. The Adviser paid the offering costs associated with the IPO on behalf of the Company. The Company is not obligated to reimburse any such offering costs paid by the Adviser.

Income Taxes

For U.S. federal income tax purposes, the Company has elected, and intends to qualify annually, to be treated as a RIC under the Code. In order to qualify as a RIC, the Company must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Company is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Company to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Company may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Company is subject to a 4% U.S. nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to U.S. federal income tax at corporate rates is considered to have been distributed. The Company intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Company may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. CLO-I, CLO-II, CLO-III, SPV IV and SPV V are disregarded entities for tax purposes and are consolidated with the tax return of the Company. NCDL Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three and nine months ended September 30, 2024, the Company did no t incur any excise tax expense. For the three and nine months ended September 30, 2023, the Company did no t incur any excise tax expense.
52

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Dividends and Distributions to Common Shareholders
To the extent that the Company has taxable income, the Company intends to continue to make quarterly distributions to its common shareholders. Dividends and distributions to common shareholders are recorded on the applicable record date. The amount to be distributed to common shareholders is determined by the Board each quarter and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Company may decide to retain such capital gains for investment.
In connection with the IPO, the Board approved an amended and restated dividend reinvestment plan (the "Amended DRIP"), which became effective on January 29, 2024, concurrent with the consummation of the IPO.
The Amended DRIP changed the dividend reinvestment plan from an “opt in” dividend reinvestment plan to an “opt out” dividend reinvestment plan. As a result of the foregoing, if the Board authorizes, and the Company declares, a cash dividend or distribution, shareholders that acquired their shares in the IPO and do not “opt out” of the Amended DRIP will have their cash distributions automatically reinvested in additional shares rather than receiving cash. Notwithstanding the foregoing, a shareholder’s election (or deemed election) under the dividend reinvestment plan, dated December 19, 2019, will remain in effect for such shareholder and no further action is required by such shareholder with respect to their election under the Amended DRIP.

With respect to each distribution under the Amended DRIP, the Company reserves the right to either issue new shares of common stock or purchase shares of common stock in the open market for the accounts of participants in the Amended DRIP. If newly issued shares are used to implement the Amended DRIP, the number of shares to be issued to a shareholder will be determined by dividing the total dollar amount of the distribution payable to such participant by the market price per share of the Company's common stock at the close of regular trading of the NYSE on the distribution payment date, or if no sale is reported for such day, the average of the reported bid and asked prices. However, if the market price per share on the distribution payment date exceeds the most recently computed net asset value ("NAV") per share, the Company will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed NAV per share). If shares are purchased in the open market to implement the Amended DRIP, the number of shares to be issued to a participant will be determined by dividing the dollar amount of the distribution payable to such participant by the weighted average price per share for all shares of common stock purchased by the plan administrator in the open market in connection with the dividend or distribution. Although each participant may from time to time have an undivided fractional interest in a share, no certificates for a fractional share will be issued. However, dividends and distributions on fractional shares will be credited to each participant’s account.

Functional Currency
The functional currency of the Company is the U.S. Dollar and all transactions were in U.S. Dollars.
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) , which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company does not expect this guidance to impact its consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09 “ Income Taxes (Topic 740): Improvements to Income Tax Disclosures ,” (“ASU 2023-09”). ASU 2023-09 requires additional disaggregated disclosures on the entity’s effective tax rate reconciliation and additional details on income taxes paid. ASU 2023-09 is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2024, with early adoption permitted. The Company does not expect the adoption of ASU 2023-09 to have a material impact on its consolidated financial statements.
53

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

3. INVESTMENTS
As of September 30, 2024 and December 31, 2023, our investments consisted of the following (dollar amounts in thousands):
September 30, 2024 December 31, 2023
Amortized Cost Fair Value % of Fair Value Amortized Cost Fair Value % of Fair Value
First-Lien Debt
$ 1,855,467 $ 1,843,607 90.07 % $ 1,450,120 $ 1,427,492 86.95 %
Subordinated Debt 1
190,016 169,455 8.28 % 190,454 183,387 11.17 %
Equity Investments 29,882 33,825 1.65 % 25,595 30,807 1.88 %
Total $ 2,075,365 $ 2,046,887 100.00 % $ 1,666,169 $ 1,641,686 100.00 %
_____________________
1 As of September 30, 2024, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $ 67,947 , mezzanine debt of $ 99,925 and $ 1,583 of structured debt at fair value and second lien term loans and/or second lien notes of $ 80,348 , mezzanine debt of $ 105,364 and $ 4,304 of structured debt at amortized cost.
As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $ 97,203 , mezzanine debt of $ 83,528 and $ 2,656 of structured debt at fair value and second lien term loans and/or second lien notes of $ 100,711 , mezzanine debt of $ 86,495 and $ 3,247 of structured debt at amortized cost.
The industry composition of our portfolio as a percentage of fair value as of September 30, 2024 and December 31, 2023 was as follows:
Industry September 30, 2024 December 31, 2023
Aerospace & Defense 3.32 % 3.13 %
Automotive 3.42 % 4.95 %
Banking, Finance, Insurance & Real Estate 2.33 % 3.95 %
Beverage, Food & Tobacco 8.25 % 7.76 %
Capital Equipment 5.62 % 4.21 %
Chemicals, Plastics & Rubber 1.36 % 2.29 %
Construction & Building 4.90 % 3.90 %
Consumer Goods: Durable 0.98 % 1.51 %
Consumer Goods: Non-durable 3.02 % 3.31 %
Containers, Packaging & Glass 4.01 % 3.97 %
Energy: Electricity 2.80 % 1.75 %
Environmental Industries 3.71 % 2.73 %
Healthcare & Pharmaceuticals 14.18 % 12.72 %
High Tech Industries 8.68 % 8.97 %
Media: Advertising, Printing & Publishing 0.91 % 1.12 %
Media: Diversified & Production 0.95 % 0.96 %
Retail 0.28 % 0.35 %
Services: Business 16.47 % 18.43 %
Services: Consumer 4.45 % 4.86 %
Sovereign & Public Finance 0.66 % 0.65 %
Telecommunications 3.22 % 3.17 %
Transportation: Cargo 3.03 % 3.20 %
Transportation: Consumer 0.62 % 0.13 %
Utilities: Electric 1.18 % 0.89 %
Utilities: Water 0.43 % %
Wholesale 1.22 % 1.09 %
Total 100.00 % 100.00 %




54

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

The geographic composition of investments at cost and fair value was as follows:
September 30, 2024
Amortized Cost Fair Value % of Total Investments at Fair Value Fair Value as % of Net Assets
United States
$ 1,996,273 $ 1,967,950 96.14 % 198.66 %
Canada 43,552 43,604 2.13 % 4.40 %
Germany
22,192 22,139 1.08 % 2.23 %
United Kingdom 13,348 13,194 0.65 % 1.33 %
$ 2,075,365 $ 2,046,887 100.00 % 206.62 %
December 31, 2023
Amortized Cost Fair Value % of Total Investments at Fair Value Fair Value as % of Net Assets
United States
$ 1,613,815 $ 1,589,384 96.82 % 212.52 %
Canada 38,462 38,292 2.33 % 5.12 %
United Kingdom 13,892 14,010 0.85 % 1.87 %
$ 1,666,169 $ 1,641,686 100.00 % 219.51 %
As of September 30, 2024 and December 31, 2023, on a fair value basis, 94.25 % and 94.61 %, respectively, of the Fund’s debt investments bore interest at a floating rate, and 5.75 % and 5.39 %, respectively, of the Fund’s debt investments bore interest at a fixed rate.
4. FAIR VALUE MEASUREMENTS
Fair Value Disclosures
The following tables present fair value measurements of investments, by major class, and cash equivalents as of September 30, 2024 and December 31, 2023, according to the fair value hierarchy:
As of September 30, 2024 Level 1 Level 2 Level 3 Total
Assets:
First-Lien Debt
$ $ 52,036 $ 1,791,571 $ 1,843,607
Subordinated Debt 1
169,455 169,455
Equity Investments 33,825 33,825
Cash Equivalents 62,480 62,480
Total $ 62,480 $ 52,036 $ 1,994,851 $ 2,109,367
_____________________
1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $ 67,947 , mezzanine debt of $ 99,925 and $ 1,583 of structured debt.

As of December 31, 2023
Level 1 Level 2 Level 3 Total
Assets:
First-Lien Debt
$ $ 34,481 $ 1,393,011 $ 1,427,492
Subordinated Debt 1
8,691 174,696 183,387
Equity Investments 30,807 30,807
Cash Equivalents 64,477 64,477
Total $ 64,477 $ 43,172 $ 1,598,514 $ 1,706,163
_____________________
1 Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $ 97,203 , mezzanine debt of $ 83,528 and $ 2,656 of structured debt.
55

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)


The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the following periods:
As of and for the Three Months Ended September 30, 2024
First-Lien Debt Subordinated Debt Equity Investments Total
Balance as of June 30, 2024
$ 1,724,399 $ 154,692 $ 32,176 $ 1,911,267
Purchase of investments 185,445 14,802 1,372 201,619
Proceeds from principal repayments and sales of investments ( 120,908 ) ( 4,103 ) ( 125,011 )
Payment-in-kind interest 172 2,331 2,503
Amortization of premium/accretion of discount, net 708 119 827
Net realized gain (loss) on investments 810 103 913
Net change in unrealized appreciation (depreciation) on investments 2,233 1,511 277 4,021
Transfers out of Level 3 (1)
( 17,813 ) ( 17,813 )
Transfers to Level 3 (1)
16,525 16,525
Balance as of September 30, 2024
$ 1,791,571 $ 169,455 $ 33,825 $ 1,994,851
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2024
$ 2,661 $ 1,564 $ 277 $ 4,502
As of and for the Nine Months Ended September 30, 2024
First-Lien Debt Subordinated Debt Equity Investments Total
Balance as of December 31, 2023
$ 1,393,011 $ 174,696 $ 30,807 $ 1,598,514
Purchase of investments 626,552 24,953 4,360 655,865
Proceeds from principal repayments and sales of investments ( 244,709 ) ( 22,692 ) ( 73 ) ( 267,474 )
Payment-in-kind interest 580 5,444 6,024
Amortization of premium/accretion of discount, net 118 420 538
Net realized gain (loss) on investments ( 2,176 ) 375 ( 1,801 )
Net change in unrealized appreciation (depreciation) on investments 10,594 ( 13,741 ) ( 1,269 ) ( 4,416 )
Transfers out of Level 3 (1)
( 11,899 ) ( 11,899 )
Transfers to Level 3 (1)
19,500 19,500
Balance as of September 30, 2024
$ 1,791,571 $ 169,455 $ 33,825 $ 1,994,851
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2024
$ 5,370 $ ( 13,916 ) $ ( 1,269 ) $ ( 9,815 )
_______________
(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2024, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.
56

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

As of and for the Three Months Ended September 30, 2023
First-Lien Debt Subordinated Debt Equity Investments Total
Balance as of June 30, 2023
$ 1,152,917 $ 155,148 $ 24,894 $ 1,332,959
Purchase of investments 126,344 19,437 5,064 150,845
Proceeds from principal repayments and sales of investments ( 17,172 ) ( 252 ) ( 17,424 )
Payment-in-kind interest 951 951
Amortization of premium/accretion of discount, net 373 82 455
Net realized gain (loss) on investments ( 13,153 ) 1 ( 13,152 )
Net change in unrealized appreciation (depreciation) on investments 14,327 ( 549 ) ( 1,943 ) 11,835
Transfers out of Level 3 (1)
( 9,540 ) ( 8,360 ) ( 17,900 )
Balance as of September 30, 2023
$ 1,254,096 $ 166,458 $ 28,015 $ 1,448,569
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023
$ 2,153 $ ( 548 ) $ ( 1,943 ) $ ( 338 )
As of and for the Nine Months Ended September 30, 2023
First-Lien Debt Subordinated Debt Equity Investments Total
Balance as of December 31, 2022
$ 1,016,856 $ 133,243 $ 27,313 $ 1,177,412
Purchase of investments 290,203 54,688 7,880 352,771
Proceeds from principal repayments and sales of investments ( 41,652 ) ( 12,300 ) ( 8,667 ) ( 62,619 )
Payment-in-kind interest 1,823 1,823
Amortization of premium/accretion of discount, net 1,642 314 1,956
Net realized gain (loss) on investments ( 12,762 ) 197 6,111 ( 6,454 )
Net change in unrealized appreciation (depreciation) on investments 5,503 ( 3,060 ) ( 4,622 ) ( 2,179 )
Transfers out of Level 3 (1)
( 14,042 ) ( 8,447 ) ( 22,489 )
Transfers to Level 3 (1)
8,348 8,348
Balance as of September 30, 2023
$ 1,254,096 $ 166,458 $ 28,015 $ 1,448,569
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023
$ ( 1,035 ) $ ( 3,036 ) $ 1,426 $ ( 2,645 )
_______________
(1)Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for certain portfolio companies.
57

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Significant Unobservable Inputs
ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of September 30, 2024 and December 31, 2023 were as follows:
Investment Type
Fair Value at September 30, 2024
Valuation Techniques Unobservable Inputs Ranges Weighted Average
First-Lien Debt $ 1,584,187 Yield Method Market Yield Discount Rates 6.09 % 22.50 % 9.48 %
First-Lien Debt 19,979 Market Approach EBITDA Multiple 6.50 x 12.00 x 9.15 x
Subordinated Debt 152,687 Yield Method Market Yield Discount Rates 11.46 % 25.41 % 15.00 %
Subordinated Debt 1,800 Market Approach EBITDA Multiple 8.63 x 8.63 x 8.63 x
Subordinated Debt 1,825 Black-Scholes EBITDA Multiple 11.25 x 11.25 x 11.25 x
Equity 168 Yield Method Market Yield Discount Rates 8.36 % 8.36 % 8.36 %
Equity 33,160 Market Approach EBITDA Multiple 5.75 x 20.50 x 11.85 x
Equity 6 Market Approach Revenue Multiple 0.85 x 0.85 x 0.85 x
Total $ 1,793,812
First-Lien Debt in the amount of $ 187,405 , Subordinated Debt in the amount of $ 13,143 and equity investments in the amount of $ 491 at September 30, 2024 have been excluded from the table above, because the investments are valued using a recent transaction.
Investment Type
Fair Value at December 31, 2023
Valuation Techniques Unobservable Inputs Ranges Weighted Average
First-Lien Debt $ 1,192,190 Yield Method Market Yield Discount Rates 6.13 % 18.73 % 10.63 %
First-Lien Debt 19,519 Market Approach EBITDA Multiple 6.50 x 9.25 x 7.21 x
Subordinated Debt 162,646 Yield Method Market Yield Discount Rates 9.70 % 24.91 % 14.44 %
Equity 158 Yield Method Market Yield Discount Rates 8.36 % 8.36 % 8.36 %
Equity 29,390 Market Approach EBITDA Multiple 6.50 x 19.50 x 10.96 x
Equity 2 Market Approach Blended EBITDA Multiple 13.25 x 13.25 x 13.25 x
Blended Revenue Multiple 1.40 x 1.40 x 1.40 x
Total $ 1,403,905
First-Lien Debt in the amount of $ 181,302 , Subordinated Debt in the amount of $ 12,050 and equity investments in the amount of $ 1,257 at December 31, 2023 have been excluded from the table above, because the investments are valued using a recent transaction.
Debt investments are generally valued using the yield method. Under the yield method, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to the expected life, portfolio company performance since close, and other terms and risks associated with an investment. Among other factors, a determinant of risk is the amount of leverage used by the portfolio company relative to its total enterprise value, and the rights and remedies of the Company’s investment within the portfolio company’s capital structure. Debt investments may also be valued using a market approach, The market approach utilizes market value (EBITDA) multiples of publicly traded comparable companies and available precedent sales transactions of comparable companies. Certain factors are considered when selecting the appropriate companies whose multiples are used in the valuation. These factors may include the type of organization, similarity to the business being valued and, relevant risk factors, as well as size, profitability and growth expectations. A recent transaction, if applicable, also may be factored into the valuation if the transaction price is believed to be an indicator of value.
Equity investments are generally valued using a market approach, which utilizes market value (EBITDA or revenue) multiples of publicly traded comparable companies and available precedent sales transactions of comparable companies. The selected multiple is used to estimate the enterprise value of the underlying investment.

The significant unobservable input used under the yield method is a discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the performance multiple, which may include a revenue multiple, EBITDA multiple, or forward-looking metrics. The multiple is used to estimate the enterprise value of the underlying investment. An increase or decrease in the multiple would result in an increase or decrease, respectively, in the fair value.
58

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Alternative valuation methodologies may be used as deemed appropriate for debt or equity investments, and may include, but are not limited to, a market approach, income approach, or liquidation (recovery) approach.
Weighted average inputs are calculated based on the relative fair value of the investments.
Financial Instruments disclosed but not carried at fair value
The fair value of the Company's credit facilities, which would be categorized as Level 3 within the fair value hierarchy approximates their carrying values. These fair value measurements were based on significant inputs not observable and thus represent Level 3 measurements. The fair value of the 2022 Debt, the 2023 Debt and the 2024 Debt (as defined in Note 6 ) were based on market quotations(s) received from broker/dealer(s). These fair value measurements were based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly and thus represent Level 2 measurements. The carrying value and fair value of the Company’s debt obligations were as follows:
September 30, 2024
December 31, 2023
Carrying Value (1)
Fair Value
Carrying Value (1)
Fair Value
Wells Fargo Financing Facility
$ 95,000 $ 95,000 $ 231,000 $ 231,000
SMBC Financing Facility
122,500 122,500 37,377 37,377
Revolving Credit Facility
112,750 112,750 126,500 126,500
2022 Debt
342,000 345,256 342,000 338,345
2023 Debt
214,714 217,238 215,000 213,976
2024 Debt
215,000 216,317
Total $ 1,101,964 $ 1,109,061 $ 951,877 $ 947,198
_______________
(1) Carrying value on the consolidated statements of assets and liabilities are net of deferred financing costs.

5. RELATED PARTY TRANSACTIONS
Advisory Agreements
On December 31, 2019, immediately prior to its election to be regulated as a BDC, the Company entered into the investment advisory agreement with the Adviser. The Board, including all of the directors who are not “interested persons” (as defined in the 1940 Act) of the Company (the “Independent Directors”), approved the investment advisory agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, the 1940 Act. On January 29, 2024, the Company entered into an amended and restated investment advisory agreement (the “Advisory Agreement”), which became effective upon the consummation of the IPO on January 29, 2024.
On December 31, 2019, immediately prior to the Company’s election to be regulated as a BDC, the Adviser entered into an investment sub-advisory agreement with Churchill, which was subsequently amended and restated on December 11, 2020, October 7, 2021 and March 8, 2022 (the “CAM Sub-Advisory Agreement”). The Adviser has delegated substantially all of its day-to-day portfolio-management obligations under the Advisory Agreement to Churchill pursuant to the CAM Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Company and manages the capital structure of the Company, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Company’s performance under the terms of the Advisory Agreement. The Adviser retains 32.5 % of the management fee and incentive fee payable by the Company. The remaining amount is paid by the Adviser to Churchill as compensation for services provided by Churchill pursuant to the CAM Sub-Advisory Agreement.
59

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

On January 29, 2024, the Adviser and Churchill entered into an investment sub-advisory agreement with Nuveen Asset Management (the “NAM Sub-Advisory Agreement”, and together with the Advisory Agreement and the CAM Sub-Advisory Agreement, the “Advisory Agreements”), pursuant to which Nuveen Asset Management may manage a portion of the Company’s portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”), subject to the pace and amount of investment activity in the middle market investment program. The Company typically refers to an investment as liquid if the investment is, or we expect it to be, actively traded (with a typical settlement period of one month with respect to broadly syndicated loans). The percentage of the Company’s portfolio allocated to the Liquid Investments strategy managed by Nuveen Asset Management is at the discretion of Churchill. The fees payable to Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement to manage the Company’s Liquid Investment allocation is payable by Churchill and does not impact the advisory fees payable by the Company’s shareholders. Churchill will pay Nuveen Asset Management monthly in arrears, 0.375 % of the daily weighted average principal amount of the Liquid Investments managed by Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement. The fees payable to Nuveen Asset Management pursuant to the NAM Sub-Advisory Agreement will not impact the advisory fees payable by the Company's shareholders.
Advisory agreements remain in effect for an initial period of two years and will remain in effect on a year-to-year basis thereafter if approved annually either by the Board or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of our Independent Directors. On October 27, 2023, the Board, including all of the Independent Directors, approved the Advisory Agreement and the NAM Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by the 1940 Act for an initial two-year term expiring on January 29, 2026. In addition, on October 27, 2023, the Board, including all of the Independent Directors, approved the renewal of the CAM Sub-Advisory Agreement in accordance with, and on the basis of, an evaluation satisfactory to such directors as required by the 1940 Act for an additional one-year term expiring on December 31, 2024. Each Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the applicable investment adviser and may be terminated by either the Company or the applicable investment adviser without penalty upon not less than 60 days’ written notice to the other. The holders of a majority of our outstanding voting securities may also terminate any of the Advisory Agreements without penalty.
Compensation of the Adviser - Management Fee
Under the Advisory Agreement, for the first five quarters beginning with the calendar quarter in which the IPO was consummated (i.e., beginning with the calendar quarter ended March 31, 2024 through the calendar quarter ending March 31, 2025), the management fee is calculated at an annual rate of 0.75 % of average total assets, excluding cash and cash equivalents and including assets financed using leverage (“Average Total Assets”), at the end of the two most recently completed calendar quarters, and thereafter, the management fee will step up to 1.00 % of Average Total Assets. For purposes of this calculation, cash and cash equivalents include any temporary investments in cash-equivalents, U.S. government securities and other high quality investment grade debt investments that mature in 12 months or less from the date of investment. Any management fees will be payable quarterly in arrears.
Compensation of the Adviser - Incentive Fee
Under the Advisory Agreement, the Adviser is waiving the incentive fee on income and incentive fee on capital gains for the first five quarters beginning with the calendar quarter in which the IPO was consummated (i.e., beginning with the calendar quarter ended March 31, 2024 through the calendar quarter ending March 31, 2025). Following the expiration of the fee waiver, the Company will pay an incentive fee to the Adviser that will consist of two parts. The incentive fees will be based on income and capital gains, each as described below. The portion of the incentive fee based on income will be calculated, subject to a cap (the “Incentive Fee Cap”), and payable quarterly in arrears based on pre-incentive fee net investment income in respect of the current calendar quarter and the eleven preceding calendar quarters (or, if fewer, the number of calendar quarters beginning with the calendar quarter in which the IPO was consummated) (such period, the “Trailing Twelve Quarters”) commencing from the beginning of the calendar quarter in which the IPO was consummated, as follows:
no incentive fee in any calendar quarter in which the aggregate pre-incentive fee net investment income (as defined below) in respect of the Trailing Twelve Quarters does not exceed the hurdle rate of 1.50 % ( 6 % annually) for such Trailing Twelve Quarters;
60

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

100 % of our aggregate pre-incentive fee net investment income in respect of the Trailing Twelve Quarters with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 1.7647 % in any calendar quarter following the consummation of the IPO. The Company refers to this portion of the pre-incentive fee net investment income as the “catch-up” provision. The catch-up is meant to provide the Adviser with 15 % of the pre-incentive fee net investment income as if a hurdle rate did not apply if this net investment income exceeds 1.7647 % multiplied by our NAV at the beginning of each applicable calendar quarter comprising of the relevant Trailing Twelve Quarters; and
15 % of the aggregate pre-incentive fee net investment income, if any, in respect of the Trailing Twelve Quarters that exceeds 1.7647 %.
Under the Advisory Agreement, the incentive fee on income for a particular quarter will be subject to the Incentive Fee Cap. The Incentive Fee Cap will be equal to the difference between (x) 15 % of the Cumulative Pre-Incentive Fee Net Return (as defined below) over the Trailing Twelve Quarters and (y) the aggregate incentive fee on income that was paid to the Adviser by the Company in respect of the first eleven calendar quarters (or, if fewer, the number of calendar quarters beginning with the calendar quarter in which the IPO was consummated) included in the relevant Trailing Twelve Quarters. These calculations will be adjusted for any share issuances or repurchases during the applicable calendar quarter.

“Cumulative Pre-Incentive Fee Net Return” during the relevant Trailing Twelve Quarters, beginning with the calendar quarter in which the IPO was consummated, means (x) the pre-incentive fee net investment income in respect of the relevant Trailing Twelve Quarters less (y) any Net Capital Loss (as defined below), if any, in respect of the relevant Trailing Twelve Quarters. If, in any quarter, the Incentive Fee Cap is zero or a negative value, the Company will pay no incentive fee on income to the Adviser in respect of that quarter. If, in any quarter, the Incentive Fee Cap for such quarter is a positive value but is less than the incentive fee on income that is payable to the Adviser for such quarter calculated as described above, the Company will pay an incentive fee on income to the Adviser equal to the Incentive Fee Cap in respect of such quarter. If, in any quarter, the Incentive Fee Cap for such quarter is equal to or greater than the incentive fee on income that is payable to the Adviser for such quarter calculated as described above, the Company will pay an incentive fee on income to the Adviser equal to the incentive fee calculated as described above for such quarter without regard to the Incentive Fee Cap.

“Net Capital Loss” in respect of a particular period, beginning with the calendar quarter in which the IPO was consummated, means the difference, if positive, between (i) aggregate capital losses, whether realized or unrealized, in respect of such period and (ii) aggregate capital gains, whether realized or unrealized, in respect of such period.

Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies but excluding fees for providing managerial assistance) accrued during the relevant calendar quarters, minus operating expenses for the relevant calendar quarters (including the management fee, any expenses payable under the Administration Agreement (as defined below), interest expense and dividends paid on any outstanding preferred shares, but excluding the incentive fee). Pre-incentive fee net investment income will include, in the case of investments with a deferred interest feature such as market discount, debt instruments with PIK interest, preferred shares with PIK dividends and zero-coupon securities, accrued income that the Company has not yet received in cash. The Adviser is not under any obligation to reimburse the Company for any part of the incentive fee it received that was based on accrued interest that the Company never received. Pre-incentive fee net investment income will not include any realized capital gains, realized capital losses or unrealized capital gains or losses. If any distributions from portfolio companies are characterized as a return of capital, such returns of capital would affect the capital gains incentive fee to the extent a gain or loss is realized.

Under the Advisory Agreement, the second part of the incentive fee will be a capital gains incentive fee that will be determined and payable in arrears as of the end of each fiscal year (or upon termination of the Advisory Agreement, as of the termination date), and equals 15.0 % of our realized capital gains as of the end of the fiscal year following the IPO. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.
61

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

In determining the capital gains incentive fee payable to the Adviser, the Company will calculate the cumulative aggregate realized capital gains and cumulative aggregate realized capital losses beginning with the calendar quarter in which the IPO was consummated, and the aggregate unrealized capital depreciation as of the date of the calculation, as applicable, with respect to each of the investments in our portfolio. For this purpose, cumulative aggregate realized capital gains, if any, equals the sum of the differences between the net sales price of each investment, when sold, and the amortized cost of such investment. Cumulative aggregate realized capital losses equals the sum of the amounts by which the net sales price of each investment, when sold, is less than the amortized cost of such investment beginning with the calendar quarter in which this offering is consummated. Aggregate unrealized capital depreciation equals the sum of the difference, if negative, between the valuation of each investment as of the applicable calculation date and the amortized cost of such investment. At the end of the applicable year, the amount of capital gains that will serve as the basis for the calculation of the capital gains incentive fee equals the cumulative aggregate realized capital gains less cumulative aggregate realized capital losses, less aggregate unrealized capital depreciation, with respect to our portfolio of investments.

For the three and nine months ended September 30, 2024, base management fees were $ 3,873 and $ 10,727 , respectively. For the three and nine months ended September 30, 2023, base management fees were $ 2,722 and $ 7,503 , respectively. As of September 30, 2024 and December 31, 2023, $ 3,873 and $ 3,006 , respectively, of such base management fees, were unpaid and are included in management fees payable in the accompanying consolidated statements of assets and liabilities. For the three and nine months ended September 30, 2024, income based incentive fees of $ 5,496 and $ 13,030 , respectively, were waived in accordance with the terms of the Advisory Agreement. As of September 30, 2024, no amounts were payable to the Adviser related to income based incentive fees. As of December 31, 2023, the Adviser was not entitled to any incentive fees under the Advisory Agreement.
Administration Agreement
On December 31, 2019, the Company entered into an administration agreement (the "Administration Agreement"), which was approved by the Board. Pursuant to the Administration Agreement, the Administrator furnishes the Company with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Company with the preparation of the financial records that the Company is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or Churchill, the Administrator also may provide significant managerial assistance on the Company’s behalf to those portfolio companies that have accepted the Company’s offer to provide such assistance. U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), provides the Company with certain fund administration and bookkeeping services pursuant to a sub-administration agreement with the Administrator.
For the three and nine months ended September 30, 2024, the Company incurred $ 535 and $ 1,561 , respectively, in fees under the Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. For the three and nine months ended September 30, 2023, the Company incurred $ 370 and $ 1,029 , respectively, in fees under the Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of September 30, 2024 and December 31, 2023, fees of $ 1,176 and $ 505 , respectively, were unpaid and included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities.
Expense Support Agreement
On December 31, 2019, the Company entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO on January 29, 2024. Under the Expense Support Agreement, the Adviser was able to pay certain expenses of the Company, provided that no portion of the payment was used to pay any interest expense of the Company (each, an “Expense Payment”). Such Expense Payment was made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from the Adviser to pay such expense, and/or by an offset against amounts due from the Company to the Adviser or its affiliates. The cumulative amount of expense payments by the Adviser under the Expense Support Agreement was $ 2,979 , of which $ 1,101 was reimbursed by the Company prior to the termination of the Expense Support Agreement.
62

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Directors' Fees
The Board consists of seven members, five of whom are Independent Directors. The Board established an Audit Committee, a Nominating and Corporate Governance Committee, a Compensation Committee, and a Co-Investment Committee, each consisting solely of the Independent Directors, and may establish additional committees in the future. For the three and nine months ended September 30, 2024, the Company incurred $ 128 and $ 383 , respectively, in fees which are included in Directors’ fees in the accompanying consolidated statements of operations. For the three and nine months ended September 30, 2023, the Company incurred $ 96 and $ 287 , respectively, in fees which are included in Directors’ fees in the accompanying consolidated statements of operations. As of September 30, 2024 and December 31, 2023, $ 128 and $ 96 , respectively, were unpaid and are included in Directors’ fees payable in the accompanying consolidated statements of assets and liabilities.
Other Related Party Transactions
From time to time, Churchill, in its capacity as sub-adviser, and the Administrator may pay amounts owed by the Company to third-party providers of goods or services and the Company will subsequently reimburse Churchill and Administrator for such amounts paid on its behalf. Amounts payable to Churchill and the Administrator are settled in the normal course of business without formal payment terms. As of September 30, 2024 and December 31, 2023, the Company owed Churchill and the Administrator $ 436 and $ 353 , respectively, for reimbursements including the Company's allocable portion of overhead, which are included in accounts payable and accrued expenses in the accompanying consolidated statements of assets and liabilities.
6. SECURED BORROWINGS
The Company, CLO-I, CLO-II, CLO-III, SPV IV and SPV V are party to credit facilities or debt obligations as described below. In accordance with the 1940 Act, the Company is currently only allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowings. As of September 30, 2024 and December 31, 2023, asset coverage was 189.89 % and 178.57 %, respectively. Proceeds of the credit facilities or debt obligations are used for general corporate purposes, including the funding of portfolio investments. The Company, CLO-I, CLO-II, CLO-III, SPV IV and SPV V were in compliance with all covenants and other requirements of their respective agreements.
Subscription Facility
On September 10, 2020, the Company entered into a revolving credit agreement (the “Subscription Facility Agreement” and the facility thereunder, the “Subscription Facility”) with Sumitomo Mitsui Banking Corporation (“SMBC”), as the administrative agent for certain secured parties, the syndication agent, the lead arranger, the book manager, the letter of credit issuer and the lender. The Subscription Facility had a maximum commitment of $ 50,000 , subject to availability under the "Borrowing Base." The Borrowing Base was calculated based on the unfunded capital commitments of certain investors that had subscribed to purchase shares of the Company, to the extent the capital commitments of such investors also had been approved by SMBC for inclusion in the Borrowing base and met certain additional criteria.
The Subscription Facility Agreement expired on September 8, 2023, and the Company fully paid down the outstanding balance including the accrued interest expense.
For the three months ended September 30, 2024 and 2023, the components of interest expense related to the Subscription Facility were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ $ 252
Unused fees 14
Amortization of deferred financing costs 25
Total interest and debt financing expenses $ $ 291
63

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the Subscription Facility were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ $ 611
Unused fees 64
Amortization of deferred financing costs 108
Total interest and debt financing expenses $ $ 783
Wells Fargo Financing Facility
On December 31, 2019, a wholly owned subsidiary of the Company entered into a credit agreement ("the “Wells Fargo Financing Facility” and the agreement relating thereto, as amended from time to time, the “Wells Fargo Financing Facility Agreement”), with Wells Fargo Bank, N.A. as lender (“Wells Fargo”) and administrative agent. The Wells Fargo Financing Facility Agreement was amended on October 28, 2020, March 31, 2022, March 14, 2024 and August 27, 2024. The most recent amendment on August 27, 2024, among other things, increased the maximum facility amount available from $ 150,000 to $ 225,000 .
The Wells Fargo Financing Facility reinvestment period expires on March 31, 2025 and has a maturity date of March 31, 2027. The Wells Fargo Financing Facility Agreement also requires the Company to maintain an asset coverage ratio equal to at least 1.50 :1.00. The amount of the borrowings under the Wells Fargo Financing Facility equals the amount of the outstanding advances. Advances under the Wells Fargo Financing Facility may be prepaid and reborrowed at any time during the reinvestment period, but any termination or reduction of the facility amount prior to the first anniversary of the date of the amendment (subject to certain exceptions) is subject to a commitment reduction fee of 1 %. Under the Wells Fargo Financing Facility Agreement, the Company paid a fee on daily undrawn amounts under the Wells Fargo Financing Facility of 0.25 % per annum during the period ended June 14, 2024. For the six months following June 14, 2024, the Company paid a fee on daily undrawn amounts under the Wells Fargo Facility of 0.50 % per annum, and, thereafter, pays 0.50 % per annum on undrawn amounts of up to 40 % of the maximum facility amount and 1.50 % per annum on undrawn amounts in excess of 40 % of the maximum facility amount.
As of September 30, 2024 and December 31, 2023, the Wells Fargo Financing Facility bore interest at a rate of SOFR, reset daily, plus 2.20 %, per annum.
On March 14, 2024, SPV V entered into the borrower joinder agreement to become party to the Wells Fargo Financing Facility Agreement and pledged all of its assets to the collateral agent to secure their obligations under the Wells Fargo Financing Facility. The Company and SPV V have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.
For the three months ended September 30, 2024 and 2023, the components of interest expense related to the Wells Fargo Financing Facility were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ 1,783 $ 3,207
Unused fees 109 135
Amortization of deferred financing costs 73 122
Total interest and debt financing expenses $ 1,965 $ 3,464
64

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the Wells Fargo Financing Facility were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ 5,596 $ 7,926
Unused fees 285 494
Amortization of deferred financing costs 941 361
Total interest and debt financing expenses $ 6,822 $ 8,781
SMBC Financing Facility
On November 24, 2020, a wholly owned subsidiary of the Company entered into a senior secured revolving credit facility (the “SMBC Financing Facility” and the agreement relating thereto the “SMBC Financing Facility Agreement”) with SMBC, as the administrative agent, the collateral agent and the lender. On October 19, 2023, SPV IV entered into the borrower joinder agreement (the “SMBC Joinder”) to become party to the SMBC Financing Facility Agreement.
The SMBC Financing Facility Agreement was amended on December 23, 2021, June 29, 2022 and November 21, 2023. The most recent amendment on November 21, 2023 (the "SMBC Financing Facility Amendment"), among other things: (i) extended the reinvestment period from November 24, 2023 to November 24, 2024 and the stated maturity date from November 24, 2025 to November 24, 2026; (ii) changed the interest rate for loans under the SMBC Financing Facility Agreement from (A) either the Base Rate (as defined in the SMBC Financing Facility Agreement) plus 1.15 % or the Term SOFR (as defined in the SMBC Financing Facility Agreement) plus 2.15 % to (B) either the Base Rate plus 1.65 % or Term SOFR plus 2.65 %; (iii) reduced the maximum facility amount from $ 300,000 to $ 150,000 upon the occurrence of a permitted securitization, subject to a subsequent increase to $ 250,000 , in the sole discretion of the administrative agent, if so requested by the borrowers; and (iv) provide for an unused commitment fee of, from the three month anniversary of the SMBC Financing Facility Amendment date to the six-month anniversary of the SMBC Financing Facility Amendment date, 0.50 % per annum on the unused commitments and on or after the six month anniversary of the Amendment date, 0.50 % per annum on the unused commitments if such unused commitments are less than 50% of the total commitments and 1.00 % per annum on the unused commitments if such unused commitments are greater than or equal to 50% of the total commitments. In connection with the SMBC Financing Facility Amendment, the borrowers paid an extension fee of $ 450 plus an annualized fee of 0.30 % multiplied by $ 150,000 based on the length of time (in years) until the occurrence of a permitted securitization. Advances under the SMBC Financing Facility Agreement may be prepaid and reborrowed at any time during the reinvestment period. As of September 30, 2024 and December 31, 2023, the SMBC Financing Facility bore interest at one-month SOFR plus 2.65 % per annum.
Effective December 7, 2023, following the closing of the 2023 Debt Securitization (discussed further below), the maximum facility amount available was reduced to $ 150,000 from $ 300,000 and SPV IV began borrowing under the SMBC Financing Facility.
SPV IV, beginning October 19, 2023, has pledged all of its assets to the collateral agent to secure its obligations under the SMBC Financing Facility. The Company, and SPV IV have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.
For the three months ended September 30, 2024 and 2023, the components of interest expense related to the SMBC Financing Facility were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ 3,582 $ 5,322
Unused fees 18 24
Amortization of deferred financing costs 112 129
Total interest and debt financing expenses $ 3,712 $ 5,475
65

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the SMBC Financing Facility were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ 5,680 $ 14,636
Unused fees 187 105
Amortization of deferred financing costs 333 383
Total interest and debt financing expenses $ 6,200 $ 15,124
Revolving Credit Facility
On June 23, 2023, the Company entered into a senior secured revolving credit agreement (the “Senior Secured Revolving Credit Agreement" and facility thereunder, the “Revolving Credit Facility”) with SMBC as the lender, administrative agent, and one of the lead arrangers along with Wells Fargo. The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain subsidiaries of the Company that are formed or acquired by the Company in the future (collectively, the “Guarantors”).
The Revolving Credit Facility was amended on April 9, 2024. The amendment, among other things, increased the maximum principal amount available under the Revolving Credit Facility from $ 185,000 to $ 250,000 pursuant to the accordion feature, subject to availability under the borrowing base, which is based on the Company’s portfolio investments and other outstanding indebtedness. Maximum capacity under the Revolving Credit Facility may be increased to $ 300,000 through the exercise by the Company of an optional accordion feature through which existing and new lenders may agree to provide additional financing. The Revolving Credit Facility is secured by a perfected first-priority interest in substantially all of the portfolio investments held by the Company and each Guarantor, subject to certain exceptions, and includes a $ 25,000 limit for swingline loans.
The availability period under the Revolving Credit Facility will terminate on June 23, 2027 (the “Commitment Termination Date”) and will mature on June 23, 2028 (the “Final Maturity Date”). During the period from the Commitment Termination Date to the Final Maturity Date, the Company will be obligated to make mandatory prepayments out of the proceeds of certain asset sales and other recovery events and equity and debt issuances.
The Company may borrow amounts in U.S. dollars or certain other permitted currencies. Amounts drawn in U.S. dollars will bear interest at either term SOFR plus a margin, or the prime rate plus a margin. The Company may elect either the term SOFR or prime rate at the time of drawdown, and loans denominated in U.S. dollars may be converted from one rate to another at any time at the Company’s option, subject to certain conditions. Amounts drawn in other permitted currencies will bear interest at the relevant rate specified therein plus an applicable margin. The Company also will pay a fee of 0.375 % per annum on average daily undrawn amounts. As of September 30, 2024 and December 31, 2023, the Revolving Credit Facility bore interest at one-month SOFR plus 2.25 % per annum.
The Senior Secured Revolving Credit Agreement includes customary covenants, including certain limitations on the incurrence by the Company of additional indebtedness and on the Company’s ability to make distributions to its shareholders, or redeem, repurchase or retire shares of stock, upon the occurrence of certain events and certain financial covenants related to asset coverage and minimum shareholders’ equity, as well as customary events of default.
For the three months ended September 30, 2024 and 2023, the components of interest expense related to the Revolving Credit Facility were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ 2,377 $ 279
Unused fees 105 169
Amortization of deferred financing costs 130 113
Total interest and debt financing expenses $ 2,612 $ 561
66

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the Revolving Credit Facility were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ 4,091 $ 279
Unused fees 437 186
Amortization of deferred financing costs 360 123
Total interest and debt financing expenses $ 4,888 $ 588
CLO-I
On May 20, 2022 (the “Closing Date”), the Company completed a $ 448,325 term debt securitization (the “2022 Debt Securitization”). Term debt securitization is also known as a collateralized loan obligation and is a form of secured financing incurred by the Company.
The notes offered in the 2022 Debt Securitization (the “2022 Notes”) were issued by CLO-I, an indirect, wholly owned, consolidated subsidiary of the Company. The 2022 Notes consist of $ 199,000 of AAA Class A-1 2022 Notes, which bear interest at the three-month Term SOFR plus 1.80 %; $ 34,250 of AAA Class A-1F 2022 Notes, which bear interest at 4.42 %; $ 47,250 of AA Class B 2022 Notes, which bear interest at the three-month Term SOFR plus 2.30 %; $ 31,500 of A Class C 2022 Notes, which bear interest at the three-month Term SOFR plus 3.15 %; $ 27,000 of BBB Class D 2022 Notes, which bear interest at the three-month Term SOFR plus 4.15 %; and $ 79,325 of Subordinated 2022 Notes, which do not bear interest. The Company directly owns all of the BBB Class D 2022 Notes and the Subordinated 2022 Notes and, as such, these notes are eliminated in consolidation.
As part of the 2022 Debt Securitization, CLO-I also entered into a loan agreement (the “CLO-I Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-I Loan Agreement as lenders (the “Lenders”) committed to make $ 30,000 of AAA Class A-L 2022 Loans to CLO-I (the “2022 Loans” and, together with the 2022 Notes, the “2022 Debt”). The 2022 Loans bear interest at the three-month Term SOFR plus 1.80 % and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all of the Class A-L 2022 Loans held by such Lenders into Class A-1 2022 Notes upon written notice to CLO-I in accordance with the CLO-I Loan Agreement.
The 2022 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through April 20, 2026, all principal collections received on the underlying collateral may be used by CLO-I to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-I and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2022 Debt Securitization. The 2022 Notes are due on April 20, 2034. The 2022 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on April 20, 2034.
The 2022 Debt is the secured obligation of CLO-I, and the indenture and the CLO-I Loan Agreement, as applicable, governing the 2022 Debt includes customary covenants and events of default. The 2022 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.
The Company serves as collateral manager to CLO-I under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.
For the three months ended September 30, 2024 and 2023, the components of interest expense related to the CLO-I were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ 6,204 $ 6,106
Unused fees
Amortization of deferred financing costs 152 151
Total interest and debt financing expenses $ 6,356 $ 6,257
67

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)


For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the CLO-I were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ 18,390 $ 17,364
Unused fees
Amortization of deferred financing costs 452 449
Total interest and debt financing expenses $ 18,842 $ 17,813
CLO-II
On December 7, 2023 (the “Closing Date”), the Company completed a $ 298,060 term debt securitization (the “2023 Debt Securitization”).
The notes offered in the 2023 Debt Securitization (the “2023 Notes”) were issued by CLO-II, an indirect, wholly owned, consolidated subsidiary of the Company. The 2023 Notes consist of $ 2,000 of AAA Class X 2023 Notes, which bear interest at the three-month Term SOFR plus 2.00 %, $ 100,500 of AAA Class A-1 2023 Notes, which bear interest at the three-month Term SOFR plus 2.35 %; $ 37,500 of AA Class B 2023 Notes, which bear interest at three-month Term SOFR plus 3.20 % and approximately $ 83,060 of Subordinated 2023 Notes, which do not bear interest. The Company directly owns all of the Subordinated 2023 Notes and as such, these notes are eliminated in consolidation.
As part of the 2023 Debt Securitization, CLO-II also entered into a loan agreement (the “CLO-II Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-II Loan Agreement as lenders (the “Lenders”) committed to make $ 25,000 of AAA Class A-L-A 2023 Loans and $ 50,000 AAA Class A-L-B 2023 Loans to CLO-II (the “2023 Loans” and, together with the 2023 Notes, the “2023 Debt”). The 2023 Loans bear interest at the three-month Term SOFR plus 2.35 % and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all or a portion of the Class A-L-A 2023 Loans held by such Lenders into Class A-1 2023 Notes upon written notice to CLO-II in accordance with the CLO-II Loan Agreement.
The 2023 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through January 20, 2028, all principal collections received on the underlying collateral may be used by CLO-II to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-II and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2023 Debt Securitization. The 2023 Notes are due on January 20, 2036. The 2023 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on January 20, 2036.
The 2023 Debt is the secured obligation of CLO-II, and the indenture and the CLO-II Loan Agreement, as applicable, governing the 2023 Debt includes customary covenants and events of default. The 2023 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.
The Company serves as collateral manager to CLO-II under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.
For the three months ended September 30, 2024 and 2023, the components of interest expense related to the CLO-II were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ 4,280 $
Unused fees
Amortization of deferred financing costs 111
Total interest and debt financing expenses $ 4,391 $
68

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the CLO-II were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ 12,752 $
Unused fees
Amortization of deferred financing costs 332
Total interest and debt financing expenses $ 13,084 $
CLO-III
On March 14, 2024 (the “Closing Date”), the Company completed a $ 296,970 term debt securitization (the “2024 Debt Securitization”).
The notes offered in the 2024 Debt Securitization (the “2024 Notes” or “2024 Debt”) were issued by Churchill NCDLC CLO-III, LLC (formerly known as Nuveen Churchill BDC SPV III, LLC) (the “2024 Issuer”), a direct, wholly owned, consolidated subsidiary of the Company, pursuant to an indenture (the “Indenture”) dated as of the Closing Date. The 2024 Notes consist of $ 2,000 of AAA Class X 2024 Notes, which bear interest at the three-month Term SOFR plus 1.40 %; $ 175,500 of AAA Class A 2024 Notes, which bear interest at the three-month Term SOFR plus 2.00 %; $ 37,500 of AA Class B 2024 Notes, which bear interest at the three-month Term SOFR plus 2.65 %; and $ 81,970 of Subordinated 2024 Notes, which do not bear interest. The Company directly retained all of the Subordinated 2024 Notes and as such, these notes are eliminated in consolidation.

The 2024 Notes are backed by a diversified portfolio of senior secured and second lien loans. The Indenture contains certain
conditions pursuant to which loans can be acquired by the 2024 Issuer, in accordance with rating agency criteria or as otherwise agreed with certain institutional investors who purchased the 2024 Notes. Through April 20, 2028, all principal collections received on the underlying collateral may be used by the 2024 Issuer to purchase new collateral under the direction of the Company, in its capacity as collateral manager of the 2024 Issuer and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2024 Debt Securitization. The 2024 Notes are due on April 20, 2036.

The 2024 Notes are the secured obligation of the 2024 Issuer, and the Indenture governing the 2024 Notes includes customary covenants and events of default. The 2024 Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or any state “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or applicable exemption from registration.

The Company serves as collateral manager to the 2024 Issuer under a collateral management agreement (the “Collateral Management Agreement”) and has waived any management fee due to it in consideration for providing these services.

For the three months ended September 30, 2024 and 2023, the components of interest expense related to the CLO-III were as follows:
Three Months Ended September 30,
2024 2023
Borrowing interest expense $ 4,061 $
Unused fees
Amortization of deferred financing costs 101
Total interest and debt financing expenses $ 4,162 $
69

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the nine months ended September 30, 2024 and 2023, the components of interest expense related to the CLO-III were as follows:
Nine Months Ended September 30,
2024 2023
Borrowing interest expense $ 8,804 $
Unused fees
Amortization of deferred financing costs 220
Total interest and debt financing expenses $ 9,024 $
Summary of Secured Borrowings
The Company's debt obligations consisted of the following as of September 30, 2024 and December 31, 2023:
September 30, 2024
Wells Fargo Financing Facility
SMBC Financing Facility
CLO-I CLO-II
CLO-III
Revolving Credit Facility
Total
Total Commitment $ 225,000 $ 150,000 $ 342,000 $ 214,714 $ 215,000 $ 250,000 $ 1,396,714
Amount Outstanding (1)
95,000 122,500 342,000 214,714 215,000 112,750 1,101,964
Unused Portion (2)
130,000 27,500 137,250 294,750
Amount Available (3)
130,000 24,240 137,250 291,490
_______________
(1) Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.
(2) The unused portion on the credit facilities is the amount upon which commitment fees are based.
(3) Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.
December 31, 2023
Wells Fargo Financing Facility
SMBC Financing Facility
CLO -I
CLO-II
Revolving Credit Facility
Total
Total Commitment $ 275,000 $ 150,000 $ 342,000 $ 215,000 $ 185,000 $ 1,167,000
Amount Outstanding (1)
231,000 37,377 342,000 215,000 126,500 951,877
Unused Portion (2)
44,000 112,623 58,500 215,123
Amount Available (3)
43,837 112,623 58,500 214,960
_______________
(1) Amount outstanding on the consolidated statements of assets and liabilities is net of deferred financing costs.
(2) The unused portion on the credit facilities is the amount upon which commitment fees are based.
(3) Available for borrowing on the credit facilities based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.
70

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

For the three and nine months ended September 30, 2024 and 2023, the components of interest expense and debt financing expenses were as follows:
Three Months Ended September 30,
2024 2023
Interest expense $ 22,287 $ 15,166
Unused fees 232 342
Amortization of deferred financing costs 679 540
Total interest and debt financing expenses $ 23,198 $ 16,048
Average interest rate (1)
7.74 % 7.51 %
Average daily borrowings $ 1,156,703 $ 819,047
Nine Months Ended September 30,
2024 2023
Interest expense $ 55,313 $ 40,816
Unused fees 909 849
Amortization of deferred financing costs 2,638 1,424
Total interest and debt financing expenses $ 58,860 $ 43,089
Average interest rate (1)
7.70 % 7.17 %
Average daily borrowings $ 974,676 $ 777,454
_______________
(1) Average interest rate includes borrowing interest expense and unused fees.
Contractual Obligations
The following tables show the contractual maturities of the Company's debt obligations as of September 30, 2024 and December 31, 2023:
Payments Due by Period
As of September 30, 2024
Total Less than 1 Year 1 to 3 years 3 to 5 years More than 5 Years
Wells Fargo Financing Facility $ 95,000 $ $ 95,000 $ $
SMBC Financing Facility 122,500 122,500
Revolving Credit Facility
112,750 112,750
CLO-I 342,000 342,000
CLO-II 214,714 214,714
CLO-III 215,000 215,000
Total debt obligations $ 1,101,964 $ $ 217,500 $ 112,750 $ 771,714

Payments Due by Period
As of December 31, 2023
Total Less than 1 Year 1 to 3 years 3 to 5 years More than 5 Years
Wells Fargo Financing Facility $ 231,000 $ $ $ 231,000 $
SMBC Financing Facility 37,377 37,377
Revolving Credit Facility 126,500 126,500
CLO-I 342,000 342,000
CLO-II 215,000 215,000
Total debt obligations $ 951,877 $ $ 37,377 $ 357,500 $ 557,000

71

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

7. COMMITMENTS AND CONTINGENCIES
In the ordinary course of its business, the Company enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Company. The Company believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of September 30, 2024 and December 31, 2023 for any such exposure.
As of September 30, 2024 and December 31, 2023, the Company had the following unfunded investment commitments:
Portfolio Company September 30, 2024 December 31, 2023
360 Training - Delayed Draw Loan $ 3,093 $
Action Behavior Centers - Delayed Draw Loan 2,850
Allstar Holdings - Delayed Draw Loan 990 7,373
Alternative Logistics Technologies Buyer, LLC - Delayed Draw Loan 3,040
AmerCareRoyal - Delayed Draw Loan 280
Anne Arundel - Delayed Draw Loan 366 366
Apex Companies - Delayed Draw Loan 1,115
Apex Services - Delayed Draw Loan 293
Apex Services - First Lien Term Loan 635
Apex Services - Revolving Loan 55
ARMstrong - Delayed Draw Loan 3,541 3,847
Ascend - Delayed Draw Loan 12,642
ASTP Holdings Co-Investment - Units 106 34
Bounteous - Delayed Draw Loan 4,467
BTX Precision - Delayed Draw Loan 898
BusinesSolver - Delayed Draw Loan 873 970
Chroma Color - Delayed Draw Loan 1,379 1,379
ClaimLogiq - Delayed Draw Loan 3,225
Classic Collision - Delayed Draw Loan 21,867
CMP Ren Partners I-A LP 15 15
Coding Solutions Acquisition Inc. - Delayed Draw Loan 2,165
Coding Solutions Acquisition Inc. - Revolving Loan 935
Contract Land Staff - Delayed Draw Loan 4,999
Covercraft - Delayed Draw Loan 4,386
CRCI Holdings Inc - Revolving Loan 963
CRCI Holdings Inc - Delayed Draw Loan 2,615
Crete - Delayed Draw Loan 1,443
CrossCountry Consulting - Delayed Draw Loan 3,320 3,320
D&H United Fueling Solutions - Delayed Draw Loan 3,512 1,567
Diligent Corporation - Delayed Draw Loan 3,830
DMC Power - Delayed Draw Loan 1,671 1,671
E78 - Delayed Draw Loan 15,639 2,570
Elevation Labs - Delayed Draw Loan 2,188 3,125
Eliassen Group, LLC - Delayed Draw Loan 1,903
Engage - Delayed Draw Loan 6,214 8,113
Ergotech (INS) - Delayed Draw Loan 1,979 1,979
Evergreen Services Group II - Delayed Draw Loan 4,488
Excel Fitness - Delayed Draw Loan 2,371
EyeSouth - Delayed Draw Loan 885 885
Fairway Lawns - Delayed Draw Loan 3,360 419
72

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Portfolio Company September 30, 2024 December 31, 2023
Firstcall Mechanical Group - Delayed Draw Loan $ 20,000 $
Gannett Fleming - Revolving Loan 2,131
GHR Healthcare - Delayed Draw Loan 2,594
Health Management Associates - Delayed Draw Loan 754 1,026
Heartland Paving Partners - Delayed Draw Loan 11,429
Heartland Veterinary Partners - Delayed Draw Loan 2,200
High Bar Brands - Delayed Draw Loan 596 596
Impact Environmental Group - Delayed Draw Loan 3,655 7,203
Infobase - Delayed Draw Loan 721
Insulation Technology Group - Delayed Draw Loan 5,912
Integrated Power Services - Delayed Draw Loan 5,112
ITSavvy - Delayed Draw Loan 158
Kenco - Delayed Draw Loan 7,950 1,416
Legacy Service Partners - Delayed Draw Loan 764
Leo Facilities - Delayed Draw Loan 15,118 6,429
Liberty Group - Delayed Draw Loan 449 449
Market Performance Group - Delayed Draw Loan 1,851
MEI Buyer LLC - Delayed Draw Loan 1,814 1,814
MGM Transformer Company - Delayed Draw Loan 6,388
Mobile Communications America Inc - Delayed Draw Loan 5,167 5,970
Mosaic Dental - Delayed Draw Loan 254 553
National Power - Delayed Draw Loan 3,051 3,051
NearU - Delayed Draw Loan 2,792 3,291
NJEye, LLC - Delayed Draw Loan 489
North Haven Spartan US Holdco LLC - Delayed Draw Loan 3,260
Online Labels Group - Delayed Draw Loan 807 807
Options IT - Delayed Draw Loan 236
Options IT - Revolving Loan 67
Ovation Holdings - Delayed Draw Loan 343 343
Palmetto Exterminators - Delayed Draw Loan 652
Pinnacle Supply Partners, LLC - Delayed Draw Loan 2,242 3,636
Precision Aviation Group - Delayed Draw Loan 4,961
Prompt Care - Delayed Draw Loan 1,437
Propark Mobility - Delayed Draw Loan 422 1,797
PT Intermediate Holdings III, LLC - Delayed Draw Loan 1,106
Randy's Worldwide Automotive - Delayed Draw Loan 2,636 3,750
Repipe Specialists - Delayed Draw Loan 691
Rhino Tool House - Delayed Draw Loan 36 921
Riveron - Delayed Draw Loan 1,607
RMA Companies - Delayed Draw Loan 1,943 3,510
RoadOne - Delayed Draw Loan 1,397
RoadOne- Common 235 235
S&S Truck Parts - Delayed Draw Loan 246
Sciens Building Solutions, LLC - Delayed Draw Loan 1,623
SI Solutions - Delayed Draw Loan 5,601
Sunny Sky Products - Delayed Draw Loan 1,773 1,773
Tech24 - Delayed Draw Loan 2,618 3,655
Technical Safety Services - Delayed Draw Loan 1,631 2,429
73

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Portfolio Company September 30, 2024 December 31, 2023
The Facilities Group - Delayed Draw Loan $ 4,861 $ 5,028
TIDI Products - Delayed Draw Loan 4,085 4,085
Trilon Group - Delayed Draw Loan 4,407
USA Water - Delayed Draw Loan 2,703
Velosio - Delayed Draw Loan 1,284
Vensure - Delayed Draw Loan 730
Vessco - Delayed Draw Loan 3,898
Vessco - Revolving Loan 1,726
Watermill Express - Delayed Draw Loan 1,796
Wellspring - Delayed Draw Loan 1,190 3,756
Wpromote - Delayed Draw Loan 588 588
WSB / EST - Delayed Draw Loan 1,307 4,357
Young Innovations - Delayed Draw Loan 3,448 3,448
Total unfunded commitments $ 234,540 $ 180,547
The Company seeks to carefully consider its unfunded portfolio company commitments for the purpose of planning its ongoing liquidity. As of September 30, 2024, the Company had adequate financial resources to satisfy the unfunded portfolio company commitments.

74

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

8. NET ASSETS
The Company has the authority to issue 500,000,000 shares of common stock, par value $ 0.01 per share.
IPO and Private Offerings
On January 29, 2024, the Company closed its IPO, issuing 5,500,000 shares of its common stock at a public offering price of $ 18.05 per share. The Company received total cash proceeds of $ 99,275 . The Company's common stock began trading on the NYSE under the symbol “NCDL” on January 25, 2024.
Prior to April 28, 2023, in connection with the Private Offerings, the Company entered into subscription agreements (“Subscription Agreements”) with investors, pursuant to which investors were required to fund drawdowns to purchase the Company's shares of common stock up to the amount of their respective capital commitment each time the Company delivered a drawdown notice. Following the final drawdown notice dated December 21, 2023 and due on January 5, 2024, all capital commitments had been drawn.
The following table summarizes total shares issued and proceeds received in connection with the IPO and the Company's capital drawdowns delivered pursuant to the Subscription Agreements from inception through September 30, 2024:
Date Shares Issued Proceeds Received Issuance Price per Share
January 29, 2024 5,500,000 $ 99,275 $ 18.05
January 5, 2024 7,888,094 $ 142,382 $ 18.05
November 3, 2023 5,497,609 $ 100,000 $ 18.19
July 17, 2023 4,357,515 $ 78,565 $ 18.03
April 20, 2023 2,205,038 $ 40,000 $ 18.14
December 21, 2022 3,193,195 $ 60,000 $ 18.79
August 1, 2022 2,652,775 $ 50,082 $ 18.88
April 25, 2022 1,800,426 $ 34,964 $ 19.42
January 21, 2022 1,541,568 $ 30,000 $ 19.46
December 9, 2021 1,491,676 $ 29,207 $ 19.58
November 1, 2021 1,546,427 $ 30,000 $ 19.40
August 23, 2021 2,593,357 $ 50,000 $ 19.28
July 26, 2021 1,564,928 $ 30,000 $ 19.17
June 22, 2021 1,034,668 $ 20,000 $ 19.33
April 23, 2021 1,845,984 $ 35,000 $ 18.96
March 11, 2021 785,751 $ 15,000 $ 19.09
November 6, 2020 1,870,660 $ 35,000 $ 18.71
October 16, 2020 1,057,641 $ 20,000 $ 18.91
August 6, 2020 1,105,425 $ 20,000 $ 18.09
May 7, 2020 1,069,522 $ 20,000 $ 18.70
December 31, 2019 3,310,540 $ 66,211 $ 20.00
December 19, 2019 50 $ 1 $ 20.00
75

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

Distributions
The following table summarizes the Company's distributions declared from inception through September 30, 2024:
Date Declared Record Date Payment Date Dividend per Share
July 31, 2024 September 30, 2024 October 28, 2024 $ 0.45
May 1, 2024 June 28, 2024 July 29, 2024 $ 0.45
January 10, 2024 February 12, 2025 April 28, 2025
$ 0.10 (3)
January 10, 2024 November 11, 2024 January 28, 2025
$ 0.10 (3)
January 10, 2024 August 12, 2024 October 28, 2024
$ 0.10 (3)
January 10, 2024 May 13, 2024 July 29, 2024
$ 0.10 (3)
January 10, 2024 March 30, 2024 April 29, 2024 $ 0.45
December 28, 2023 December 29, 2023 January 10, 2024 $ 0.50
December 28, 2023 December 29, 2023 January 10, 2024
$ 0.05 (2)
September 28, 2023 September 28, 2023 October 12, 2023 $ 0.50
September 28, 2023 September 28, 2023 October 12, 2023
$ 0.05 (2)
June 28, 2023 June 28, 2023 July 12, 2023 $ 0.50
June 28, 2023 June 28, 2023 July 12, 2023
$ 0.05 (2)
March 30, 2023 March 30, 2023 April 12, 2023 $ 0.50
March 30, 2023 March 30, 2023 April 12, 2023
$ 0.26 (1)
December 29, 2022 December 29, 2022 January 17, 2023 $ 0.50
September 28, 2022 September 28, 2022 October 11, 2022 $ 0.47
June 30, 2022 June 30, 2022 July 12, 2022 $ 0.43
March 30, 2022 March 31, 2022 April 12, 2022 $ 0.41
December 29, 2021 December 29, 2021 January 18, 2022 $ 0.40
September 29, 2021 September 29, 2021 October 11, 2021 $ 0.38
June 29, 2021 June 29, 2021 July 12, 2021 $ 0.31
March 29, 2021 March 29, 2021 April 19, 2021 $ 0.30
December 29, 2020 December 29, 2020 January 18, 2021 $ 0.28
November 4, 2020 November 4, 2020 November 11, 2020 $ 0.23
August 4, 2020 August 4, 2020 August 11, 2020 $ 0.28
April 16, 2020 April 16, 2020 April 21, 2020 $ 0.17
________________
(1)    Represents a special dividend and a supplemental dividend.
(2)    Represents a supplemental dividend.
(3)    Represents a special dividend.

The distributions declared were derived from investment company taxable income and net capital gain, if any. The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the Company’s investment company taxable income for the full fiscal year and distributions paid during the full year.
76

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

The following table reflects the shares issued pursuant to the dividend reinvestment from inception through September 30, 2024:
Date Declared Record Date Payment Date
Shares Issued 1
May 1, 2024 June 28, 2024 July 29, 2024 168,527
January 10, 2024 May 13, 2024 July 29, 2024 37,333
January 10, 2024 March 30, 2024 April 29, 2024 189,256
December 28, 2023 December 29, 2023 January 10, 2024 185,541
September 28, 2023 September 28, 2023 October 12, 2023 158,545
June 28, 2023 June 28, 2023 July 12, 2023 128,818
March 30, 2023 March 30, 2023 April 12, 2023 150,703
December 29, 2022 December 29, 2022 January 17, 2023 93,329
September 28, 2022 September 28, 2022 October 11, 2022 68,093
June 30, 2022 June 30, 2022 July 12, 2022 45,341
March 30, 2022 March 31, 2022 April 12, 2022 32,320
December 29, 2021 December 29, 2021 January 18, 2022 23,017
September 29, 2021 September 29, 2021 October 11, 2021 10,639
June 29, 2021 June 29, 2021 July 12, 2021 3,039
March 29, 2021 March 29, 2021 April 19, 2021 1,824
December 29, 2020 December 29, 2020 January 18, 2021 1,550
November 4, 2020 November 4, 2020 November 11, 2020 98
August 4, 2020 August 4, 2020 August 11, 2020 34
________________
(1)    All shares issued to shareholders are newly issued shares.

Share Repurchase Plan

On March 5, 2024, the Company entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which the Company may purchase up to $ 99,275 in the aggregate of its outstanding shares of common stock in the open market at prices below its NAV per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan are conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company adopted the Company 10b5-1 Plan because it believes that, if its common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for the Company to reinvest in its portfolio.

The Company 10b5-1 Plan is designed to allow the Company to repurchase its shares of common stock at times when the Company otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by the Company to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the Company's common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of the Company's common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $ 99,275 and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.

77

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

The following table reflects the shares repurchased pursuant to the Company 10b5-1 Plan for each month from inception through September 30, 2024 (dollar amounts in thousands, except per share data):

Period
Total Number of Shares Repurchased
Average Price Paid per Share
Approximate Dollar Value of Shares that have been Purchased Under the Plan
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
April 1, 2024 - April 30, 2024 104,075 $ 17.57 $ 1,828 $ 97,447
May 1, 2024 - May 31, 2024 96,598 $ 17.56 1,696 95,751
June 1, 2024 - June 30, 2024 91,637 $ 17.73 1,625 94,126
July 1, 2024 - July 31, 2024 75,675 $ 17.61 1,333 92,793
August 1, 2024 - August 31, 2024 154,668 $ 17.24 2,666 90,127
September 1, 2024 - September 30, 2024 109,150 $ 17.69 1,931 88,196
Total 631,803 $ 11,079

9. EARNINGS PER SHARE

The following table presents the computation of basic and diluted earnings per common share for the following periods ($ in thousands, except per share amounts) :

Three Months Ended September 30, Nine Months Ended September 30,

2024 2023 2024 2023
Net increase (decrease) in net assets resulting from operations $ 36,643 $ 20,149 $ 86,872 $ 47,172
Weighted average common shares outstanding - basic and diluted 54,688,860 34,812,720 54,080,979 31,409,296
Net increase (decrease) in net assets resulting from operations per share - basic and diluted $ 0.67 $ 0.58 $ 1.61 $ 1.50
78

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

10. CONSOLIDATED FINANCIAL HIGHLIGHTS
The following is a schedule of financial highlights for the nine months ended September 30, 2024 and 2023:
Nine Months Ended September 30,
2024 2023
Per share data:
Net asset value, beginning of period
$ 18.13 $ 18.32
Net investment income (1)(2)
1.71 1.85
Net realized gain (loss) (1)
( 0.03 ) ( 0.21 )
Total net change in unrealized gain (loss) (1) (2)
( 0.07 ) ( 0.14 )
Net increase (decrease) in net assets resulting from operations (1)
1.61 1.50
Shareholder distributions from net investment income (3)
( 1.55 ) ( 1.86 )
Other (4)
( 0.04 )
Net asset value, end of period
$ 18.15 $ 17.96
Net assets, end of period
$ 990,609 $ 638,959
Shares outstanding, end of period
54,571,650 35,585,951
Per share market value, end of period
$ 17.42 N/A
Total return based on NAV (5)
8.92 % 8.45 %
Total return based on market value (6)
5.15 % N/A
Ratio/Supplemental data:
Ratio of net expenses to average net assets before expense support and waived fees (2) (7) (8)
12.60 % 13.10 %
Ratio of net expenses to average net assets after expense support and waived fees (2) (7) (8)
10.73 % 13.07 %
Ratio of net investment income to average net assets (2) (7)
13.24 % 13.87 %
Portfolio turnover rate (9)
16.62 % 4.98 %
Asset Coverage Ratio 189.89 % 173.74 %
________________
(1) The per share data was derived by using the weighted average shares outstanding during the period.
(2) Ratios and per share information have been updated to reflect reclassifications on the consolidated statements of operations for the nine months ended September 30, 2023.
(3) The per share data for distributions reflects the actual amount of distributions declared during the period.
(4) Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.
(5) Total return is calculated as the change in NAV per share during the period, plus distributions per share, if any, reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning NAV per share and is not annualized.
(6) Total return based on market value is calculated as the change in market value per share during the respective periods, taking into account distributions, if any, reinvested in accordance with the Company’s dividend reinvestment plan. The beginning market value per share is based on the initial public offering price of $ 18.05 per share and is not annualized.
(7) Ratios are annualized except for expense included in the Expense Support Agreement (defined in Note 5 ). The ratio of total expenses to average net assets before expense support and waived fees was 12.60 % and 13.10 % for the nine months ended September 30, 2024 and 2023, respectively, on an annualized basis, excluding the effect of expense support which represented 0.00 % and ( 0.03 )% of average net assets, respectively. The Expense Support Agreement terminated upon consummation of the IPO on January 29, 2024. Average net assets is calculated utilizing quarterly net assets.
(8) The ratio of interest and debt financing expenses to average net assets for the nine months ended September 30, 2024 and 2023 was 8.45 % and 10.29 %, respectively. Average net assets is calculated utilizing quarterly net assets.
(9) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

79

NUVEEN CHURCHILL DIRECT LENDING CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data)

11. SUBSEQUENT EVENTS
The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of September 30, 2024, except as discussed below.
On October 4, 2024, the Company entered into a second amendment (the “Second Amendment”) to the Revolving Credit Facility, among the Company, as borrower, the lenders and issuing banks from time to time party thereto, SMBC, as administrative agent and sole bookrunner, and SMBC and Wells Fargo as joint lead arrangers. The Second Amendment, among other things, (x) added a term loan tranche, (y) increased the total committed facility amount from $ 250,000 to $ 325,000 and (z) reduced (i) the applicable margin from 2.125 % to 2.00 % and (ii) the credit spread adjustment from 0.15 % to 0.10 % for Term SOFR borrowings with a three-month tenor and from 0.25 % to 0.10 % for Term SOFR borrowings with a six-month tenor.
On October 29, 2024, the Board, including all of the Independent Directors, approved the renewal of each Advisory Agreement in accordance with, and on the basis of, an evaluation satisfactory to such directors as required by the 1940 Act for an additional one-year term expiring on December 1, 2025.
On November 4, 2024, the Board declared a fourth quarter regular dividend of $ 0.45 per share payable on or around January 28, 2025 to shareholders of record as of December 31, 2024.
On November 5, 2024, the Company terminated in full the SMBC Financing Facility Agreement, dated as of November 24, 2020, and the SMBC Financing Facility thereunder. In connection with the termination of the SMBC Financing Facility, the Company also terminated the security interest over the collateral granted to SMBC and the lenders pursuant to the SMBC Financing Facility Agreement. The SMBC Financing Facility was terminated concurrent with the satisfaction of all obligations and liabilities of the Company to the lenders thereunder, including, without limitation, payments of principal and interest, other fees, breakage costs and other amounts owing to the lenders.
80


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The information in this section contains forward-looking statements, which relate to future events, or the future performance or financial condition of Nuveen Churchill Direct Lending Corp., including its wholly owned subsidiaries (collectively, "we", "us", "our", or the "Company"), and involves numerous risks and uncertainties, including, but not limited to, those set forth in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023 and Part II, Item 1A of and elsewhere in this Quarterly Report on Form 10-Q. This discussion also should be read in conjunction with the “Forward-Looking Statements” in this Quarterly Report on Form 10-Q. Actual results could differ materially from those implied or expressed in any forward-looking statements.
Overview
We were formed on March 13, 2018 as a Delaware limited liability company and converted into a Maryland corporation on June 18, 2019, prior to the commencement of operations. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, we have elected, and intend to qualify annually thereafter, to be treated for U.S. federal income tax purposes as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
Our investment objective is to generate attractive risk-adjusted returns primarily through current income by investing primarily in senior secured loans to private equity-owned U.S. middle market companies, which we define as companies with approximately $10 million to $250 million of annual earnings before interest, taxes, depreciation and amortization (“EBITDA”). We primarily focus on investing in U.S. middle market companies, with $10 million to $100 million in EBITDA, which we consider the core middle market. Our portfolio is comprised primarily of first-lien senior secured debt and unitranche loans. Although it is not our primary strategy, we also opportunistically invest in junior capital opportunities, including second-lien loans, subordinated debt, and equity co-investments and similar equity-related securities.
We have entered into an investment advisory agreement (as amended and restated, the “Advisory Agreement”) with Churchill DLC Advisor LLC (f/k/a Nuveen Churchill Advisors LLC) (the “Adviser”), under which the Adviser has delegated substantially all of its day-to-day portfolio management obligations through a sub-advisory agreement (as amended and restated, the “CAM Sub-Advisory Agreement”) to Churchill Asset Management LLC (“Churchill”). In addition, the Adviser and Churchill have engaged Nuveen Asset Management, LLC (“Nuveen Asset Management” and together with the Adviser and Churchill, the "Advisers") pursuant to a sub-advisory agreement (the "NAM Sub-Advisory Agreement"), pursuant to which Nuveen Asset Management may manage a portion of our portfolio consisting of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments, subject to the pace and amount of investment activity in the middle market investment program. Under the administration agreement (the “Administration Agreement”), we are provided with certain services by an administrator, Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC) (the “Administrator”). The Adviser, Churchill, Nuveen Asset Management and Administrator are all affiliates and subsidiaries of Nuveen, LLC (“Nuveen”), a wholly owned subsidiary of Teachers Insurance and Annuity Association of America (“TIAA”).
Churchill NCDLC CLO-I, LLC (“CLO-I”), Churchill NCDLC CLO-II, LLC (“CLO-II”), Churchill NCDLC CLO-III, LLC (“CLO-III”), Nuveen Churchill BDC SPV IV, LLC (“SPV IV”), Nuveen Churchill BDC SPV V, LLC (“SPV V”) and NCDL Equity Holdings LLC ("NCDL Equity Holdings") are wholly owned subsidiaries of the Company and are consolidated in these financial statements commencing from the date of their formation. CLO-I, CLO-II and CLO-III completed term debt securitizations in May 2022, December 2023 and March 2024, respectively. SPV IV and SPV V primarily invest in first-lien senior secured debt and unitranche loans. NCDL Equity Holdings was formed to hold certain equity-related securities.
Beginning with our initial closing in March 2020, we conducted private offerings ("Private Offerings") of our shares of common stock to accredited investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). We held our final closing on April 28, 2023.
On January 29, 2024, we closed our initial public offering (“IPO”) and our common stock began trading on the New York Stock Exchange (“NYSE”) under the symbol “NCDL” on January 25, 2024.


81


Key Components of Our Results of Operations
Investments
Our level of investment activity varies substantially from period to period depending on many factors, including the amount we have available to invest as well as the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity in the middle market, the general economic environment and the competitive environment for the types of investments we make.
To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements. To the extent we continue to qualify as a RIC, we generally will not be subject to U.S federal income tax on any income we timely distribute to our shareholders.
As a BDC, we are required to comply with certain regulatory requirements. For instance, we are generally required to invest at least 70% of our total assets in “qualifying assets,” including securities of private or thinly traded public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less.
As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Under the 1940 Act, the term “eligible portfolio company” includes all private companies, companies whose securities are not listed on a national securities exchange, and certain public companies that have listed their securities on a national securities exchange and have a market capitalization of less than $250.0 million. In addition, we must be organized in the United States to qualify as a BDC.
Revenues
We generate revenue primarily in the form of interest income on debt investments we hold. In addition, we may generate income from dividends on direct equity investments, and capital gains on the sales of loans or debt and equity securities. Our debt investments generally bear interest at a floating rate usually determined on the basis of a benchmark, such as the Secured Overnight Financing Rate (“SOFR”). Interest on these debt investments is generally paid quarterly. In some instances, we receive payments on our debt investments based on scheduled amortization of the outstanding balances. In addition, we may receive repayments of some of our debt investments prior to their scheduled maturity dates. The frequency or volume of these repayments fluctuates significantly from period to period. Our portfolio activity also may reflect the proceeds of sales of securities. In addition, we may generate revenue in the form of commitment, origination, structuring, diligence, consulting or prepayment fees associated with our investment activities as well as any fees for managerial assistance services rendered by us to portfolio companies and other investment related income.
Expenses
The Adviser, Churchill, Nuveen Asset Management and their respective affiliates are responsible for bearing the compensation and routine overhead expenses allocable to personnel providing investment advisory and management services to us. We bear all other out-of-pocket costs and expenses of its operations and transactions, including those costs and expenses incidental to the provision of investment advisory and management services to us (such as items in the third and fourth bullets listed below).
our organizational costs;
calculating net asset value (including the cost and expenses of any independent valuation firm);
expenses, including travel, entertainment, lodging and meal expenses, incurred by the Advisers, or members of their investment teams or payable to third parties, in evaluating, developing, negotiating, structuring and performing due diligence on prospective portfolio companies, including such expenses related to potential investments that were not consummated, and, if necessary, enforcing our rights;
fees and expenses incurred by the Advisers (and their affiliates) or the Administrator (or its affiliates) payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs for us and in conducting research and due diligence on prospective investments and equity sponsors, analyzing investment opportunities, structuring our investments and monitoring investments and portfolio companies on an ongoing basis;
costs and expenses incurred in connection with the incurrence of leverage and indebtedness, including borrowings, credit facilities, securitizations, margin financing, and including any principal or interest on our borrowings and indebtedness;
offerings, sales, and repurchases of our shares and other securities;
82


fees and expenses payable under any underwriting, dealer manager or placement agent agreements;
investment advisory fees payable under the Advisory Agreement;
administration fees and expenses, if any, payable under the Administration Agreement (including payments under the Administration Agreement between us and the Administrator, based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of our chief financial officer and chief compliance officer, and their respective staffs);
any applicable administrative agent fees or loan arranging fees incurred with respect to portfolio investments by the Advisers, the Administrator or an affiliate thereof;
costs and expenses incurred in implementing or maintaining third-party or proprietary software tools, programs or other technology;
transfer agent, dividend agent and custodial fees and expenses;
federal and state registration fees;
all costs of registration and listing our shares on any securities exchange;
federal, state and local taxes;
independent directors’ fees and expenses, including reasonable travel, entertainment, lodging and meal expenses, and any legal counsel or other advisors retained by, or at the discretion or for the benefit of, the independent directors;
costs of preparing and filing reports or other documents required by the SEC or other regulators, and all fees, costs and expenses related to compliance-related matters and regulatory filings related to our activities and/or other regulatory filings, notices or disclosures of the Advisers and their affiliates relating to us and its activities;
costs of any reports, proxy statements or other notices to shareholders, including printing costs;
fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums;
direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors, tax preparers and outside legal costs;
proxy voting expenses;
all expenses relating to payments of dividends or interest or distributions in cash or any other form made or caused to be made by our Board to or on account of holders of our securities, including in connection with any dividend reinvestment plan or direct stock purchase plan;
costs incurred in connection with the formation or maintenance of entities or vehicles to hold our assets for tax or other purposes;
the allocated costs incurred by the Advisers and/or the Administrator in providing managerial assistance to those portfolio companies that request;
allocable fees and expenses associated with marketing efforts on our behalf;
all fees, costs and expenses of any litigation involving us or our portfolio companies and the amount of any judgments or settlements paid in connection therewith, directors and officers, liability or other insurance (including costs of title insurance) and indemnification (including advancement of any fees, costs or expenses to persons entitled to indemnification) or extraordinary expense or liability relating to our affairs;
fees, costs and expenses of winding up and liquidating our assets; and
all other expenses incurred by us, the Advisers or the Administrator in connection with administering our business.


83


Portfolio and Investment Activity
Portfolio Composition
Our portfolio and investment activity for three months ended September 30, 2024 and 2023 is presented below (dollar amounts in thousands):
Three Months Ended September 30,
2024 2023
Net funded investment activity
New gross commitments at par 1
$ 225,612 $ 216,710
Net investments funded
203,159 150,866
Investments sold or repaid
(155,616) (20,490)
Net funded investment activity
$ 47,543 $ 130,376
Gross commitments at par 1
First-Lien Debt $ 221,097 $ 193,794
Subordinated Debt 3,145 17,852
Equity Investments 1,370 5,064
Total gross commitments
$ 225,612 $ 216,710
Portfolio company activity
Portfolio companies, beginning of period
198 161
Number of new portfolio companies 18 14
Number of exited portfolio companies (14) (1)
Portfolio companies, end of period
202 174
Count of investments 457 363
Count of industries 26 24
New Investment Activity
Weighted average annual interest rate on new debt investments at par
9.63 % 12.07 %
Weighted average annual interest rate on new floating rate debt investments at par
9.59 % 11.50 %
Weighted average spread on new debt investments at par
5.00 % 6.10 %
Weighted average annual coupon on new debt investments at par
13.67 % 13.80 %
_______________________
1 Gross commitments at par includes unfunded investment commitments.
As of September 30, 2024, our debt portfolio reflected the following characteristics, based on fair value:
Weighted average reported annual EBITDA of $76.8 million. 1
Weighted average of 2.1x interest coverage ratio for our first-lien loans 2
Weighted average of 4.85x net leverage. 3
Approximately 83% of our debt investments have financial covenants. 4
________________________________________
1 These calculations include all private debt investments for which fair value is determined by the Adviser in its capacity as the Valuation Designee of the Company's board of directors (the “Board”), and excludes quoted assets. Amounts are weighted based on fair market value of each respective investment as of its most recent quarterly valuation, which are derived from the most recently available portfolio company financial statements.
84


2 The interest coverage ratio calculation is derived from the most recently available portfolio company financial information received by the Adviser, and is a weighted average based on the fair market value of each respective first lien loan investment as of its most recent reporting to lenders. Such reporting may include assumptions regarding the impact of interest rate hedges established by borrowers to reduce their exposure to floating interest rates (resulting in a reduced hedging rate being used for the total interest expense in respect of such hedges, rather than any higher rates applicable under the documentation for such loans), even if such hedging instruments are not pledged as collateral to lenders in respect of such loans and do not secure the loans themselves. The interest rate coverage ratio excludes junior capital investments and equity co-investments, and applies solely to traditional middle market first lien loans held by us, which also excludes any upper middle market or other first lien loans investments that do not have maintenance financial covenants, and first lien loans that the Adviser has assigned a risk rating of ‘8’ or higher, as well as any portfolio companies with net senior leverage of 15x or greater. As a result of the foregoing exclusions, the interest coverage ratio shown herein applies to 73.99% of our total investments, and 82.15% of our total first lien loan investments, in each case based upon fair value.
3 Net leverage is the ratio of total debt minus cash divided by EBITDA, taking into account only the debt issued through the tranche in which we are a lender. Leverage is derived from the most recently available portfolio company financial statements, and weighted by the fair value of each investment. Net leverage presented excludes equity investments as well as debt instruments to which the Adviser has assigned a risk rating of 8 or higher, and any portfolio companies with net leverage of 15x or greater.
4 Represents the percentage of debt investments with one or more maintenance financial covenants.

As of September 30, 2024 and December 31, 2023, our investments consisted of the following (dollar amounts in thousands):
September 30, 2024 December 31, 2023
Amortized Cost Fair Value % of Fair Value Amortized Cost Fair Value % of Fair Value
First-Lien Debt
$ 1,855,467 $ 1,843,607 90.07 % $ 1,450,120 $ 1,427,492 86.95 %
Subordinated Debt 1
$ 190,016 $ 169,455 8.28 % 190,454 183,387 11.17 %
Equity Investments $ 29,882 $ 33,825 1.65 % 25,595 30,807 1.88 %
Total $ 2,075,365 $ 2,046,887 100.00 % $ 1,666,169 $ 1,641,686 100.00 %
Largest portfolio company investment $ 31,272 $ 30,940 1.51 % $ 25,309 $ 25,108 1.53 %
Average portfolio company investment $ 10,274 $ 10,133 0.50 % $ 9,308 $ 9,171 0.56 %
_____________________
1 As of September 30, 2024, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $67,947, mezzanine debt of $99,925 and $1,583 of structured debt at fair value and second lien term loans and/or second lien notes of $80,348, mezzanine debt of $105,364 and $4,304 of structured debt at amortized cost.
As of December 31, 2023, Subordinated Debt is comprised of second lien term loans and/or second lien notes of $97,203 mezzanine debt of $83,528 and $2,656 of structured debt at fair value and second lien term loans and/or second lien notes of $100,711, mezzanine debt of $86,495 and $3,247 of structured debt at amortized cost.
85


The industry composition of our portfolio as a percentage of fair value as of September 30, 2024 and December 31, 2023 was as follows:
Industry September 30, 2024 December 31, 2023
Aerospace & Defense 3.32 % 3.13 %
Automotive 3.42 % 4.95 %
Banking, Finance, Insurance & Real Estate 2.33 % 3.95 %
Beverage, Food & Tobacco 8.25 % 7.76 %
Capital Equipment 5.62 % 4.21 %
Chemicals, Plastics & Rubber 1.36 % 2.29 %
Construction & Building 4.90 % 3.90 %
Consumer Goods: Durable 0.98 % 1.51 %
Consumer Goods: Non-durable 3.02 % 3.31 %
Containers, Packaging & Glass 4.01 % 3.97 %
Energy: Electricity 2.80 % 1.75 %
Environmental Industries 3.71 % 2.73 %
Healthcare & Pharmaceuticals 14.18 % 12.72 %
High Tech Industries 8.68 % 8.97 %
Media: Advertising, Printing & Publishing 0.91 % 1.12 %
Media: Diversified & Production 0.95 % 0.96 %
Retail 0.28 % 0.35 %
Services: Business 16.47 % 18.43 %
Services: Consumer 4.45 % 4.86 %
Sovereign & Public Finance 0.66 % 0.65 %
Telecommunications 3.22 % 3.17 %
Transportation: Cargo 3.03 % 3.20 %
Transportation: Consumer 0.62 % 0.13 %
Utilities: Electric 1.18 % 0.89 %
Utilities: Water 0.43 % %
Wholesale 1.22 % 1.09 %
Total 100.00 % 100.00 %

The weighted average yields of our investments as of September 30, 2024 and December 31, 2023 were as follows:
September 30, 2024 December 31, 2023
Weighted average yield on debt and income producing investments, at cost 1
10.86 % 11.72 %
Weighted average yield on debt and income producing investments, at fair value 2
10.94 % 11.94 %
Percentage of debt investments bearing a floating rate 94.25 % 94.61 %
Percentage of debt investments bearing a fixed rate 5.75 % 5.39 %
_____________________
1 Weighted average yield inclusive of debt and income producing investments on non-accrual status, at cost, as of September 30, 2024 was 10.70%. There were no investments on non-accrual as of December 31, 2023.
2 Weighted average yield inclusive of debt and income producing investments on non-accrual status, at fair value, as of September 30, 2024 was 10.87%. There were no investments on non-accrual as of December 31, 2023.

As of September 30, 2024, 93.83% and 93.93% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that govern the minimum applicable interest rates on such loans. As of December 31, 2023, 94.43% and 94.55% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that govern the minimum applicable interest rates on such loans.

86


The weighted average yield of our debt and income producing securities is not the same as a return on investment for our shareholders, but rather relates to our investment portfolio and is calculated before the payment of all of our and our subsidiaries’ fees and expenses. The weighted average yield was computed using the effective interest rates as of each respective date, including accretion of original issue discount, but excluding any investments on non-accrual status, if any. There can be no assurance that the weighted average yield will remain at its current level. Total weighted average yields of our debt and income producing investments, at cost, decreased from 11.72% to 10.86% from December 31, 2023 to September 30, 2024. The decrease in weighted average yields was primarily due to the tightening of spreads in newly originated investments made year to date in 2024. We also saw an increase in repricing transactions for existing portfolio investments in the first three quarters of 2024.

As financial markets stabilize and private equity firms become more active in an effort to deploy dry powder and return capital to their investors we are seeing private equity mergers and acquisitions ("M&A") volumes increase, leading to higher levels of demand for middle-market financings. Prepayment activity is also increasing as a result, driven primarily by M&A activity, but also in part by repricing and refinancing while spreads continue to tighten. While prepayments serve as an offset to new transaction activity, we believe that lenders who are well positioned with available liquidity as well as incumbent positions in portfolio companies will benefit from increased levels of activity in the market.
Keeping the macro-economic environment in mind, we are closely monitoring the impacts to our portfolio companies, and we will continue to seek to invest in defensive businesses with low levels of cyclicality and strong levels of free cash flow generation. While we are not seeing signs of a broad-based deterioration in our performance or that of our portfolio companies at this time, there can be no assurance that the performance of certain of our portfolio companies will not be negatively impacted by economic conditions, which could have a negative impact on our future results.
Asset Quality
In addition to various risk management and monitoring tools, we use the Advisers’ investment rating system to characterize and monitor the credit profile and expected level of returns on each investment in our portfolio. Churchill, in its capacity as sub-adviser, utilizes a systematic, consistent approach to credit evaluation, with a particular focus on an acceptable level of debt repayment and deleveraging under a “base case” set of projections (the “Base Case”), which reflects a more conservative estimate than the set of projections provided by a prospective portfolio company (the “Management Case”). The following is a description of the conditions associated with each investment rating:
1. Performing - Superior: Borrower is performing significantly above Management Case.
2. Performing - High: Borrower is performing at or near the Management Case (i.e., in a range slightly below to slightly above).
3. Performing - Low Risk: Borrower is operating well ahead of the Base Case to slightly below the Management Case.
4. Performing - Stable Risk: Borrower is operating at or near the Base Case (i.e., in a range slightly below to slightly above). This is the initial rating assigned to all new borrowers.
5. Performing - Management Notice: Borrower is operating below the Base Case. Adverse trends in business conditions and/or industry outlook are viewed as temporary. There is no immediate risk of payment default and only a low to moderate risk of covenant default.
6. Watch List - Low Maintenance: Borrower is operating below the Base Case, with declining margin of protection. Adverse trends in business conditions and/or industry outlook are viewed as probably lasting for more than a year. Payment default is still considered unlikely, but there is a moderate to high risk of covenant default.
7. Watch List - Medium Maintenance: Borrower is operating well below the Base Case, but has adequate liquidity. Adverse trends are more pronounced than in Internal Risk Rating 6 above. There is a high risk of covenant default, or it may have already occurred. Payments are current, although subject to greater uncertainty, and there is a moderate to high risk of payment default.
8. Watch List - High Maintenance: Borrower is operating well below the Base Case. Liquidity may be strained. Covenant default is imminent or may have occurred. Payments are current, but there is a high risk of payment default. Negotiations to restructure or refinance debt on normal terms may have begun. Further significant deterioration appears unlikely and no loss of principal is currently anticipated.
9. Watch List - Possible Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Liquidity is strained. Payment default may have occurred or is very likely in the short term unless creditors grant some relief. Loss of principal is possible.
87


10. Watch List - Probable Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Payment default is very likely or may have already occurred. Liquidity is extremely limited. The prospects for improvement in the borrower’s situation are sufficiently negative that loss of some or all principal is probable.
Churchill regularly monitors and, when appropriate, changes the investment rating assigned to each investment in our portfolio. Each investment team will review the investment ratings in connection with monthly or quarterly portfolio reviews.
The following table shows the investment ratings of the investments in our portfolio (dollar amounts in thousands):
September 30, 2024 December 31, 2023
Fair Value % of Portfolio Number of Portfolio Companies Fair Value % of Portfolio Number of Portfolio Companies
1 $ % $ %
2 % %
3 126,013 6.16 % 9 80,342 4.89 % 7
4 1,690,401 82.58 % 157 1,353,243 82.44 % 140
5 115,092 5.62 % 19 138,916 8.46 % 21
6 56,683 2.77 % 8 35,686 2.17 % 6
7 47,007 2.30 % 6 27,653 1.68 % 4
8 2,341 0.11 % 1 5,846 0.36 % 1
9 % %
10 9,350 0.46 % 2 %
Total $ 2,046,887 100.00 % 202 $ 1,641,686 100.00 % 179
As of September 30, 2024 and December 31, 2023, the weighted average Internal Risk Rating of our investment portfolio. at fair value, was 4.15 and 4.14, respectively. As of September 30, 2024, there were three portfolio companies on non-accrual. As of September 30, 2024, the amortized cost of the portfolio companies on non-accrual status were $29.1 million, which represents approximately 1.40% of total investments at amortized cost. As of December 31, 2023, there were no loans on non-accrual.
Results of Operations
Operating results for the three and nine months ended September 30, 2024 and 2023 were as follows (dollars amounts in thousands):
Three Months Ended September 30,
2024 2023
Investment Income
Interest income $ 57,317 $ 40,370
Payment-in-kind interest income 2,503 951
Dividend income 16 16
Other income 444 409
Total investment income 60,280 41,746
Expenses
Interest and debt financing expenses 23,198 16,048
Management fees 3,873 2,722
Incentive fees on net investment income 5,496
Professional fees
912 730
Directors' fees 128 96
Administration fees 535 370
Other general and administrative expenses 145 125
Total expenses before expense support and Incentive fees waived
34,287 20,091
Expense support
88


Incentive fees waived
(5,496)
Net Expenses after expense support
28,791 20,091
Net investment income $ 31,489 $ 21,655
Net Realized and Change in Unrealized Gains (Losses)
Net realized gains (losses) $ 1,086 $ (13,107)
Net change in unrealized gains (losses) 4,050 11,574
Income tax (provision) benefit 18 27
Total net change in unrealized gains (losses)
4,068 11,601
Total net realized and change in unrealized gains (losses) 5,154 (1,506)
Net increase (decrease) in net assets resulting from operations $ 36,643 $ 20,149
Nine Months Ended September 30,
2024 2023
Investment Income
Interest income $ 159,413 $ 110,049
Payment-in-kind interest income 6,024 1,823
Dividend income 357 56
Other income 1,170 879
Total investment income 166,964 112,807
Expenses
Interest and debt financing expenses 58,860 43,089
Management fees 10,727 7,503
Incentive fees on net investment income 13,030
Professional fees
2,315 2,284
Directors' fees 383 287
Administration fees 1,561 1,029
Other general and administrative expenses 888 653
Total expenses before expense support and Incentive fees waived
87,764 54,845
Expense support (158)
Incentive fees waived
(13,030)
Net Expenses after expense support
74,734 54,687
Net investment income $ 92,230 $ 58,120
Net Realized and Change in Unrealized Gains (Losses)
Net realized gains (losses) $ (1,522) $ (6,408)
Net change in unrealized gains (losses) (3,995) (3,805)
Income tax (provision) benefit 159 (735)
Total net change in unrealized gains (losses)
(3,836) (4,540)
Total net realized and change in unrealized gains (losses) (5,358) (10,948)
Net increase (decrease) in net assets resulting from operations $ 86,872 $ 47,172
Net increase (decrease) in net assets resulting from operations can vary from period to period as a result of various factors, including the level of new investment commitments, expenses, the recognition of realized gains and losses, and changes in unrealized appreciation and depreciation on the investment portfolio.
Investment income
Investment income, attributable to interest and fees on our debt investments, increased to $60.3 million and $167.0 million for the three and nine months ended September 30, 2024, respectively, from $41.7 million and $112.8 million for the three and nine months ended September 30, 2023 respectively, primarily due to increased investment activity driven by an increase in our deployed capital, slightly offset by a decrease in the weighted average yield of our debt and income producing investments as a result of market spread tightening and a decline in SOFR. As of September 30, 2024, the size of our portfolio increased to $2.1 billion from $1.5 billion as of September 30, 2023, at cost. As of September 30, 2024, the weighted average yield of our debt and income
89


producing investments decreased to 10.86% from 11.60% as of September 30, 2023 on cost, primarily due to overall tightening of spreads in newly originated investments, the refinancing and repricing of existing portfolio companies, and the decline in base interest rates. Shifting base interest rates, such as SOFR and any applicable alternate rates, may affect our investment income in the future.
Expenses
Total expenses before expense support and waived incentive fees increased to $34.3 million and $87.8 million for the three and nine months ended September 30, 2024, respectively, from $20.1 million and $54.8 million for the three and nine months ended September 30, 2023, respectively.
Interest and debt financing expenses increased for the three and nine months ended September 30, 2024 compared to the three and nine months ended September 30, 2023 primarily due to higher average daily borrowings, higher average interest rates, the use of the Revolving Credit Facility (as defined below) in the third quarter of 2023 and the completion of the 2023 Debt Securitization and the 2024 Debt Securitization (each as defined below) on December 7, 2023 and March 14, 2024, respectively. The average daily borrowings for the three and nine months ended September 30, 2024 were $1,156.7 million and $974.7 million, respectively, compared to $819.0 million and $777.5 million for the three and nine months ended September 30, 2023, respectively. The average annual interest rate for the three and nine months ended September 30, 2024 was 7.74% and 7.70%, respectively, compared to 7.51% and 7.17%, respectively, for the three and nine months ended September 30, 2023.
The increases in management fees increased for the three and nine months ended September 30, 2024 from the comparable periods in 2023 were driven by increases in our total assets. Incentive fees based on income for the three and nine months ended September 30, 2024 of $5.5 million and $13.0 million, respectively, were waived in accordance with our Advisory Agreement.
Professional fees include legal, audit, tax, valuation, and other professional fees incurred related to the management of us. Administrative fees represent fees paid to the Administrator for our allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the administration agreement, including our allocable portion of the cost of the our chief financial officer and chief compliance officer, and their respective staffs. Other general and administrative expenses include insurance, filing, research, rating agencies, subscriptions and other costs. The increases in professional, administration, and other general and administrative fees for the three and nine months ended September 30, 2024 from the comparable periods in 2023 was primarily driven by growing needs of the business given the increase in the Company's size year over year.
The expense support amount represents the amount of expenses paid by the Adviser on our behalf in accordance with the Expense Support Agreement (described further below). These expenses were primarily related to professional fees, specifically ordinary course legal expenses incurred by the Company. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO. Refer to the "Related Party Transactions" section below for further details on the Expense Support Agreement.
Net realized gain (loss) and Net change in unrealized gains (losses) on investments
For the three months ended September 30, 2024, we had a net realized gain on investments of $1.1 million compared to a net realized loss of $(13.1) million for the three months ended September 30, 2023. The net realized gain for the three months ended September 30, 2024 was driven by full or partial repayments and sales of certain of our investments. For the nine months ended September 30, 2024, we had a net realized loss on investments of $(1.5) million, compared to a net realized loss of $(6.4) million for the nine months ended September 30, 2023. The net realized loss the nine months ended September 30, 2024 was primarily driven by a final realization of an underperforming debt position which generated a realized loss in the first quarter of 2024, offset by realized gains in the second and third quarters of 2024.
For the three months ended September 30, 2024, we recorded a net change in unrealized gain of $4.1 million, which resulted from an increase in fair value primarily attributable to market spread tightening and net positive credit performance of our portfolio companies in the third quarter of 2024. We recorded a net change in unrealized loss of $(4.0) million for the nine months ended September 30, 2024, which resulted from a decrease in fair value of two underperforming portfolio companies in the second quarter of 2024, offset by unrealized gains driven primarily from a reversal of unrealized losses on certain of our underperforming debt positions that were ultimately realized in the first quarter of 2024 and the overall tightening in market spreads.
For the three months ended September 30, 2023, we recorded a net unrealized gain of $11.6 million primarily attributable to modest softening of certain of our portfolio companies' credit metrics partially offset by tightening in market spreads. We recorded a net unrealized loss of $(3.8) million for the nine months ended September 30, 2023, primarily due to modest softening of certain of our portfolio companies' credit metrics.
90


Financial Condition, Liquidity and Capital Resources
Due to the diverse capital resources available to us at this time, we believe we have adequate liquidity to support our near-term capital requirements. Our liquidity and capital resources are generated primarily from cash flows from income earned from our investments and principal repayments, and our net borrowings from our credit facilities and CLO debt issuances (discussed further below). Prior to our IPO on January 29, 2024, we also generated cash flow from the proceeds of capital drawdowns of our privately placed capital commitments. In the future, we may also generate cash flow from future offerings of securities including issuances of debt and/or equity securities through both public registered offerings using a shelf registration statement and private offerings. Due to an uncertain economic outlook and current market volatility, we regularly evaluate our overall liquidity position and take proactive steps to maintain that position based on such circumstances. The primary uses of our cash are (i) purchases of investments in portfolio companies, (ii) funding the cost of our operations (including fees paid to our Adviser), (iii) debt service, repayment and other financing costs of our borrowings, (iv) cash distributions to the holders of our shares, and (v) share repurchases under the Company 10b5-1 Plan (defined below).
We are generally permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our shares if our asset coverage, as defined in the 1940 Act, is at least equal to 150%, if certain requirements are met. In connection with our organization, our Board and TIAA (as our initial shareholder) authorized us to adopt the 150% asset coverage ratio. As of September 30, 2024 and December 31, 2023, our asset coverage ratio was 189.89% and 178.57%, respectively.
Cash and cash equivalents as of September 30, 2024, taken together with the availability under our credit facilities, are expected to be sufficient for our investing activities and to conduct our operations in the near term. As of September 30, 2024, we had $130.0 million available under our Wells Fargo Financing Facility (as defined below), $24.2 million available under our SMBC Financing Facility (as defined below), and $137.3 million available under our SMBC Corporate Revolver (as defined below), subject to asset coverage limitations.
For the nine months ended September 30, 2024, our cash and cash equivalents balance increased by $1.9 million. During that period, $309.2 million was used in operating activities, primarily relating to investment purchases of $712.5 million, offset by $310.5 million in repayments and sales of investments in portfolio companies. During the same period, $311.1 million was provided by financing activities, consisting primarily of proceeds from issuance of common shares and secured borrowings of $241.7 million and $717.8 million, respectively, net of shareholder distributions and repayments of secured borrowings of $67.4 million and $567.7 million, respectively.
Equity
Our authorized stock consists of 500,000,000 shares of stock, par value $0.01 per share, all of which are initially designated as common stock.
IPO and Private Offerings
On January 29, 2024, we closed our IPO, issuing 5,500,000 shares of its common stock at a public offering price of $18.05 per share. We received total cash proceeds of $99.3 million. Our common stock began trading on the NYSE under the symbol “NCDL” on January 25, 2024.
Prior to April 28, 2023, in connection with our Private Offerings, we entered into subscription agreements (“Subscription Agreements”) with investors, pursuant to which investors were required to fund drawdowns to purchase our shares of common stock up to the amount of their respective capital commitment each time we delivered a drawdown notice. Following the final drawdown notice dated December 21, 2023 and due on January 5, 2024, all capital commitments had been drawn.
91


The following table summarizes total shares issued and proceeds received in connection with the IPO and the capital drawdowns delivered pursuant to the Subscription Agreements from inception through September 30, 2024 (dollar amounts in thousands, except per share data):
Date Shares Issued Proceeds Received Issuance Price per Share
January 29, 2024 5,500,000 $99,275 $18.05
January 5, 2024 7,888,094 $142,382 $18.05
November 3, 2023 5,497,609 $100,000 $18.19
July 17, 2023 4,357,515 $78,565 $18.03
April 20, 2023 2,205,038 $40,000 $18.14
December 21, 2022 3,193,195 $60,000 $18.79
August 1, 2022 2,652,775 $50,082 $18.88
April 25, 2022 1,800,426 $34,964 $19.42
January 21, 2022 1,541,568 $30,000 $19.46
December 9, 2021 1,491,676 $29,207 $19.58
November 1, 2021 1,546,427 $30,000 $19.40
August 23, 2021 2,593,357 $50,000 $19.28
July 26, 2021 1,564,928 $30,000 $19.17
June 22, 2021 1,034,668 $20,000 $19.33
April 23, 2021 1,845,984 $35,000 $18.96
March 11, 2021 785,751 $15,000 $19.09
November 6, 2020 1,870,660 $35,000 $18.71
October 16, 2020 1,057,641 $20,000 $18.91
August 6, 2020 1,105,425 $20,000 $18.09
May 7, 2020 1,069,522 $20,000 $18.70
December 31, 2019 3,310,540 $66,211 $20.00
December 19, 2019 50 $1 $20.00
Dividends and Distributions
To the extent that we have taxable income, we intend to make quarterly distributions to our common shareholders. Dividends and distributions to common shareholders are recorded on the applicable record date. The amount to be distributed to common shareholders is determined by our Board each quarter and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although we may decide to retain such capital gains for investment.
In connection with the IPO, our Board approved an amended and restated dividend reinvestment plan (the "Amended DRIP"), which became effective on January 29, 2024, concurrent with the consummation of the IPO.

The Amended DRIP changed the dividend reinvestment plan from an “opt in” dividend reinvestment plan to an “opt out” dividend reinvestment plan. As a result of the foregoing, if our Board authorizes, and we declare, a cash dividend or distribution, shareholders that acquired their shares in the IPO and do not “opt out” of the Amended DRIP will have their cash distributions automatically reinvested in additional shares rather than receiving cash. Notwithstanding the foregoing, a shareholder’s election (or deemed election) under the dividend reinvestment plan, dated December 19, 2019, will remain in effect for such shareholder and no further action is required by such shareholder with respect to their election under the Amended DRIP.

With respect to each distribution under the Amended DRIP, our Board reserves the right to either issue new shares of common stock or purchase shares of common stock in the open market for the accounts of participants in the Amended DRIP. If newly issued shares are used to implement the Amended DRIP, the number of shares to be issued to a shareholder will be determined by dividing the total dollar amount of the distribution payable to such participant by the market price per share of our common stock at the close of regular trading of the NYSE on the distribution payment date, or if no sale is reported for such day, the average of the reported bid and asked prices. However, if the market price per share on the distribution payment date exceeds the most recently computed NAV per share, we will issue shares at the greater of (i) the most recently computed NAV per share and (ii) 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed NAV per share). If shares are purchased in the open market to implement the Amended DRIP, the number of shares to be issued to a participant will be determined by dividing the dollar amount of the distribution payable to such participant by the weighted
92


average price per share for all shares of common stock purchased by the plan administrator in the open market in connection with the dividend or distribution. Although each participant may from time to time have an undivided fractional interest in a share, no certificates for a fractional share will be issued. However, dividends and distributions on fractional shares will be credited to each participant’s account.

The following table summarizes the dividends declared from inception through September 30, 2024:
Date Declared Record Date Payment Date Dividend per Share
July 31, 2024 September 30, 2024 October 28, 2024 $0.45
May 1, 2024 June 28, 2024 July 29, 2024 $0.45
January 10, 2024 February 12, 2025 April 28, 2025
$0.10 (3)
January 10, 2024 November 11, 2024 January 28, 2025
$0.10 (3)
January 10, 2024 August 12, 2024 October 28, 2024
$0.10 (3)
January 10, 2024 May 13, 2024 July 29, 2024
$0.10 (3)
January 10, 2024 March 30, 2024 April 29, 2024 $0.45
December 28, 2023 December 29, 2023 January 10, 2024 $0.50
December 28, 2023 December 29, 2023 January 10, 2024
$0.05 (2)
September 28, 2023 September 28, 2023 October 12, 2023 $0.50
September 28, 2023 September 28, 2023 October 12, 2023
$0.05 (2)
June 28, 2023 June 28, 2023 July 12, 2023 $0.50
June 28, 2023 June 28, 2023 July 12, 2023
$0.05 (2)
March 30, 2023 March 30, 2023 April 12, 2023 $0.50
March 30, 2023 March 30, 2023 April 12, 2023
$0.26 (1)
December 29, 2022 December 29, 2022 January 17, 2023 $0.50
September 28, 2022 September 28, 2022 October 11, 2022 $0.47
June 30, 2022 June 30, 2022 July 12, 2022 $0.43
March 30, 2022 March 31, 2022 April 12, 2022 $0.41
December 29, 2021 December 29, 2021 January 18, 2022 $0.40
September 29, 2021 September 29, 2021 October 11, 2021 $0.38
June 29, 2021 June 29, 2021 July 12, 2021 $0.31
March 29, 2021 March 29, 2021 April 19, 2021 $0.30
December 29, 2020 December 29, 2020 January 18, 2021 $0.28
November 4, 2020 November 4, 2020 November 11, 2020 $0.23
August 4, 2020 August 4, 2020 August 11, 2020 $0.28
April 16, 2020 April 16, 2020 April 21, 2020 $0.17
________________
(1) Represents a special dividend and a supplemental dividend.
(2) Represents a supplemental dividend.
(3) Represents a special dividend.
93



The distributions declared were derived from investment company taxable income and net capital gain, if any. The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon our investment company taxable income for the full fiscal year and distributions paid during the full year.

The following table reflects the shares issued pursuant to the dividend reinvestment plan from inception through September 30, 2024:
Date Declared Record Date Payment Date
Shares Issued 1
May 1, 2024 June 28, 2024 July 29, 2024 168,527
January 10, 2024 May 13, 2024 July 29, 2024 37,333
January 10, 2024 March 30, 2024 April 29, 2024 189,256
December 28, 2023 December 29, 2023 January 10, 2024 185,541
September 28, 2023 September 28, 2023 October 12, 2023 158,545
June 28, 2023 June 28, 2023 July 12, 2023 128,818
March 30, 2023 March 30, 2023 April 12, 2023 150,703
December 29, 2022 December 29, 2022 January 17, 2023 93,329
September 28, 2022 September 28, 2022 October 11, 2022 68,093
June 30, 2022 June 30, 2022 July 12, 2022 45,341
March 30, 2022 March 31, 2022 April 12, 2022 32,320
December 29, 2021 December 29, 2021 January 18, 2022 23,017
September 29, 2021 September 29, 2021 October 11, 2021 10,639
June 29, 2021 June 29, 2021 July 12, 2021 3,039
March 29, 2021 March 29, 2021 April 19, 2021 1,824
December 29, 2020 December 29, 2020 January 18, 2021 1,550
November 4, 2020 November 4, 2020 November 11, 2020 98
August 4, 2020 August 4, 2020 August 11, 2020 34
________________
(1)    All shares issued to shareholders are newly issued shares.

Share Repurchase Plan
On March 5, 2024, we entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which we may purchase up to $99.3 million in the aggregate of its outstanding shares of common stock in the open market at prices below its net asset value (“NAV”) per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan will be conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We adopted the Company 10b5-1 Plan because we believes that, if our common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for us to reinvest in our portfolio.

The Company 10b5-1 Plan is designed to allow us to repurchase our shares of common stock at times when we otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by us to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the our common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of our common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan
94


is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $99.3 million and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.


The following table reflects the shares repurchased pursuant to the Company 10b5-1 Plan for each month from inception through September 30, 2024 (dollar amounts in thousands, except per share data):

Period
Total Number of Shares Repurchased
Average Price Paid per Share
Approximate Dollar Value of Shares that have been Purchased Under the Plan
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
April 1, 2024 - April 30, 2024 104,075 $ 17.57 $ 1,828 $ 97,447
May 1, 2024 - May 31, 2024 96,598 $ 17.56 1,696 95,751
June 1, 2024 - June 30, 2024 91,637 $ 17.73 1,625 94,126
July 1, 2024 - July 31, 2024 75,675 $ 17.61 1,333 92,793
August 1, 2024 - August 31, 2024 154,668 $ 17.24 2,666 90,127
September 1, 2024 - September 30, 2024 109,150 $ 17.69 1,931 88,196
Total 631,803 $ 11,079

As of October 31, 2024, BofA Securities, Inc., as agent, repurchased an additional 155,618 shares of the Company’s common stock pursuant to the Company 10b5-1 Plan for approximately $2.69 million.

Shareholder Transfer Restrictions

With respect to any shares of common stock held by a shareholder prior to the date of the IPO prospectus (January 24, 2024), without the prior written consent of the Board:

for 365 days following the date of the IPO prospectus (January 24, 2024), a shareholder that is affiliated with the Advisers is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any shares of common stock held by such shareholder prior January 24, 2024;

for 90 days following the date of the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber any shares of common stock held by such shareholder prior to January 24, 2024;

beginning with the 91st day following the date of the IPO prospectus (January 24, 2024) through the 180th day following the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 85% of the shares of common stock held by such shareholder prior to January 24, 2024; and

beginning with the 181st day following the date of the IPO prospectus (January 24, 2024) through the 270th day following the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) is not permitted to transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber 50% of the shares of common stock held by such shareholder prior to January 24, 2024.

Beginning with the 271st day following the date of the IPO prospectus (January 24, 2024), a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) may transfer (whether by sale, gift, merger, by operation of law or otherwise), exchange, assign, pledge, hypothecate or otherwise dispose of or encumber all of the shares of common stock held by such shareholder prior to the date of the IPO.

This means that, as a result of these transfer restrictions, without the consent of the Board, a shareholder (other than certain individuals and entities affiliated with the Advisers, who are subject to the 365-day restriction above) who owned 100 shares of common stock on January 24, 2024 could not sell any of such shares for 90 days following January 24, 2024; 91 days following
95


January 24, 2024, such shareholder could only sell up to 15 of such shares; 181 days following January 24, 2024, such shareholder could only sell up to 50 of such shares; 271 days following January 24, 2024, such shareholder could sell all of such shares.
Income Taxes

We have elected and intend to qualify annually to be treated as a RIC for U.S. federal income tax purposes under the Code. If we qualify as a RIC, we will not be taxed on our investment company taxable income or realized net capital gains, to the extent that such taxable income or gains are distributed, or deemed to be distributed, to shareholders on a timely basis.
Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation until realized. Dividends declared and paid by us in a year may differ from taxable income for that year as such dividends may include the distribution of current year taxable income or the distribution of prior year taxable income carried forward into and distributed in the current year. Distributions also may include returns of capital.
To qualify for RIC tax treatment, we must, among other things, distribute, with respect to each taxable year, at least 90% of our investment company net taxable income (i.e., our net ordinary income and our realized net short-term capital gains in excess of realized net long-term capital losses, if any). If we qualify as a RIC, we may also be subject to a U.S. federal excise tax, based on distribution requirements of our taxable income on a calendar year basis. Depending on the level of taxable income earned in a tax year, we may choose to carry forward taxable income in excess of current year distributions into the next year and pay a 4% U.S. federal excise tax on such income. Any such carryover taxable income must be distributed through a dividend declared prior to filing the final tax return related to the year that generated such taxable income.
We intend to distribute to our shareholders between 90% and 100% of our annual taxable income (which includes our taxable interest and fee income). We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. We cannot assure shareholders that they will receive any distributions or distributions at a particular level.
96


Secured Borrowings
See Note 6 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information on our secured borrowings.
Subscription Facility
On September 10, 2020, we entered into a revolving credit agreement (the “Subscription Facility Agreement” and the facility thereunder, the “Subscription Facility”) with Sumitomo Mitsui Banking Corporation (“SMBC”), as the administrative agent for certain secured parties, the syndication agent, the lead arranger, the book manager, the letter of credit issuer and the lender. The Subscription Facility had a maximum commitment of $50 million, subject to availability under the "Borrowing Base." The Borrowing Base was calculated based on the unfunded capital commitments of certain investors that had subscribed to purchase shares of the Company, to the extent the capital commitments of such investors also had been approved by SMBC for inclusion in the Borrowing base and met certain additional criteria. The Subscription Facility Agreement expired on September 8, 2023, and we fully paid down the outstanding balance including the accrued interest expense.
Wells Fargo Financing Facility
On December 31, 2019, a wholly owned subsidiary of the Company entered into a credit agreement ("the “Wells Fargo Financing Facility” and the agreement relating thereto, as amended from time to time, the “Wells Fargo Financing Facility Agreement”), with Wells Fargo Bank, N.A. as lender (“Wells Fargo”) and administrative agent. The Wells Fargo Financing Facility Agreement was amended on October 28, 2020, March 31, 2022, March 14, 2024 and August 27, 2024. The most recent amendment on August 27, 2024, among other things, increased the maximum facility amount available from $150 million to $225 million.
The Wells Fargo Financing Facility reinvestment period expires on March 31, 2025 and has a maturity date of March 31, 2027. The Wells Fargo Financing Facility Agreement also requires the Company to maintain an asset coverage ratio equal to at least 1.50:1.00. The amount of the borrowings under the Wells Fargo Financing Facility equals the amount of the outstanding advances. Advances under the Wells Fargo Financing Facility may be prepaid and reborrowed at any time during the reinvestment period, but any termination or reduction of the facility amount prior to the first anniversary of the date of the amendment (subject to certain exceptions) is subject to a commitment reduction fee of 1%. Under the Wells Fargo Financing Facility Agreement, we paid a fee on daily undrawn amounts under the Wells Fargo Financing Facility of 0.25% per annum during the period ended June 14, 2024. For the six months following June 14, 2024, the Company pays a fee on daily undrawn amounts under the Wells Fargo Facility of 0.50% per annum. and, thereafter, will pay 0.50% per annum on undrawn amounts of up to 40% of the maximum facility amount and 1.50% per annum on undrawn amounts in excess of 40% of the maximum facility amount.
As of September 30, 2024 and December 31, 2023, the Wells Fargo Financing Facility bore interest at a rate of SOFR, reset daily, plus 2.20% per annum.
On March 14, 2024, SPV V entered into the borrower joinder agreement to become party to the Wells Fargo Financing Facility Agreement and pledged all of its assets to the collateral agent to secure their obligations under the Wells Fargo Financing Facility. The Company, and SPV V have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.
SMBC Financing Facility
On November 24, 2020, a wholly owned subsidiary of the Company entered into a senior secured revolving credit facility (the “SMBC Financing Facility” and the agreement relating thereto the “SMBC Financing Facility Agreement”) with SMBC, as the administrative agent, the collateral agent and the lender. On October 19, 2023, SPV IV entered into the borrower joinder agreement (the “SMBC Joinder”) to become party to the SMBC Financing Facility Agreement.
97


The SMBC Financing Facility Agreement was amended on December 23, 2021, June 29, 2022 and November 21, 2023. The most recent amendment on November 21, 2023 (the "SMBC Financing Facility Amendment"), among other things: (i) extended the reinvestment period from November 24, 2023 to November 24, 2024 and the stated maturity date from November 24, 2025 to November 24, 2026; (ii) changed the interest rate for loans under the SMBC Financing Facility Agreement from (A) either the Base Rate (as defined in the SMBC Financing Facility Agreement) plus 1.15% or the Term SOFR (as defined in the SMBC Financing Facility Agreement) plus 2.15% to (B) either the Base Rate plus 1.65% or Term SOFR plus 2.65%; (iii) reduced the maximum facility amount from $300 million to $150 million upon the occurrence of a permitted securitization, subject to a subsequent increase to $250 million, in the sole discretion of the administrative agent, if so requested by the borrowers; and (iv) provide for an unused commitment fee of, from the three month anniversary of the SMBC Financing Facility Amendment date to the six month anniversary of the Amendment date, 0.50% per annum on the unused commitments and on or after the six month anniversary of the SMBC Financing Facility Amendment date, 0.50% per annum on the unused commitments if such unused commitments are less than 50% of the total commitments and 1.00% per annum on the unused commitments if such unused commitments are greater than or equal to 50% of the total commitments. In connection with the SMBC Financing Facility Amendment, the borrowers paid an extension fee of $450 thousand plus an annualized fee of 0.30% multiplied by $150 million based on the length of time (in years) until the occurrence of a permitted securitization. Advances under the SMBC Financing Facility Agreement may be prepaid and reborrowed at any time during the reinvestment period. As of September 30, 2024 and December 31, 2023, the SMBC Financing Facility bore interest at one-month SOFR plus 2.65% and one-month SOFR plus 2.65%, respectively, per annum.
Effective December 7, 2023, following the closing of the 2023 Debt Securitization (discussed further below), the maximum facility amount available was reduced to $150 million from $300 million and SPV IV began borrowing under the SMBC Financing Facility.
SPV IV, beginning October 19, 2023, has pledged all of its assets to the collateral agent to secure its obligations under the SMBC Financing Facility. The Company and SPV IV have made customary representations and warranties and are required to comply with various financial covenants related to liquidity and other maintenance covenants, reporting requirements and other customary requirements for similar facilities.
Revolving Credit Facility
On June 23, 2023, we entered into a senior secured revolving credit agreement (the “Senior Secured Revolving Credit Agreement” and facility thereunder, the “Revolving Credit Facility” and together with the Wells Fargo Financing Facility and SMBC Financing Facility, the “Financing Facilities”) with SMBC as the lender, administrative agent, and one of the lead arrangers along with Wells Fargo. The Revolving Credit Facility is guaranteed by NCDL Equity Holdings and will be guaranteed by certain of our subsidiaries that are formed or acquired in the future (collectively, the “Guarantors”).
The Revolving Credit Facility was amended on April 9, 2024. The amendment, among other things, increased the maximum principal amount available under the Revolving Credit Facility from $185 million to $250 million pursuant to the accordion feature, subject to availability under the borrowing base,, subject to availability under the borrowing base, which is based on our portfolio investments and other outstanding indebtedness. Maximum capacity under the Revolving Credit Facility may be increased to $300 million through the exercise by us of an uncommitted accordion feature through which existing and new lenders may, at their option, agree to provide additional financing. The Revolving Credit Facility is secured by a perfected first-priority interest in substantially all of the portfolio investments held by the Company and each Guarantor, subject to certain exceptions, and includes a $25 million limit for swingline loans.
The availability period under the Revolving Credit Facility will terminate on June 23, 2027 (the “Commitment Termination Date”) and will mature on June 23, 2028 (the “Final Maturity Date”). During the period from the Commitment Termination Date to the Final Maturity Date, we will be obligated to make mandatory prepayments out of the proceeds of certain asset sales and other recovery events and equity and debt issuances.
We may borrow amounts in U.S. dollars or certain other permitted currencies. Amounts drawn in U.S. dollars will bear interest at either term SOFR plus a margin, or the prime rate plus a margin. We may elect either the term SOFR or prime rate at the time of drawdown, and loans denominated in U.S. dollars may be converted from one rate to another at any time at our option, subject to certain conditions. Amounts drawn in other permitted currencies will bear interest at the relevant rate specified therein plus an applicable margin. We also will pay a fee of 0.375% on average daily undrawn amounts. As of September 30, 2024, the Revolving Credit Facility bore interest at one-month SOFR plus 2.25% per annum.
The Senior Secured Revolving Credit Agreement includes customary covenants, including certain limitations on the incurrence by the Company of additional indebtedness and on the Company’s ability to make distributions to its shareholders, or redeem, repurchase or retire shares of stock, upon the occurrence of certain events, and certain financial covenants related to asset coverage and minimum shareholders’ equity, as well as customary events of default.
98


CLO-I
On May 20, 2022 (the “Closing Date”), the Company completed a $448.3 million term debt securitization (the “2022 Debt Securitization”). Term debt securitization is also known as a collateralized loan obligation and is a form of secured financing incurred by the Company.
The notes offered in the 2022 Debt Securitization (the “2022 Notes”) were issued by CLO-I, an indirect, wholly owned, consolidated subsidiary of the Company. The 2022 Notes consist of $199.0 million of AAA Class A-1 2022 Notes, which bear interest at the three-month Term SOFR plus 1.80%; $34.3 million of AAA Class A-1F 2022 Notes, which bear interest at 4.42%; $47.3 million of AA Class B 2022 Notes, which bear interest at the three-month Term SOFR plus 2.30%; $31.5 million of A Class C 2022 Notes, which bear interest at the three-month Term SOFR plus 3.15%; $27.0 million of BBB Class D 2022 Notes, which bear interest at the three-month Term SOFR plus 4.15%; and approximately $79.3 million of Subordinated 2022 Notes, which do not bear interest. The Company directly owns all of the BBB Class D 2022 Notes and the Subordinated 2022 Notes and as such, these notes are eliminated in consolidation.
As part of the 2022 Debt Securitization, CLO-I also entered into a loan agreement (the “CLO-I Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-I Loan Agreement as lenders (the “Lenders”) committed to make $30.0 million of AAA Class A-L 2022 Loans to CLO-I (the “2022 Loans” and, together with the 2022 Notes, the “2022 Debt”). The 2022 Loans bear interest at the three-month Term SOFR plus 1.80% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all of the Class A-L 2022 Loans held by such Lenders into Class A-1 2022 Notes upon written notice to CLO-I in accordance with the CLO-I Loan Agreement.
The 2022 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through April 20, 2026, all principal collections received on the underlying collateral may be used by CLO-I to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-I and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2022 Debt Securitization. The 2022 Notes are due on April 20, 2034. The 2022 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on April 20, 2034.
The 2022 Debt is the secured obligation of CLO-I, and the indenture and the CLO-I Loan Agreement, as applicable, governing the 2022 Debt includes customary covenants and events of default. The 2022 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.
The Company serves as collateral manager to CLO-I under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.
CLO-II
On December 7, 2023 (the “Closing Date”), the Company completed a $298.1 million term debt securitization (the “2023 Debt Securitization”).
The notes offered in the 2023 Debt Securitization (the “2023 Notes”) were issued by CLO-II, an indirect, wholly owned, consolidated subsidiary of the Company. The 2023 Notes consist of $2.0 million of AAA Class X 2023 Notes, which bear interest at the three-month Term SOFR plus 2.00%, $100.5 million of AAA Class A-1 2023 Notes, which bear interest at the three-month Term SOFR plus 2.35%; $37.5 million of AA Class B 2023 Notes, which bear interest at three-month Term SOFR plus 3.20% and approximately $83.1 million of Subordinated 2023 Notes, which do not bear interest. The Company directly owns all of the Subordinated 2023 Notes and as such, these notes are eliminated in consolidation.
As part of the 2023 Debt Securitization, CLO-II also entered into a loan agreement (the “CLO-II Loan Agreement”) on the Closing Date, pursuant to which various financial institutions and other persons which are, or may become, parties to the CLO-II Loan Agreement as lenders (the “Lenders”) committed to make $25.0 million of AAA Class A-L-A 2023 Loans and $50.0 million AAA Class A-L-B 2023 Loans to CLO-II (the “2023 Loans” and, together with the 2023 Notes, the “2023 Debt”). The 2023 Loans bear interest at the three-month Term SOFR plus 2.35% and were fully drawn upon the closing of the transactions. Any Lender may elect to convert all or a portion of the Class A-L-A 2023 Loans held by such Lenders into Class A-1 2023 Notes upon written notice to CLO-II in accordance with the CLO-II Loan Agreement.
The 2023 Debt is backed by a diversified portfolio of senior secured and second lien loans. Through January 20, 2028, all principal collections received on the underlying collateral may be used by CLO-II to purchase new collateral under the direction of the Company, in its capacity as collateral manager of CLO-II and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2023 Debt Securitization. The 2023 Notes are due on January 20, 2036. The 2023 Loans are scheduled to mature, and, unless earlier repaid, the entire unpaid principal balance thereof is due and payable on January 20, 2036.
99


The 2023 Debt is the secured obligation of CLO-II, and the indenture and the CLO-II Loan Agreement, as applicable, governing the 2023 Debt includes customary covenants and events of default. The 2023 Debt has not been, and will not be, registered under the Securities Act, or any state “blue sky” laws.
The Company serves as collateral manager to CLO-II under a collateral management agreement (the “Collateral Management Agreement”) and has waived the management fee due to it in consideration for providing these services.
CLO-III
On March 14, 2024 (the “Closing Date”), the Company completed a $296,970 term debt securitization (the “2024 Debt Securitization”).
The notes offered in the 2024 Debt Securitization (the “2024 Notes” or “2024 Debt”) were issued by Churchill NCDLC CLO-III, LLC (formerly known as Nuveen Churchill BDC SPV III, LLC) (the “2024 Issuer”), a direct, wholly owned, consolidated subsidiary of the Company, pursuant to an indenture (the “Indenture”) dated as of the Closing Date. The 2024 Notes consist of $2,000 of AAA Class X 2024 Notes, which bear interest at the three-month Term SOFR plus 1.40%; $175,500 of AAA Class A 2024 Notes, which bear interest at the three-month Term SOFR plus 2.00%; $37,500 of AA Class B 2024 Notes, which bear interest at the three-month Term SOFR plus 2.65%; and $81,970 of Subordinated 2024 Notes, which do not bear interest. The Company directly retained all of the Subordinated 2024 Notes and as such, these notes are eliminated in consolidation.

The 2024 Notes are backed by a diversified portfolio of senior secured and second lien loans. The Indenture contains certain
conditions pursuant to which loans can be acquired by the 2024 Issuer, in accordance with rating agency criteria or as otherwise agreed with certain institutional investors who purchased the 2024 Notes. Through April 20, 2028, all principal collections received on the underlying collateral may be used by the 2024 Issuer to purchase new collateral under the direction of the Company, in its capacity as collateral manager of the 2024 Issuer and in accordance with the Company’s investment strategy, allowing the Company to maintain the initial leverage in the 2024 Debt Securitization. The 2024 Notes are due on April 20, 2036.

The 2024 Notes are the secured obligation of the 2024 Issuer, and the Indenture governing the 2024 Notes includes customary covenants and events of default. The 2024 Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or any state “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or applicable exemption from registration.

The Company serves as collateral manager to the 2024 Issuer under a collateral management agreement (the “Collateral Management Agreement”) and has waived any management fee due to it in consideration for providing these services.

Contractual Obligations
The following tables show the contractual maturities of our debt obligations as of September 30, 2024 and December 31, 2023 (dollar amounts in thousands):
Payments Due by Period
As of September 30, 2024
Total Less than 1 Year 1 to 3 years 3 to 5 years More than 5 Years
Wells Fargo Financing Facility $ 95,000 $ $ 95,000 $ $
SMBC Financing Facility 122,500 122,500
Revolving Credit Facility
112,750 112,750
CLO-I 342,000 342,000
CLO-II 214,714 214,714
CLO-III
215,000 215,000
Total debt obligations $ 1,101,964 $ $ 217,500 $ 112,750 $ 771,714
100



Payments Due by Period
As of December 31, 2023
Total Less than 1 Year 1 to 3 years 3 to 5 years More than 5 Years
Wells Fargo Financing Facility $ 231,000 $ $ $ 231,000 $
SMBC Financing Facility 37,377 37,377
Revolving Credit Facility 126,500 126,500
CLO-I 342,000 342,000
CLO-II 215,000 215,000
Total debt obligations $ 951,877 $ $ 37,377 $ 357,500 $ 557,000

Related-Party Transactions
We have entered into a number of business relationships with affiliated or related parties, including the following:
the Advisory Agreement;
the CAM Sub-Advisory Agreement;
the NAM Sub-Advisory Agreement;
the Administration Agreement; and
the Expense Support Agreement.
On June 7, 2019, the SEC granted an exemptive order (the “Order”) that permits us to participate in negotiated co-investment transactions with certain other funds and accounts sponsored or managed by either of the Advisers and/or their affiliates, subject to the conditions of the Order. Pursuant to the Order, the Company is permitted to co-invest with its affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Board's independent directors make certain conclusions in connection with a co-investment transaction, including, but not limited to, that (1) the terms of the potential co-investment transaction, including the consideration to be paid, are reasonable and fair to the Company and its stockholders and do not involve overreaching in respect of the Company or its stockholders on the part of any person concerned, and (2) the potential co-investment transaction is consistent with the interests of the Company's stockholders and is consistent with its then-current investment objective and strategies. Neither we nor the affiliated funds are obligated to invest or co-invest when investment opportunities are referred to us or them.
In addition, pursuant to an exemptive order issued by the SEC on April 8, 2020 and applicable to all BDCs through December 31, 2020 (the “Temporary Relief”), the Company was permitted, subject to the satisfaction of certain conditions, to complete follow-on investments in our existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company. Without the Temporary Relief, such private funds would not be able to participate in such follow-on investments with us unless the private funds had previously acquired securities of the portfolio company in a co-investment transaction with the Company. Although the Temporary Relief expired on December 31, 2020, the SEC’s Division of Investment Management had indicated that until March 31, 2022, it would not recommend enforcement action, to the extent that any BDC with an existing co-investment order continues to engage in certain transactions described in the Temporary Relief, pursuant to the same terms and conditions described therein. The conditional exemptive order is no longer effective; however, on October 14, 2022, the SEC granted an exemptive order to permit the Company to continue to complete follow-on investments in its existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company, subject to certain conditions.
Expense Support Agreement
On December 31, 2019, we entered into the Expense Support Agreement with the Adviser. The Expense Support Agreement automatically terminated pursuant to its terms upon the consummation of the IPO on January 29, 2024. Under the Expense Support Agreement, the Adviser was able to pay certain of our expenses (each, an “Expense Payment”), provided that no portion of the payment was used to pay any of our interest expense. Such Expense Payment was made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from the Adviser to pay such expense, and/or by an offset against amounts due from us to the Adviser or its affiliates. The cumulative amount of expense payments by the Adviser under the Expense Support Agreement was $2,979, of which $1,101 was reimbursed by the Company prior to the termination of the Expense Support Agreement.
101


Off-Balance Sheet Arrangements
In the ordinary course of its business, the Company enters into contracts or agreements that contain indemnifications or warranties. Future events could occur which may give rise to liabilities arising from these provisions against us. We believe that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in these consolidated financial statements as of September 30, 2024 and December 31, 2023. We have in the past and may in the future become obligated to fund commitments such as delayed draw commitments, revolvers, and equity investment commitments.
For more information on our off-balance sheet arrangements, commitments and contingencies see Note 7 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report Form 10-Q.
Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies and estimates, including those relating to the valuation of our portfolio investments, are described below. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, and U.S. Federal Income Taxes, are described below. The valuation of investments is our most significant critical estimate. The critical accounting policies and estimates should be read in connection with our risk factors as disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for year ended December 31, 2023.
Valuation of Portfolio Investments
At all times, consistent with U.S. GAAP and the 1940 Act, we conduct a valuation of our assets, pursuant to which our net asset value is determined.
Our assets are valued on a quarterly basis, or more frequently if required under the 1940 Act. Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company's valuation designee (the “Valuation Designee”) to determine the fair value of the Company's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Company's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Company's assets for which market quotations are not readily available, subject to the oversight of the Board.
Investments for which market quotations are readily available are typically valued at those market quotations. Market quotations are obtained from independent pricing services, where available. Generally investments marked in this manner will be marked at the mean of the bid and ask of the quotes obtained. To validate market quotations, we utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations.
With respect to investments for which market quotations are not readily available, we or an independent third-party valuation firm engaged by the Valuation Designee, will take into account relevant factors in determining the fair value of our investments, including and in combination of: comparison to publicly traded securities, including factors such as yield, maturity and measures of credit quality; the enterprise value of a portfolio company; the nature and realizable value of any collateral; the portfolio company's ability to make payments and its earnings and discounted cash flows; and the markets in which the portfolio company does business. Investment performance data utilized are the most recently available financial statements and compliance certificates received from the portfolio companies as of the measurement date which in many cases may reflect a lag in information. The independent third-party valuation firm provides a fair valuation report, a description of the methodology used to determine the fair value and their analysis and calculations to support their conclusion.
When an external event such as a purchase transaction, public offering or subsequent sale or paydown occurs, we use the pricing indicated by the external event to corroborate our valuation.
U.S. GAAP establishes a hierarchical disclosure framework which ranks the level of observability of market price inputs used in measuring investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment and the characteristics specific to the investment and state of the marketplace, including the existence and transparency of transactions between market participants. Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets generally have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. W e review pricing and methodologies in order to determine if observable market information is being used, versus unobservable inputs.
102


Our accounting policy on the fair value of our investments is critical because the determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of these valuations, and any change in these valuations, on the consolidated financial statements.
For more information on the fair value hierarchies, our framework for determining fair value and the composition of our portfolio see Note 4 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report Form 10-Q.
Revenue Recognition
Our revenue recognition policies are as follows:
Net realized gains (losses) on investments: Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method.
Investment Income: Interest income, including amortization of premium and accretion of discount on loans are recorded on the accrual basis. We accrue interest income based on the effective yield if we expect that, ultimately, we will be able to collect such income. We may have loans in our portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.
Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with our investment activities as well as any fees for managerial assistance services rendered by us to our portfolio companies. Such fees are recognized as income when earned or the services are rendered.
Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.
Non-accrual: Generally, if a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments, the Sub-Adviser will place the loan on non-accrual status and we will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible even though we remain contractually entitled to this interest. We may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated.
U.S. Federal Income Taxes
We have elected to be treated as a BDC under the 1940 Act. We have elected, and intend to qualify annually thereafter, to be treated as a RIC under the Code. So long as we maintain our qualification as a RIC, we generally will not be subject to U.S. federal income or excise taxes on any ordinary income or capital gains that we timely distribute at least annually to our stockholders as dividends. As a result, any tax liability related to income earned and distributed by us represents obligations of our stockholders and will not be reflected in our consolidated financial statements.
We evaluate tax positions taken or expected to be taken in the course of preparing our financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reversed and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. As of September 30, 2024, the Company did not have any uncertain tax positions that met the recognition or measurement criteria, nor did the Company have any unrecognized tax benefits.
Our accounting policy on income taxes is critical because if we are unable to maintain our status as a RIC, we would be required to record a provision for U.S. federal income taxes which may be significant to our financial results.
103


Recent Developments
On October 4, 2024, we entered into a second amendment (the “Second Amendment”) to the Revolving Credit Facility, among the Company, as borrower, the lenders and issuing banks from time to time party thereto, SMBC, as administrative agent and sole bookrunner, and SMBC and Wells Fargo as joint lead arrangers. The Second Amendment, among other things, (x) added a term loan tranche, (y) increased the total committed facility amount from $250 million to $325 million and (z) reduced (i) the applicable margin from 2.125% to 2.00% and (ii) the credit spread adjustment from 0.15% to 0.10% for Term SOFR borrowings with a three-month tenor and from 0.25% to 0.10% for Term SOFR borrowings with a six-month tenor.
On October 29, 2024, the Board, including all of the Independent Directors, approved the renewal of each Advisory Agreement in accordance with, and on the basis of, an evaluation satisfactory to such directors as required by the 1940 Act for an additional one-year term expiring on December 1, 2025.
On November 4, 2024, the Board declared a fourth quarter regular dividend of $0.45 per share payable on or around January 28, 2025 to shareholders of record as of December 31, 2024.
On November 5, 2024, the Company terminated in full the SMBC Financing Facility Agreement, dated as of November 24, 2020, and the SMBC Financing Facility thereunder. In connection with the termination of the SMBC Financing Facility, the Company also terminated the security interest over the collateral granted to SMBC and the lenders pursuant to the SMBC Financing Facility Agreement. The SMBC Financing Facility was terminated concurrent with the satisfaction of all obligations and liabilities of the Company to the lenders thereunder, including, without limitation, payments of principal and interest, other fees, breakage costs and other amounts owing to the lenders.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Uncertainty with respect to, among other things, elevated interest rates, inflationary pressures, the ongoing conflict between Russia and Ukraine, the ongoing war in the Middle East, and the failure of major financial institutions introduced significant volatility in the financial markets, and the effects of this volatility has materially impacted and could continue to materially impact our market risks, including those listed below.
Valuation Risk
We have invested, and plan to continue to invest, primarily in illiquid debt and equity securities of private companies. Most of our investments do not have a readily available market price, and we value these investments at fair value as determined in good faith by the Adviser, as the Valuation Designee, in accordance with our valuation policy subject to the oversight of the Board and, based on, among other things, the input of the independent third-party valuation firms engaged by the Valuation Designee. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.
Interest Rate Risk
We are subject to interest rate risk. Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, variability of spread relationships, the difference in re-pricing internals between our assets and liabilities and the effect that interest rates may have on our cash flows. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. Our net investment income is also affected by fluctuations in various interest rates, including the replacement of LIBOR with alternate rates and prime rates, to the extent our debt investments include floating interest rates. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.
On September 18, 2024, the Federal Reserve cut its benchmark interest rate for the first time in four years by 0.50%, bringing it to the 4.75% to 5.00% range. Although, the Federal Reserve has signaled in favor of cutting its benchmark rates again in the fourth quarter of 2024 they still remain focused on mitigating inflationary pressures, and there can be no assurance that the Federal Reserve will continue to make downward adjustments to the federal funds rate in the future. Additionally, there can be no assurance that the Federal Reserve will not make upward adjustments to the federal funds rate in the future. In a high interest rate environment, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve's tightening cycle could result the United States into a recession, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR or other alternate rates, are not offset by corresponding increases in the spread over such base rate that we earn on any portfolio investments, a decrease in our operating expenses, or a decrease in the interest rate associated with our borrowings.
104


As of September 30, 2024, on a fair value basis, approximately 5.75% of our debt investments bear interest at a fixed rate and approximately 94.25% of our debt investments bear interest at a floating rate. As of September 30, 2024, 99.59% of our floating rate debt investments are subject to interest rate floors. Our credit facilities along with our debt issued in our collateralized loan obligations are predominantly subject to floating interest rates and are currently paid based on floating SOFR rates.
The following table estimates the potential changes in net cash flow generated from interest income and expenses, should interest rates increase or decrease by 100, 200 or 300 basis points. Interest income is calculated as revenue from interest generated from our portfolio of investments held on September 30, 2024. Interest expense is calculated based on the terms of the credit facilities and the collateralized loan obligations using the outstanding balance as of September 30, 2024. Interest expense on the credit facilities and the debt issued in our collateralized loan obligations is calculated using the interest rate as of September 30, 2024, adjusted for the impact of hypothetical changes in rates, as shown below. The base interest rate case assumes the rates on our portfolio investments remain unchanged from the actual effective interest rates as of September 30, 2024.
Actual results could differ significantly from those estimated in the table (dollars amounts in thousands).
Changes in Interest Rates Interest Income Interest Expense Net Income
-300 Basis Points $ (43,143) $ (24,817) $ (18,326)
-200 Basis Points $ (28,773) $ (16,545) $ (12,228)
-100 Basis Points $ (14,387) $ (8,272) $ (6,115)
+100 Basis Points $ 14,387 $ 8,272 $ 6,115
+200 Basis Points $ 28,773 $ 16,545 $ 12,228
+300 Basis Points $ 43,160 $ 24,817 $ 18,343

105


ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
In accordance with Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.
Based on that evaluation, we, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of September 30, 2024 and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
Changes in Internal Controls Over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

106


PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS

We, and our consolidated subsidiaries, the Adviser and the Sub-Adviser are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us or them. From time to time, we, our consolidated subsidiaries and/or the Adviser and Sub-Adviser may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business also is subject to extensive regulation, which may result in regulatory proceedings against us.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors previously disclosed under Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2023. For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on February 27, 2024, which is accessible on the SEC’s website at sec.gov.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Sales of Unregistered Securities
Except as previously reported by us on our Current Reports on Form 8-K, we did not sell any securities during the period covered by this Quarterly Report on Form 10-Q that were not registered under the Securities Act of 1933, as amended.
Issuer Purchases of Equity Securities
On March 5, 2024, the Company entered into a share repurchase plan (the “Company 10b5-1 Plan”), pursuant to which the Company may purchase up to $99,275 in the aggregate of its outstanding shares of common stock in the open market at prices below its NAV per share over a specified period. Any purchase of the shares pursuant to the Company 10b5-1 Plan will be conducted in accordance with the guidelines and conditions of Rule 10b-18 and Rule 10b5-1 of the Exchange Act. The Company adopted the Company 10b5-1 Plan because it believes that, if its common stock is trading below its then-current NAV per share, it will be in the best interest of its stockholders for the Company to reinvest in its portfolio.

The Company 10b5-1 Plan is designed to allow the Company to repurchase its shares of common stock at times when the Company otherwise might be prevented from doing so under insider trading laws. The Company 10b5-1 Plan requires BofA Securities, Inc., as agent, to repurchase shares of common stock on the Company's behalf when the market price per share is below the most recently reported NAV per share (including any updates, corrections or adjustments publicly announced by the Company to any previously announced NAV per share). Under the Company 10b5-1 Plan, the agent will increase the volume of purchases made as the price of the shares of the Company's common stock declines, subject to volume restrictions. The timing and amount of any share repurchases will depend on the terms and conditions of the Company 10b5-1 Plan, the market price of the shares of the Company's common stock and trading volumes, and no assurance can be given that any particular amount of shares of the common stock will be repurchased.

The purchase of shares of common stock pursuant to the Company 10b5-1 Plan is intended to satisfy the conditions of Rule 10b5-1 and Rule 10b-18 under the Exchange Act, and will otherwise be subject to applicable law, including Regulation M, which may prohibit purchases under certain circumstances.

The Company 10b5-1 Plan became effective on March 29, 2024 and commenced on April 1, 2024. The 10b5-1 Plan will terminate upon the earliest to occur of (i) 12-months from the effective date (tolled for periods during which the Company 10b5-1 Plan is suspended), (ii) the end of the trading day on which the aggregate purchase price for all shares of common stock purchased under the Company 10b5-1 Plan equals $99,275 and (iii) the occurrence of certain other events described in the Company 10b5-1 Plan.

107


The following table reflects the shares repurchased pursuant to the Company 10b5-1 Plan for each month from inception through September 30, 2024 (dollar amounts in thousands, except per share data):

Period Total Number of Shares Repurchased Average Price Paid per Share Approximate Dollar Value of Shares that have been Purchased Under the Plan Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
April 1, 2024 - April 30, 2024 104,075 $ 17.57 $ 1,828 $ 97,447
May 1, 2024 - May 31, 2024 96,598 $ 17.56 1,696 95,751
June 1, 2024 - June 30, 2024 91,637 $ 17.73 1,625 94,126
July 1, 2024 - July 31, 2024 75,675 $ 17.61 1,333 92,793
August 1, 2024 - August 31, 2024 154,668 $ 17.24 2,666 90,127
September 1, 2024 - September 30, 2024 109,150 $ 17.69 1,931 88,196
Total 631,803 $ 11,079
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.
ITEM 5. OTHER INFORMATION

(a) Item 1.02. Termination of a Material Definitive Agreement.

On November 5, 2024, the Company terminated in full the senior secured revolving credit facility (the “SMBC Financing Facility” and the agreement relating thereto the “SMBC Financing Facility Agreement”), with Sumitomo Mitsui Banking Corporation ("SMBC"), as the administrative agent, the collateral agent and the lender, dated as of November 24, 2020. In connection with the termination of the SMBC Financing Facility, the Company also terminated the security interest over the collateral granted to SMBC and the lenders pursuant to the SMBC Financing Facility Agreement. The SMBC Financing Facility was terminated concurrent with the satisfaction of all obligations and liabilities of the Company to the lenders thereunder, including, without limitation, payments of principal and interest, other fees, breakage costs and other amounts owing to the lenders.
(b) None.

(c) For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company has entered into any (i) contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.
108


ITEM 6. EXHIBITS
3.1
3.2
3.3
3.4
4.1
4.2
10.1
10.2
31.1
31.2
32
101.INS Inline XBRL Instance Document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Filed herewith.
(1) Previously filed on January 29, 2020 with Amendment No. 1 to the Company’s Registration Statement on Form 10 (File No. 000-56133) and incorporated by reference herein.
(2) Previously filed on June 2, 2020 with the Company's Current Report on Form 8-K and incorporated by reference herein.
(3) Previously filed on September 3, 2024 with the Company's Current Report on Form 8-K and incorporated by reference herein.
(4) Previously filed on October 8, 2024 with the Company's Current Report on Form 8-K and incorporated by reference herein.


109


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Nuveen Churchill Direct Lending Corp.
By: /s/ Kenneth Kencel
Name: Kenneth Kencel
Title: President and Chief Executive Officer
By: /s/ Shai Vichness
Name: Shai Vichness
Title: Chief Financial Officer and Treasurer
Date: November 6, 2024

110
TABLE OF CONTENTS
Part I. Financial InformationItem 1. Consolidated Financial Statements (unaudited)Item 2. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 1. 02. Termination Of A Material Definitive AgreementItem 6. Exhibits

Exhibits

3.1 Articles of Amendment and Restatement(1) 3.2 Articles of Amendment(2) 3.3 Bylaws(2) 3.4 Certificate of Merger of Churchill Middle Market CLO V Ltd.(1) 4.1 Form of Subscription Agreement(1) 4.2 Form of Stock Certificate(1) 10.1 Fifth Amendment to the Amended and Restated Loan and Security Agreement, dated August 27, 2024, by and among Nuveen Churchill BDC SPV V, LLC, as borrower, Nuveen Churchill Direct Lending Corp., as the collateral managerand equity investor, and Wells Fargo Bank, National Association,as administrative agent and a lender.(3) 10.2 Amendment No. 2 toSenior Secured Revolving Credit Agreement, dated as of October 4, 2024, by and among Nuveen Churchill Direct Lending Corp., as borrower, NCDL Equity HoldingsLLC, as subsidiary guarantor, the issuing banks party thereto, and Sumitomo Mitsui Banking Corporation, as administrative agent.(4) 31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended* 31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended* 32 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended*